
<html lang="en"     class="pb-page"  data-request-id="2750987e-46b2-46cf-bf79-c0de5e4f866f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.9b00533;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-20;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases" /></meta><meta name="dc.Creator" content="Jordi  Bach" /></meta><meta name="dc.Creator" content="Paul  Eastwood" /></meta><meta name="dc.Creator" content="Jacob  González" /></meta><meta name="dc.Creator" content="Elena  Gómez" /></meta><meta name="dc.Creator" content="Juan Antonio  Alonso" /></meta><meta name="dc.Creator" content="Silvia  Fonquerna" /></meta><meta name="dc.Creator" content="Estrella  Lozoya" /></meta><meta name="dc.Creator" content="Adela  Orellana" /></meta><meta name="dc.Creator" content="Mónica  Maldonado" /></meta><meta name="dc.Creator" content="Elena  Calaf" /></meta><meta name="dc.Creator" content="Joan  Albertí" /></meta><meta name="dc.Creator" content="Juan  Pérez" /></meta><meta name="dc.Creator" content="Ana  Andrés" /></meta><meta name="dc.Creator" content="Neus  Prats" /></meta><meta name="dc.Creator" content="Cristina  Carreño" /></meta><meta name="dc.Creator" content="Elena  Calama" /></meta><meta name="dc.Creator" content="Jorge  De Alba" /></meta><meta name="dc.Creator" content="Marta  Calbet" /></meta><meta name="dc.Creator" content="Montserrat  Miralpeix" /></meta><meta name="dc.Creator" content="Isabel  Ramis" /></meta><meta name="dc.Description" content="Janus kinases (JAKs) have a key role in regulating the expression and function of relevant inflammatory cytokines involved in asthma and chronic obstructive pulmonary disease. Herein are described ..." /></meta><meta name="Description" content="Janus kinases (JAKs) have a key role in regulating the expression and function of relevant inflammatory cytokines involved in asthma and chronic obstructive pulmonary disease. Herein are described ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 14, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00533" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00533" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00533" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00533" /></link>
        
    
    

<title>Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00533" /></meta><meta property="og:title" content="Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0025.jpeg" /></meta><meta property="og:description" content="Janus kinases (JAKs) have a key role in regulating the expression and function of relevant inflammatory cytokines involved in asthma and chronic obstructive pulmonary disease. Herein are described the design, synthesis, and pharmacological evaluation of a series of novel purinone JAK inhibitors with profiles suitable for inhaled administration. Replacement of the imidazopyridine hinge binding motif present in the initial compounds of this series with a pyridone ring resulted in the mitigation of cell cytotoxicity. Further systematic structure–activity relationship (SAR) efforts driven by structural biology studies led to the discovery of pyridone 34, a potent pan-JAK inhibitor with good selectivity, long lung retention time, low oral bioavailability, and proven efficacy in the lipopolysaccharide-induced rat model of airway inflammation by the inhaled route." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00533"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00533">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00533&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00533&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00533&amp;href=/doi/10.1021/acs.jmedchem.9b00533" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 9045-9060</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00294" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00607" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jordi Bach</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jordi Bach</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry & Screening, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#751f1a07111c5b1714161d351419181c071419195b161a18"><span class="__cf_email__" data-cfemail="f69c9984929fd89497959eb6979a9b9f84979a9ad895999b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jordi++Bach">Jordi Bach</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0449-0161" title="Orcid link">http://orcid.org/0000-0002-0449-0161</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul Eastwood</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Eastwood</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry & Screening, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Eastwood">Paul Eastwood</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jacob González</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jacob González</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry & Screening, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jacob++Gonz%C3%A1lez">Jacob González</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elena Gómez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elena Gómez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry & Screening, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elena++G%C3%B3mez">Elena Gómez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Juan Antonio Alonso</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juan Antonio Alonso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry & Screening, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juan+Antonio++Alonso">Juan Antonio Alonso</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Silvia Fonquerna</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Silvia Fonquerna</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry & Screening, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Fonquerna">Silvia Fonquerna</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Estrella Lozoya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Estrella Lozoya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry & Screening, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Estrella++Lozoya">Estrella Lozoya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adela Orellana</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adela Orellana</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry & Screening, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adela++Orellana">Adela Orellana</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mónica Maldonado</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mónica Maldonado</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry & Screening, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=M%C3%B3nica++Maldonado">Mónica Maldonado</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elena Calaf</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elena Calaf</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics & Metabolism, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Calaf">Elena Calaf</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joan Albertí</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joan Albertí</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics & Metabolism, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joan++Albert%C3%AD">Joan Albertí</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Juan Pérez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juan Pérez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Early Galenic Development, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juan++P%C3%A9rez">Juan Pérez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ana Andrés</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana Andrés</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pathology & Predictive Toxicology, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Andr%C3%A9s">Ana Andrés</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Neus Prats</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Neus Prats</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pathology & Predictive Toxicology, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Neus++Prats">Neus Prats</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cristina Carreño</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cristina Carreño</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Group, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Carre%C3%B1o">Cristina Carreño</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elena Calama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elena Calama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Group, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Calama">Elena Calama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jorge De Alba</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jorge De Alba</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Group, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jorge++De+Alba">Jorge De Alba</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marta Calbet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Calbet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Group, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Calbet">Marta Calbet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Montserrat Miralpeix</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Montserrat Miralpeix</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Group, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Montserrat++Miralpeix">Montserrat Miralpeix</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Isabel Ramis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isabel Ramis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory Therapeutic Group, Almirall R&D, Crta. Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isabel++Ramis">Isabel Ramis</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00533&amp;href=/doi/10.1021%2Facs.jmedchem.9b00533" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 9045–9060</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 14, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 March 2019</li><li><span class="item_label"><b>Published</b> online</span>14 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00533" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00533</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9045%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJordi%2BBach%252C%2BPaul%2BEastwood%252C%2BJacob%2BGonz%25C3%25A1lez%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D20%26contentID%3Dacs.jmedchem.9b00533%26title%3DIdentification%2Bof%2B2-Imidazopyridine%2Band%2B2-Aminopyridone%2BPurinones%2Bas%2BPotent%2BPan-Janus%2BKinase%2B%2528JAK%2529%2BInhibitors%2Bfor%2Bthe%2BInhaled%2BTreatment%2Bof%2BRespiratory%2BDiseases%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9060%26publicationDate%3DOctober%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00533"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3713</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00533" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jordi&quot;,&quot;last_name&quot;:&quot;Bach&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Eastwood&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;González&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Gómez&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;Antonio Alonso&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Fonquerna&quot;},{&quot;first_name&quot;:&quot;Estrella&quot;,&quot;last_name&quot;:&quot;Lozoya&quot;},{&quot;first_name&quot;:&quot;Adela&quot;,&quot;last_name&quot;:&quot;Orellana&quot;},{&quot;first_name&quot;:&quot;Mónica&quot;,&quot;last_name&quot;:&quot;Maldonado&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Calaf&quot;},{&quot;first_name&quot;:&quot;Joan&quot;,&quot;last_name&quot;:&quot;Albertí&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;Pérez&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Andrés&quot;},{&quot;first_name&quot;:&quot;Neus&quot;,&quot;last_name&quot;:&quot;Prats&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Carreño&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Calama&quot;},{&quot;first_name&quot;:&quot;Jorge&quot;,&quot;last_name&quot;:&quot;De Alba&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Calbet&quot;},{&quot;first_name&quot;:&quot;Montserrat&quot;,&quot;last_name&quot;:&quot;Miralpeix&quot;},{&quot;first_name&quot;:&quot;Isabel&quot;,&quot;last_name&quot;:&quot;Ramis&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;9045-9060&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00533&quot;},&quot;abstract&quot;:&quot;Janus kinases (JAKs) have a key role in regulating the expression and function of relevant inflammatory cytokines involved in asthma and chronic obstructive pulmonary disease. Herein are described the design, synthesis, and pharmacological evaluation of a series of novel purinone JAK inhibitors with profiles suitable for inhaled administration. Replacement of the imidazopyridine hinge binding motif present in the initial compounds of this series with a pyridone ring resulted in the mitigation of cell cytotoxicity. Further systematic structure–activity relationship (SAR) efforts driven by structural biology studies led to the discovery of pyridone 34, a potent pan-JAK inhibitor with good selectivity, long lung retention time, low oral bioavailability, and proven efficacy in the lipopolysaccharide-induced rat model of airway inflammation by the inhaled route.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00533&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00533" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00533&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00533" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00533&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00533" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00533&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00533&amp;href=/doi/10.1021/acs.jmedchem.9b00533" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00533" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00533" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00533%26sid%3Dliteratum%253Aachs%26pmid%3D31609613%26genre%3Darticle%26aulast%3DBach%26date%3D2019%26atitle%3DIdentification%2Bof%2B2-Imidazopyridine%2Band%2B2-Aminopyridone%2BPurinones%2Bas%2BPotent%2BPan-Janus%2BKinase%2B%2528JAK%2529%2BInhibitors%2Bfor%2Bthe%2BInhaled%2BTreatment%2Bof%2BRespiratory%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D20%26spage%3D9045%26epage%3D9060%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/jmcmar.2019.62.issue-20/20191024/jmcmar.2019.62.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Janus kinases (JAKs) have a key role in regulating the expression and function of relevant inflammatory cytokines involved in asthma and chronic obstructive pulmonary disease. Herein are described the design, synthesis, and pharmacological evaluation of a series of novel purinone JAK inhibitors with profiles suitable for inhaled administration. Replacement of the imidazopyridine hinge binding motif present in the initial compounds of this series with a pyridone ring resulted in the mitigation of cell cytotoxicity. Further systematic structure–activity relationship (SAR) efforts driven by structural biology studies led to the discovery of pyridone <b>34</b>, a potent pan-JAK inhibitor with good selectivity, long lung retention time, low oral bioavailability, and proven efficacy in the lipopolysaccharide-induced rat model of airway inflammation by the inhaled route.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05346" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05346" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Janus kinases (JAKs) are cytoplasmic protein tyrosine kinases associated with cytokine receptors. Following cytokine stimulation, JAKs phosphorylate signal transducers and activators of transcription (STAT), a family of transcription factors that dimerize, translocate to the nucleus, and activate gene transcription of inflammatory mediators. Four JAKs [namely, JAK1, 2, and 3, and tyrosine kinase 2 (Tyk2)] and seven STATs have been identified in the JAK–STAT pathway where different cytokine receptors are associated with specific combinations of paired JAKs (i.e., JAK1 and JAK3; JAK2 and JAK2) and STAT proteins.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7">(1−7)</a></div><div class="NLM_p">As JAKs are implicated in cell signaling processes that have a role in cancer as well as autoimmune and inflammatory diseases, enormous efforts have been devoted to the development of JAK inhibitors. As a consequence, several JAK inhibitors have progressed into clinical trials for the oral and topical treatment of myeloproliferative and autoimmune diseases and three of them, ruxolitinib (Incyte/Novartis), tofacitinib (Pfizer), and baricitinib (Incyte/Lilly), have reached the market for the oral treatment of myelofibrosis and rheumatoid arthritis.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> On the other hand, the potential use of JAK inhibitors for the treatment of inflammatory respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) has been far less explored. To the best of our knowledge, there are only three inhaled JAK inhibitors in preclinical studies: R256 from AstraZeneca/Rigel, a JAK1/3 inhibitor for moderate to severe asthma,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> and two pan-JAK inhibitors from Pfizer (PF-06263276)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and Vectura (VR588)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> for COPD and severe asthma, respectively.</div><div class="NLM_p">Most of the proinflammatory cytokines that play a critical role as orchestrators of the persistent inflammation observed in asthma and COPD such as interleukins IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-12, IL-13, IL-22, and IL-23, granulocyte-macrophage colony-stimulating factor (GM-CSF), and interferon γ signal through JAKs (JAK1, 2, and 3).<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> Therefore, a pan-JAK inhibitor blocking multiple cytokine signaling has the potential to be a broad anti-inflammatory therapy for the treatment of these respiratory diseases. Substantial experimental evidence supports a role for JAK–STAT signaling in airway inflammation. In several animal models of allergic asthma and COPD, it has been shown that different JAK inhibitors are efficacious reducing the airway inflammation by both the oral and inhaled routes.<a onclick="showRef(event, 'ref11 ref12 ref14 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref14 ref18 ref19 ref20 ref21">(11,12,14,18−21)</a> Moreover, in human studies, it has been reported that overexpression of pSTAT3 in COPD lung tissue relates to the degree of airway inflammation and that total STAT-6 expression is increased in the bronchial epithelium of asthma patients compared to controls.<a onclick="showRef(event, 'ref16 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref16 ref22 ref23 ref24">(16,22−24)</a></div><div class="NLM_p">Over the past few years, we have been interested in the development of inhaled pan-JAK inhibitors for the treatment of respiratory diseases with the main goal of developing a novel anti-inflammatory therapy with a favorable efficacy/safety ratio. Pan-JAK inhibition may have an additive effect on anti-inflammatory activity compared to JAK1/3 selective inhibitors as several relevant inflammatory mediators signal through JAK2 (i.e., IL-3, IL-5, and GM-CSF). On the other hand, systemic inhibition of JAK2 is associated with adverse effects such as thrombocytopenia, anemia, and hemoglobin reduction. In this sense, we selected the inhaled route of administration to avoid systemic exposure and limit the reported adverse effects observed in humans with oral JAK inhibitors.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Moreover, this strategy was supported by the fact that the majority of the target cells of JAK inhibitors are at the site of inflammation and that we and others have demonstrated that administration of JAK inhibitors by the inhaled route is also efficacious in animal models of asthma and COPD.<a onclick="showRef(event, 'ref11 ref14 ref20'); return false;" href="javascript:void(0);" class="ref ref11 ref14 ref20">(11,14,20)</a> As a result, our efforts have been devoted to the search for pan-JAK inhibitors with a suitable profile for inhaled administration. It has been reported that physicochemical properties such as basicity, polarity, and/or aqueous solubility can be used to modulate retention times in the lung and assist in finding the right balance between lung and systemic exposure.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In this context, many inhaled drugs have a long duration period in the lung due to their low aqueous solubility, which causes inhaled particles to slowly dissolve and be absorbed into the lung tissue.</div><div class="NLM_p last">Following a low dissolution rate strategy for lung retention, in this paper, we describe the design, synthesis, and pharmacological evaluation of a series of novel purinone JAK inhibitors bearing an imidazopyridine or pyridone moiety as hinge binder. This work has resulted in the identification of pyridone <b>34</b>, a potent pan-JAK inhibitor with a long lung retention time, low oral bioavailability, and proven efficacy in the lipopolysaccharide (LPS)-induced rat model of airway inflammation by the inhaled route.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The design of an imidazo[1,2-<i>a</i>]pyridine ring as hinge binder was inspired by PS-020613 (<b>1</b>), an early JAK3 inhibitor from Pharmacopeia (now Ligand Pharma) reported in the literature.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Docking studies with JAK3<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> suggested that the benzimidazole moiety would play a key role for the binding of <b>1</b> into the adenosine triphosphate (ATP) binding site of JAK enzymes. This structural motif would act as hinge binder through two interactions with two specific amino acids from the hinge region that are conserved among the different members of the JAK family: a classical hydrogen bond between the benzimidazole nitrogen and backbone NH of a leucine and a noncanonical interaction between a heteroaromatic hydrogen atom and the oxygen of the carbonyl group of a glutamic acid (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The presence of electron-withdrawing groups (i.e., a fluorine atom) attached to the benzimidazole core was contemplated as a way to improve the nonclassical interaction by increasing heteroaromatic H atom acidity. The chromane ring of <b>1</b> was postulated to fill a lipophilic pocket in the active site, whereas the purinone core would act as an optimal spacer keeping the appropriate distance between the hinge and lipophilic pocket moieties. The purinone ring might also have additional hydrophobic interactions with alkylic residues from amino acids located at the binding site. Nevertheless, the presence of the benzimidazole hinge binder was perceived as a concern for the chemical (and metabolic) stability of this compound as it could potentially act as leaving group via initial attack of a nucleophile on the purinone ring. Changing the hinge binder motif to an imidazo[1,2-<i>a</i>]pyridine ring as in compound <b>2</b> would prevent such potential instability.<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29−31)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Novel Purinone JAK Inhibitor <b>2</b> Bearing an Imidazo[1,2-<i>a</i>]pyridine Ring as Hinge Binder Motif</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Initial hit <b>2</b> showed a similar profile of JAK inhibition to benzimidazole <b>1</b>, with potency against JAK2 and JAK3 in the low nanomolar range and somewhat less potent against JAK1 (IC<sub>50</sub> = 24 nM), demonstrating that the proposed hinge binder replacement was well tolerated in terms of JAK activities. Unfortunately, compound <b>2</b> also proved to be cytotoxic in the cytotoxicity assay performed in Chinese hamster ovary (CHO) cells [IC<sub>50</sub> (CHO) = 4 μM]. Based on these findings, two main goals were initially defined to improve the overall profile of <b>2</b>: (1) to increase JAK1 potency to identify truly pan-JAK inhibitors and (2) to reduce cytotoxicity to the desired level for a clinical candidate [IC<sub>50</sub> (CHO) > 30 μM].</div><div class="NLM_p">Expansion toward the solvent-exposed region was first explored to improve JAK1 potency by targeting new interactions with amino acids in this area. Docking studies performed with <b>2</b> led to the identification of glutamic acid 966 (Glu966) in JAK1 as an ideal target amino acid due to its proximity to the imidazolone ring and potential for forming ionic and hydrogen-bond interactions through the carboxylic acid side chain. As the equivalent amino acid in both JAK2 and JAK3 is aspartic acid (Asp939 and Asp912 respectively), this approach could also be employed to improve JAK2 and JAK3 potencies as well. Docking studies also suggested that Glu966 could be easily accessed through functionalization of the imidazolone NH, with a two-carbon chain as optimal spacer for the introduction of heteroatoms to reach the targeted interactions with the carboxylic acid. To test the hypothesis, a simple tetrahydropyran ring was used as a lipophilic pocket filling group and several functionalities with potential for forming hydrogen-bond interactions were introduced onto the imidazolone core, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. In this initial structure–activity relationship (SAR) study, replacement of the fluorine atom of the hinge binder moiety by a more bulky electron-withdrawing cyano group was also evaluated.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Imidazopyridine Analogues: Solvent-Exposed Region SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0019.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0020.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">Unsubstituted analogues <b>3</b> and <b>4</b> were first synthesized revealing that replacement of fluorine by a nitrile group had no impact on JAK inhibition as both molecules showed a similar profile of moderate JAK potencies. Interestingly, the introduction of a methyl group onto the imidazolone core (compound <b>5</b>) was well tolerated in terms of JAK2 and JAK3 potencies but resulted in a dramatic loss of JAK1 potency with respect to unsubstituted compound <b>3</b>. This loss of JAK1 potency was partially recovered while maintaining JAK2 and JAK3 potencies when a hydroxyethyl side chain was introduced (compounds <b>6</b> and <b>7</b>). JAK1 potency was lost again when <b>6</b> was converted into the corresponding methyl ether <b>8</b>, suggesting a role for the hydroxyl group in JAK1 inhibition. Further modifications of <b>6</b> such as introduction of an additional hydroxyl group (compounds <b>9</b> and <b>10</b>) or replacement of the primary alcohol by a tertiary alcohol (compound <b>11</b>) failed to improve JAK potencies. The scope of solvent-exposed groups was then expanded to basic side chains, but, unfortunately, tertiary amines <b>12</b> and <b>13</b> showed poor inhibitory potency against JAK2 and JAK3 and were inactive against JAK1. In summary, imidazolone functionalization to target new interactions with solvent-exposed amino acids (JAK1 Glu966, JAK2 Asp939, and JAK3 Asp912) failed to improve potency against JAK2 and JAK3 and was detrimental to JAK1 potency.</div><div class="NLM_p">Inhibition of STAT-6 phosphorylation induced by IL-4 in human Ramos cells was used to assess JAK1/3 cellular potency of selected compounds from this series. Although both molecules were equipotent in JAK enzymatic assays, fluoro derivative <b>4</b> proved to be 3-fold more potent than the corresponding cyano analogue <b>3</b> (IC<sub>50</sub> = 350 and 1100 nM, respectively) in this cellular assay.</div><div class="NLM_p">To understand the results obtained, compound <b>6</b> was selected for structural biology studies. At this time point in the project, it was not feasible to obtain the X-ray crystallographic structure of human JAK1 with <b>6</b>, but we were successful in solving the co-crystal structure of this inhibitor with JAK3 at a resolution of 2.5 Å (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The postulated binding mode was confirmed for this series of inhibitors with the tetrahydropyran ring occupying the lipophilic pocket and the imidazopyridine moiety acting as hinge binder through a classical hydrogen bond with backbone NH of Leu905 and a noncanonical interaction with the backbone carbonyl oxygen of Glu903. As expected, the purinone core acts as a spacer between the hinge and lipophilic pocket moieties and has no hydrogen-bond interactions with the enzyme. The co-crystal structure also confirmed the targeted interaction between the hydroxylated side chain of <b>6</b> and the carboxylic acid chain of solvent-exposed Asp912. Moreover, the hydroxyl group of <b>6</b> also showed an additional hydrogen-bond interaction with the backbone NH of cysteine 909. Despite these two additional interactions with solvent-exposed amino acids, no increase in JAK3 potency compared to unsubstituted compound <b>3</b> was seen. Regarding JAK1, it seems feasible that the targeted interaction with Glu966 could be achieved with molecules bearing a hydroxyl group (compounds <b>6</b>, <b>7</b>, and <b>9</b>–<b>11</b> in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), but the dramatic loss of potency observed in molecules devoid of hydrogen-bond donors (compounds <b>5</b>, <b>8</b>, <b>12</b>, and <b>13</b>) could not be explained at this point.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0001.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystallographic structure of human JAK3 binding site in complex with <b>6</b> determined at 2.5 Å resolution [Protein Data Bank (PDB) entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZV">6HZV</a>]. For clarity, only interacting amino acids are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A more successful approach to improve JAK1 potency was based on expanding the SAR in the lipophilic pocket (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). For this SAR expansion exercise, 6-fluoroimidazopyridine was fixed as hinge binder due to the higher cellular potency observed for fluoro derivative <b>4</b> compared to cyano analogue <b>3</b>. Initial efforts were focused on modifying the tetrahydropyran ring of <b>4</b> to improve JAK activities. Although dimethyl substitution (compound <b>14</b>) and extrusion of the oxygen atom to give secondary and tertiary alcohols <b>15</b> and <b>16</b> improved on results obtained with <b>4</b>, the JAK potency profile of chromane <b>2</b> was not recovered. Taking into account that removal of the aromatic ring of <b>2</b> to yield <b>4</b> resulted in an important loss of JAK potencies and extrusion of the oxygen atom of the tetrahydropyran (THP) ring improved potency (compound <b>15</b>), alcohol <b>17</b> was designed and synthesized, and proved to be equipotent to <b>2</b>. Keeping in mind that the co-crystal structure of JAK3 with <b>6</b> unveiled that the tetrahydropyran oxygen is not involved in any key interactions with amino acids in the lipophilic pocket, a series of more flexible monocyclic compounds were explored (compounds <b>18</b>–<b>21</b>). Phenylethyl analogues <b>18</b> and <b>19</b> highlighted the importance of the absolute configuration of the chiral center on JAK potencies as <b>19</b>, having the same (R)-configuration as chromane <b>2</b>, proved to be at least 100-fold more potent against all JAKs than its enantiomer <b>18</b>. Results obtained with <b>19</b>, a molecule with a similar JAK inhibition profile to <b>2</b>, confirmed that the chromane oxygen is not essential for JAK potency. Encouraged by these results, an exhaustive SAR exploration of the aromatic ring was performed (data not shown) leading to the identification of pyridine <b>20</b> and pyrimidine <b>21</b> as both potent and balanced pan-JAK inhibitors. Both compounds fulfilled the defined goal in terms of JAK potencies, but cytotoxicity observed with these two molecules prevented them from further progression.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Imidazopyridine Analogues: Lipophilic Pocket SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0021.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0022.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">Since all potent analogues synthesized up to this point proved to be cytotoxic [IC<sub>50</sub> (CHO) < 10 μM], further SAR expansion around the lipophilic pocket was not perceived as an approach that would solve this issue. Varying the hinge binder motif was thus explored as a possible way to mitigate cytotoxicity. In this context, cytotoxicity could be overcome without dramatically affecting JAK potencies when a more polar aminopyridone scaffold was introduced as a hinge binding group. This scaffold was conceptualized as a truncated analogue of the imidazopyridine ring that would keep key interactions with amino acids Leu and Glu in the hinge region through two classical hydrogen bonds, as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The pyridone carbonyl group could act as hydrogen-bond acceptor with the backbone NH of leucine, whereas the pyridone NH could act as hydrogen-bond donor with the backbone carbonyl of the glutamic acid.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Novel Purinone JAK Inhibitors Bearing an Aminopyridone Ring as Hinge Binder</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analogues of potent imidazopyridine derivatives <b>2</b>, <b>17</b>, and <b>20</b> bearing an unsubstituted aminopyridone hinge binder were first synthesized (compounds <b>22</b>, <b>27</b>, and <b>28</b>) revealing a remarkable improvement in cytotoxicity for all cases, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Compared to the corresponding imidazopyridine analogues, chromane <b>22</b> proved to be equipotent, whereas a decrease in JAK potencies was observed for the other two molecules: moderate for alcohol <b>27</b>, more pronounced for fluoropyridine <b>28</b>. The impact of pyridone substitution on JAK potencies was then evaluated. Based on docking studies, introduction of small groups at the 5-position of the pyridone ring was explored. Regarding chromane derivatives, an improvement in JAK enzymatic and cellular potencies while keeping cytotoxicity at the desired level was achieved with the incorporation of electron-withdrawing groups such as halogen atoms (compounds <b>23</b> and <b>24</b>) at this position. On the other hand, an important decrease of JAK1 potency was observed for the methyl and methoxy derivatives <b>25</b> and <b>26</b>. A similar effect on JAK potencies was observed when halogen atoms were introduced at the pyridone hinge binder of molecules bearing the chiral fluoropyridine instead of the chromane ring (compounds <b>29</b> and <b>30</b>). For both lipophilic pocket groups, the presence of a chlorine atom in the 5-position of the pyridone ring provided the best results in terms of cellular potency in the JAK1/3 IL-4/STAT-6 Ramos assay. At this point, SAR studies varying the lipophilic pocket moiety were expanded taking advantage of reported co-crystal structures of tofacitinib with the four members of the JAK family.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> In this sense, compounds <b>31</b> and <b>34</b> were designed to position a cyano group toward the glycine-rich loop region, mimicking tofacitinib’s cyanoacetamide (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Although both molecules proved to be potent and noncytotoxic pan-JAK inhibitors, they exhibited a different behavior when tested in the cellular assay. While cyclohexane derivative <b>34</b> was the most potent compound identified in this series, chiral piperidine <b>31</b> suffered from poor cellular potency. Dramatic differences in permeability observed for these two compounds in the parallel artificial membrane permeability (PAMPA) assay (<i>P</i><sub>app</sub> = 0.03 × 10<sup>–6</sup> cm/s for <b>31</b>; 0.61 × 10<sup>–6</sup> cm/s for <b>34</b>) likely account for the difference seen in the cellular assay. The corresponding enantiomer of <b>31</b> was synthesized (compound <b>33</b>), which resulted in a drop of potency in all JAKs. With the aim of increasing cellular potency, a chlorine atom was now introduced onto the pyridone ring of <b>31</b> and <b>34</b>. Unfortunately, chlorinated compounds <b>32</b> and <b>35</b> failed to improve the overall profile of JAK enzymatic and cellular potencies compared to the corresponding unsubstituted analogues.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0002.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlapping studies with compounds <b>31</b> (pink), <b>34</b> (blue), and tofacitinib (green) showing similar arrangement of nitrile group in all of the cases and also carbonyl disposition of amides in <b>31</b> and tofacitinib.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Aminopyridones: Hinge Binder and Lipophilic Pocket SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0023.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0024.gif" alt="" id="fx6" /></img><div></div></div><div class="NLM_p">Among the most potent pyridones identified, compound <b>34</b> was selected for structural biology studies with JAK1. Compound <b>34</b> was successfully co-crystallized with human JAK1 at a 2.5 Å resolution (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), and the relevant structural information obtained from these studies provided a better understanding of JAK1 SAR. The expected binding mode for this family of inhibitors was confirmed with the pyridone ring acting as a hinge binding motif through two classical hydrogen-bond interactions with the backbone carbonyl group of Glu957 and the backbone NH of Leu959. Interestingly, the co-crystal structure unveiled an unexpected hydrogen-bonding interaction between the imidazolone NH and the carboxylic acid side chain of solvent-exposed Glu966, the amino acid that was selected as a target for possible interactions in early SAR studies (vide supra). This additional interaction would be lost in molecules where the imidazolone ring is substituted (e.g., methyl derivative <b>5</b>), resulting in the observed loss of JAK1 potency, which can be partially recovered in compounds that bear a hydrogen-bond donor as part of the solvent-exposed group. As expected, the cyano group present in <b>34</b> does not have any additional hydrogen-bond interaction but is filling a cavity in the lipophilic pocket region, in proximity to the glycine loop.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0003.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystallographic structure of human JAK1 binding site complexed with compound <b>34</b> determined at 2.2 Å resolution (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZU">6HZU</a>). For clarity, only interacting amino acids are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Due to a balanced profile of JAK enzymatic potencies and remarkable cellular potency in the JAK1/3 assay, compound <b>34</b> was selected for further profiling. Regarding additional enzymatic assays, <b>34</b> was found to be less potent against Tyk2 (IC<sub>50</sub> = 130 nM) and showed promising selectivity in a panel of 36 human kinases, which included targets commonly inhibited by JAK inhibitors (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In this study, performed at Millipore, only Aurora-A, FGFR1, Flt4, Ret, and TrkA were inhibited >75% at a compound concentration of 10 μM and were identified as potential off-target activities.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0004.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Heat map showing the kinase inhibition profile of <b>34</b> dosed at 10 μM against a panel of 38 kinases at [ATP] = <i>K</i><sub>m</sub>. Colors correspond to % inhibition of a given kinase as shown in the legend.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">JAK2/2 cellular activity of <b>34</b> was assessed by measuring the inhibition of phosphorylation of STAT-5 in monocytes isolated from human peripheral blood mononuclear cells stimulated with GM-CSF and resulted in a 5-fold drop of potency compared to JAK1/3 cellular activity (IC<sub>50</sub> = 219 nM). In the search for nonkinase off-target activities, compound <b>34</b> showed weak activity against potassium (hERG), sodium (Nav<sub>1.5</sub>), and calcium (Cav<sub>1.2</sub>) ion channels (less than 15% inhibition when tested at a 10 μM concentration), indicating a low potential to cause cardiovascular side effects. In addition, <b>34</b> also proved to be clean when tested at a 10 μM concentration against a panel of 55 diverse G protein-coupled receptors, transporters, and ion channels (Cerep ExpresSProfile). Furthermore, <b>34</b> was not genotoxic in exploratory Ames and GreenScreen HC testing.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">In terms of physicochemical properties, compound <b>34</b> has moderate lipophilicity (Log <i>D</i><sub>7.4</sub> = 2.1) and excellent chemical stability at all pHs tested (pH = 1.2, 5.5, 7.4, and 9.0). Despite its poor solubility at physiological pH (pH=7.4; 0 mg/mL), <b>34</b> showed sufficient solubility in various formulations used for in vivo testing and its high melting point (319–332 °C) allows this molecule to be micronized for potential use in a dry powder inhaler.</div><div class="NLM_p">The absorption, distribution, metabolism, and excretion properties of <b>34</b> were also investigated and are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. In vitro, <b>34</b> showed moderate permeability in the PAMPA assay (<i>P</i><sub>app</sub> = 0.61 × 10<sup>–6</sup> cm/s), moderate plasma protein binding (PPB, 79% in rat; 83% in human), and low metabolism in liver microsomes (17% rat; 21% human). To evaluate the suitability of <b>34</b> for inhaled delivery in the in vivo animal model, both oral and intratracheal (it) pharmacokinetic (PK) studies were performed in rat. Interestingly, a low oral bioavailability was observed for <b>34</b> as very low levels of compound were found in plasma after per os (po) administration of a 30 mg/kg dose (AUC<sub>inf</sub> = 32 ng h/mL; <i>C</i><sub>max</sub> = 7 ng/mL). Moreover, <b>34</b> was well retained in the lung when administered intratracheally as a nanosuspension at a 0.41 mg/kg dose (<i>t</i><sub>1/2</sub> = 16.3 h) and showed an excellent lung/plasma partition (11 364) ideal for inhaled administration (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0005.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Pharmacokinetic profile of <b>34</b> after intratracheal administration as a nanosuspension.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro and in Vivo Profiles of Compound <b>34</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">in vitro</th><th class="rowsep1 colsep0" colspan="2" align="center">in vivo</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center">PAMPA</th><th class="colsep0 rowsep0" align="center">% PPB</th><th class="colsep0 rowsep0" align="center">% metabolism (LM)</th><th class="colsep0 rowsep0" align="center">po PK (rat), 30 mg/kg</th><th class="colsep0 rowsep0" align="center">it PK (rat), 0.41 mg/kg nanosuspension</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">value</td><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> = 0.61 × 10<sup>–6</sup> cm/s</td><td class="colsep0 rowsep0" align="left">79 (R)</td><td class="colsep0 rowsep0" align="left">17 (R)</td><td class="colsep0 rowsep0" align="left">AUC<sub>inf</sub> = 32 ng h/mL</td><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> = 16.3 h; AUC<sub>lung</sub> = 1341 μg h/g</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">83 (H)</td><td class="colsep0 rowsep0" align="left">21 (H)</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> = 7 ng/mL</td><td class="colsep0 rowsep0" align="left">AUC<sub>plasma</sub> = 118 ng h/mL; AUC<sub>lung</sub>/AUC<sub>plasma</sub> = 11 364</td></tr></tbody></table></div></div><div class="NLM_p">Due to a favorable pharmacokinetic profile for inhaled administration, compound <b>34</b> was further progressed to an acute model of inhaled lipopolysaccharide (LPS)-induced airway inflammation in rats. In this model, rats were exposed to an aerosol of LPS that induces an increase of neutrophils in bronchoalveolar lavage fluid (BALF) that peaks after 4 h of LPS challenge. Further study of BALF shows an increase of several cytokines that signal through the JAK–STAT pathway, such as IL-6.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Compound <b>34</b> was administered intratracheally as an aerosolized nanosuspension, using phosphate-buffered saline containing 0.2% Tween 80 and 0.3% methylcellulose as vehicle, at doses of 0.01, 0.1, 1, and 3 mg/kg 1 h before rats were exposed to the LPS challenge. Neutrophils were counted and IL-6 levels were measured in BALF samples collected 4 h after LPS exposure. Two additional groups of rats were also challenged with aerosolized LPS: one was administered only with vehicle to determine the maximum effect of LPS challenge on neutrophil count, whereas the other was dosed intratracheally with fluticasone (0.1 mg/kg) and used as positive control. Compound <b>34</b> exhibited a dose-dependent inhibition of LPS-induced neutrophilia with a maximum effect at the 3 mg/kg dose (56% inhibition, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). At the same dose, a significant reduction of IL-6 levels in BALF (62%) was observed. Intratracheal pharmacokinetic studies performed with <b>34</b> at the efficacious dose of 3 mg/kg confirmed the high lung/plasma partition observed in previous studies (AUC<sub>lung</sub>: 14 557 μg h/g, AUC<sub>plasma</sub>: 406 ng h/mL, AUC<sub>lung</sub>/AUC<sub>plasma</sub>: 35 856), with lung levels of compound well above and unbound plasma levels [<i>C</i><sub>max</sub> (plasma): 57 ng/mL] below the cellular IC<sub>50</sub> up to 24 h post administration, suggesting that the observed efficacy is due to a local inhibition of JAK kinases in the lung. The results obtained with <b>34</b> in the LPS-induced airway inflammation model support the potential use of inhaled JAK inhibitors for the treatment of respiratory inflammatory diseases.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0006.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of intratracheal administration of compound <b>34</b> on (A) neutrophil count in BALF; <i>n</i> = 14–16/group and (B) IL-6 levels in BALF; <i>n</i> = 9–12/group, in the rat LPS challenge model. *** <i>P</i> < 0.001, ** <i>P</i> < 0.01 treated vs LPS group, analysis of variance + Dunnett’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30743" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30743" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Initial imidazopyridine compounds <b>2</b>–<b>4</b> were synthesized as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. A regioselective nucleophilic aromatic substitution (S<sub>N</sub>Ar) reaction between the corresponding amines and activated dichloropyrimidine <b>36</b> furnished compounds <b>37</b> and <b>38</b>. Catalytic hydrogenation of the nitro group in the presence of zinc(II) bromide led to dianilines <b>39</b> and <b>40</b>, which were treated with carbonyldiimidazole (CDI) to form purinone intermediates <b>41</b> and <b>42</b>, respectively. After 2-(trimethylsilyl)ethoxymethyl (SEM) protection of the imidazolone NH, hinge binder motifs were introduced in one step from commercial imidazopyridines <b>45</b> and <b>46</b> through a palladium-catalyzed heteroaryl Heck reaction using tetrakis(triphenylphosphine)palladium(0) as catalyst and potassium acetate as base at 150 °C. Finally, SEM removal using tetra-<i>n</i>-butylammonium fluoride (TBAF) or under aqueous acidic conditions afforded compounds <b>2</b>–<b>4</b>.</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Initial Imidazopyridine Compounds <b>2</b>–<b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R–NH<sub>2</sub>, <i>N</i>,<i>N</i>-diisopropylethylamine (DIEA), CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to room temperature (rt), 91–95%; (b) H<sub>2</sub>, Pd/C, ZnBr<sub>2</sub>, EtOAc, rt, 97–99%; (c) CDI, THF or CH<sub>3</sub>CN, 80 °C, 65–80%; (d) NaH, SEM–Cl, dimethylformamide (DMF), 0 °C to rt, 86–90%; (e) Pd(PPh<sub>3</sub>)<sub>4</sub>, KOAc, dimethylacetamide (DMA), 150 °C, 35–68%; (f) TBAF, CH<sub>2</sub>Cl<sub>2</sub>, rt to 70 °C or HCl 4 N, 70 °C, 32–83%.</p></p></figure><div class="NLM_p">Compounds synthesized to target new interactions in the solvent-exposed region were prepared from common intermediate <b>42</b>, as described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Compounds <b>5</b> and <b>11</b>–<b>13</b> were obtained through alkylation of the imidazolone NH of <b>42</b> with the corresponding halo derivatives followed by a heteroaryl Heck reaction to introduce the cyanoimidazopyridine hinge binder moiety. The same sequence was used to synthesize alcohols <b>6</b> and <b>7</b> and diols <b>9</b> and <b>10</b>. For these molecules, a final deprotection step under acidic conditions was needed as both the alcohol and diol functionalities were introduced protected as tetrahydropyranyl ethers and isopropylidene acetals, respectively. In the particular case of compound <b>8</b>, this molecule was synthesized in one step by alkylation of <b>3</b> with 1-bromo-2-methoxyethane.</div><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Imidazopyridines: Synthesis of N-Alkylated Purinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeI, NaH, DMF, 0 °C or R–Cl, K<sub>2</sub>CO<sub>3</sub>, DMF, rt to 90 °C, 45–88%; (b) <b>46</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, KOAc, DMA, 150 °C, 11–40%; (c) 1-bromo-2-methoxyethane, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 60%; (d) 2-(2-bromoethoxy)tetrahydro-2<i>H</i>-pyran, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 90%; (e) <b>45</b> or <b>46</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, KOAc, DMA, 150 °C then 2 N HCl, rt, 14–77%; (f) (<i>R</i>)- or (<i>S</i>)-4-(chloromethyl)-2,2-dimethyl-1,3-dioxolane, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 52–67%; (g) <b>46</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, KOAc, DMA, 150 °C then 4 N HCl, rt to 70 °C, 43–47%.</p></p></figure><div class="NLM_p">Imidazopyridines synthesized to explore lipophilic pocket SAR were prepared following an alternative synthetic approach based on intermediate <b>63</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). This approach would allow variation of groups that would ultimately reside in the lipophilic pocket at the last steps of the synthesis. Treatment of aminopyridine <b>57</b> with 3-methoxyacrylonitrile <b>58</b> in the presence of <i>N</i>-bromosuccinimide (NBS) furnished cyanoimidazopyridine <b>59</b>, which was converted into amidine <b>60</b> by reaction with catalytic sodium methoxide in methanol followed by addition of ammonium chloride. Cyclization of <b>60</b> with nitroacrylate <b>61</b> provided pyridone <b>62</b>, which was transformed into chloropyrimidine <b>63</b> by treatment with phosphorus oxychloride.</div><figure id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Imidazopyridines: Synthesis of Common Intermediate <b>63</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS, dioxane, H<sub>2</sub>O, 0–60 °C, 79%; (b) NaOMe, NH<sub>4</sub>Cl, MeOH, reflux, 90%; (c) Et<sub>3</sub>N, EtOH, 90 °C, 60%; (d) POCl<sub>3</sub>, 90 °C, 57%.</p></p></figure><div class="NLM_p">To explore SAR in the lipophilic pocket, a diverse set of groups were introduced by S<sub>N</sub>Ar reaction of the corresponding amines with <b>63</b>, as shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. Nitro reduction with tin(II) chloride in ethanol or by catalytic hydrogenation followed by cyclization with carbonyldiimidazole yielded compounds <b>14</b>, <b>16</b>, and <b>18</b>–<b>21</b>.</div><figure id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0015.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Imidazopyridines: Synthesis of 9-Substituted Purinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R–NH<sub>2</sub>, DIEA, THF, rt, 72–93%; (b) SnCl<sub>2</sub>, EtOH, 80 °C or H<sub>2</sub>, Pd/C, EtOH, 51–97%; (c) CDI, CH<sub>3</sub>CN, 80 °C, 30–74%.</p></p></figure><div class="NLM_p">Following the same synthetic approach, <i>tert</i>-butyldiphenylsilyl (TBDPS)-protected amino alcohols <b>76</b> and <b>80</b> were used for the synthesis of compounds <b>15</b> and <b>17</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). After nitro reduction and carbonyldiimidazole cyclization, the TBDPS-protecting group was removed by treatment with TBAF or cesium fluoride to yield alcohols <b>15</b> and <b>17</b>, respectively.</div><figure id="sch7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0016.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Imidazopyridines: Synthesis of Alcohols <b>15</b> and <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DIEA, THF, rt, 81–87%; (b) H<sub>2</sub>, Pd/C, EtOH, 75–82%; (c) CDI, CH<sub>3</sub>CN, 80 °C, 67–91%; (d) TBAF, THF, rt, 55%; (e) CsF, DMF, 60 °C, 47%.</p></p></figure><div class="NLM_p">The majority of purinones bearing an aminopyridone hinge binder motif were prepared as described in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>. S<sub>N</sub>Ar reaction of the corresponding amines with activated pyrimidine <b>36</b> furnished <b>37</b> and <b>84</b>–<b>85</b>. Elaboration of these intermediates to the corresponding SEM-protected purinones <b>43</b> and <b>90</b>–<b>91</b> proceeded using the same methods as described above (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). In the key step of these syntheses, a palladium-catalyzed Buchwald–Hartwig amination reaction of anilines <b>92</b>–<b>96</b> with the SEM-protected chloropurinones yielded advanced intermediates <b>97</b>–<b>105</b>. Finally, SEM deprotection of these molecules by treatment with either TBAF or trifluoroacetic acid followed by deprotection of the methoxy groups by reaction with trimethylsilyl chloride (TMSCl) and sodium iodide at 80 °C provided compounds <b>22</b>–<b>26</b>, <b>28</b>–<b>30</b>, and <b>35</b>.</div><figure id="sch8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0017.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Pyridones: Early Introduction of Lipophilic Pocket Group<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R–NH<sub>2</sub>, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 56–99%; (b) H<sub>2</sub>, Pt/C, ZnBr<sub>2</sub>, EtOAc, rt [R = (<i>R</i>)-8-fluorochromane, 75%]; H<sub>2</sub>, Pd/C, EtOH, rt [R = (<i>R</i>)-2-ethyl-5-fluoropyridine, 30%] or SnCl<sub>2</sub>, EtOH, reflux [R = <i>trans</i>-2-cyclohexylacetonitrile, 70%]; (c) CDI, CH<sub>3</sub>CN, 80 °C, 63–99%; (d) NaH, SEM–Cl, DMF, 0 °C, 58–83%; (e) Pd<sub>2</sub>(dba)<sub>3</sub>, Xanthphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C, 33–81%; (f) TBAF, THF, 70 °C or trifluoroacetic acid, NH<sub>3</sub>, MeOH, 60 °C, 56–97%; (g) TMSCl, NaI, CH<sub>3</sub>CN, 80 °C, 45–96%.</p></p></figure><div class="NLM_p">The synthesis of aminopyridines <b>93</b>–<b>96</b>, which are key intermediates utilized in the synthesis of pyridones <b>22</b>–<b>35</b> along with commercially available 2-methoxy-3-aminopyridine <b>92</b>, is outlined in <a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>. The reaction of chloropyridines <b>115</b> and <b>116</b> with sodium methoxide followed by reduction of the nitro group via catalytic hydrogenation afforded aminopyridines <b>94</b> and <b>95</b>, where the R group is a chloro atom and a methyl group, respectively. Oxidation of commercially available boronate <b>117</b> with hydrogen peroxide resulted in hydroxypyridine <b>118</b>, which was alkylated with methyl iodide to yield dimethoxypyridine <b>124</b>. Reduction of the nitro group of <b>124</b> by catalytic hydrogenation as described above provided aminopyridine <b>96</b>. For the particular case where R is a fluorine atom, nitration of hydroxypyridine <b>119</b> yielded nitro intermediate <b>120</b>. Selective O-alkylation of <b>120</b> was achieved using methyl iodide as alkylating agent and silver carbonate as base at room temperature to give <b>121</b>, which was converted to aminopyridine <b>93</b> as described above.</div><figure id="sch9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0018.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Aminopyridines <b>93</b>–<b>96</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOMe, MeOH, reflux, 78–87%; (b) H<sub>2</sub>, Pd/C, EtOH, rt, 87–98% or H<sub>2</sub>, Pt/C, ZnBr<sub>2</sub>, EtOAc, rt (R = Cl, 99%); (c) H<sub>2</sub>O<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 97%; (d) NaH, MeI, DMF, 0 °C to rt, 38%; (e) H<sub>2</sub>SO<sub>4</sub>, HNO<sub>3</sub>, 0–85 °C, 43%; (f) MeI, Ag<sub>2</sub>CO<sub>3</sub>, CHCl<sub>3</sub>, rt, 55%.</p></p></figure><div class="NLM_p">Aminonitrile <b>129</b>, a key intermediate for the synthesis of compounds <b>34</b> and <b>35</b>, was synthesized in four steps starting from commercial amino alcohol <b>125</b> (<a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>). The amino group of <b>125</b> was selectively protected by reaction with 1 equiv of di-<i>tert</i>-butyl dicarbonate, and the resultant alcohol <b>126</b> was converted into tosylate <b>127</b> by reaction with <i>p</i>-toluenesulfonyl chloride. The reaction of <b>127</b> with sodium cyanide followed by removal of the <i>tert</i>-butyloxycarbonyl (Boc) group under acidic conditions afforded aminonitrile <b>129</b>.</div><figure id="sch10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Aminonitrile <b>129</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Boc<sub>2</sub>O, THF, rt, 79%; (b) TsCl, CH<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N, rt, 83%; (c) NaCN, dimethyl sulfoxide (DMSO), 55 °C, 72%; (d) 4 N HCl, dioxane, rt, 89%.</p></p></figure><div class="NLM_p">Aminopyridones <b>31</b>–<b>34</b> were prepared following an alternative synthetic approach in which the lipophilic pocket group was introduced after the hinge binder moiety, as illustrated in <a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>. In this approach, pyrimidine <b>36</b> was first converted into thiocyanate <b>130</b> to reverse pyrimidine reactivity and direct hinge binder introduction to the 2-position. S<sub>N</sub>Ar reaction of aminopyridines <b>92</b> and <b>94</b> with pyrimidine <b>130</b> at 0 °C proceeded with moderate yields but excellent regioselectivity to the desired thiocyanates <b>131</b> and <b>132</b>. The reaction of these thiocyanates with the corresponding amines yielded intermediates <b>133</b>–<b>136</b>. Nitro reduction by catalytic hydrogenation followed by cyclization with carbonyldiimidazole afforded purinones <b>141</b>–<b>144</b>, in which both the hinge binder and the lipophilic moieties have been introduced by S<sub>N</sub>Ar reactions. For purinones <b>141</b>–<b>143</b>, where the purinone N-substituent is Boc-protected piperidine, a one-pot, double deprotection was performed under acidic conditions to give piperidines <b>145</b>–<b>147</b>, which were further converted into cyanoacetamides <b>31</b>–<b>33</b> by reaction with 2,5-dioxopyrrolidin-1-yl 2-cyanoacetamide. For the particular case of purinone <b>144</b>, with a cyclohexylacetonitrile N-substituent, methoxy deprotection under standard conditions provided compound <b>34</b>.</div><figure id="sch11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Pyridones: Early Introduction of the Hinge Binder Motif<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KSCN, AcOH, 0 °C to rt, 63%; (b) <b>92</b>, Et<sub>3</sub>N, EtOH, 0 °C (49%) or <b>94</b>, DIEA, THF, 0 °C (19%); (c) DIEA, THF, 50 °C, 21–99%; (d) H<sub>2</sub>, Pd/C, EtOH, 88–99%; (e) CDI, CH<sub>3</sub>CN, 70 °C, 21–85%; (f) 4 N HCl, dioxane, rt, 98–99%; (g) 2,5-dioxopyrrolidin-1-yl 2-cyanoacetamide, Et<sub>3</sub>N, DMF, rt, 20–54%; (h) NaI, TMSCl, CH<sub>3</sub>CN, 70 °C (81%).</p></p></figure><div class="NLM_p">Synthesis of compound <b>27</b> is outlined in <a class="ref internalNav" href="#sch12" aria-label="Scheme 12">Scheme 12</a>. The reaction of pyrimidine <b>36</b> with amine <b>80</b> provided the desired regioisomer <b>148</b>, which was elaborated as detailed above to provide compound <b>153</b>. The SEM and TBDPS groups were simultaneously removed by treatment of <b>153</b> with TBAF in tetrahydrofuran, and subsequent deprotection of the benzyl group by catalytic hydrogenation yielded the desired alcohol <b>27</b>.</div><figure id="sch12" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Pyridones: Synthesis of Compound <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DIEA, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 95%; (b) SnCl<sub>2</sub>, EtOH, 80 °C, 99%; (c) CDI, CH<sub>3</sub>CN, 70 °C, 26%; (d) NaH, SEM–Cl, DMF, 0 °C, 71%; (e) Pd<sub>2</sub>(dba)<sub>3</sub>, Xanthphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C, 79%; (f) TBAF, THF, 70 °C, 45%; (g) H<sub>2</sub>, Pd/C, THF/EtOAc, 88%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75163" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75163" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Herein are described the discovery and progression of a series of novel purinone pan-JAK inhibitors with the potential for treatment of respiratory diseases by the inhaled route. Replacement of the benzimidazole in Pharmacopeia’s JAK3 inhibitor PS-020613 by an imidazo[1,2-<i>a</i>]pyridine ring was designed as a way to improve potential instability issues. This bioisosteric hinge binder replacement was well tolerated in terms of JAK potencies giving rise to <b>2</b>, a compound with potencies against JAK2 and JAK3 in the low nanomolar range but 20-fold less potent against JAK1. In our search for a potent pan-JAK inhibitor, systematic SAR efforts driven by structural biology studies were performed to improve the JAK1 potency of <b>2</b>. Initial studies which attempted to target new interactions with the solvent-exposed amino acid Glu966 in JAK1 were unsuccessful. On the other hand, compounds with adequate JAK potencies were identified by varying the groups in the lipophilic pocket, but unfortunately, the cytotoxicity observed with these molecules prevented them for further progression. This cytotoxicity could be overcome without dramatically affecting JAK potencies by the introduction of an aminopyridone ring as the hinge binding motif. Further, SAR expansion in the lipophilic pocket region led to the discovery of pyridone <b>34</b>, a potent pan-JAK inhibitor with good selectivity, long lung retention time, low systemic exposure, and proven efficacy in the LPS model of airway inflammation by the intratracheal route. Furthermore, <b>34</b> was successfully co-crystallized with JAK1, confirming the expected binding mode for this series of inhibitors and providing a better understanding of JAK1 SAR. Pyridone <b>34</b> underwent further characterization to assess the potential as a preclinical development candidate.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Experimental</h3><div class="NLM_p">The care of animals was undertaken in compliance with the European Committee Directive 2010/63/EU and the Spanish and autonomous Catalan laws (Real Decreto 53/2013 and Decret 214/1997). Experimental procedures were reviewed by the Animal Welfare Body of Almirall and approved by the competent authority.</div><div class="NLM_p last">All test compounds have purity >95%. The purity of compounds was determined by high-performance liquid chromatography (HPLC) or ultraperformance liquid chromatography (UPLC) analysis. HPLC analyses were performed using a Waters 2795 system equipped with a Symmetry C-18 (2.1 × 100 mm, 3.5 μM) column. The mobile phases were (B): formic acid (0.4 mL), ammonia (0.1 mL), methanol (500 mL), and acetonitrile (500 mL) and (A): formic acid (0.5 mL), ammonia (0.125 mL), and water (1000 mL). A gradient between 0 and 95% of B was used. The flow rate was 0.4 mL/min. The run time was 30 min. The injection volume was 5 μL. A Waters 2996 diode array was used as a UV detector. Chromatograms were processed at 210 nm. Mass spectra of the chromatograms were acquired using positive and negative electrospray ionization (ESI) in a Waters ZQ detector coupled to the HPLC. UPLC analyses were performed using a Waters Acquity UPLC system coupled to an SQD mass spectrometer detector. The system was equipped with an ACQUITY UPLC BEH C-18 (2.1 × 50 mm, 1.7 mm) column. The mobile phases were (B): formic acid (0.4 mL), ammonia (0.1 mL), methanol (500 mL), and acetonitrile (500 mL) and (A): formic acid (0.5 mL), ammonia (0.125 mL), and water (1000 mL). A gradient between 5 and 95% of B was used. The flow rate was 0.65 mL/min. The run time was 5 min. The injection volume was 0.5 μL. Chromatograms were processed at 210 nm. Mass spectra of the chromatograms were acquired using positive and negative electrospray ionization. Reaction products were purified, when necessary, by flash chromatography on silica gel (40–63 μm) with the solvent system indicated. Purifications in reverse phase were made in a Biotage SP1 automated purification system equipped with a C-18 column and using a standard gradient of water–acetonitrile/MeOH (1:1) (0.1% v/v ammonium formate both phases) from 0 to 100% acetonitrile/MeOH (1:1) in 80 column volumes. Other conditions are stated explicitly in the text. Preparative HPLC–mass spectrometry (MS) was performed on a Waters instrument equipped with a 2767 injector/collector, a 2525 binary gradient pump, a 2996 PDA detector, a 515 pump as a make-up pump, and a ZQ4000 mass spectrometer detector. <sup>1</sup>H nuclear magnetic resonance (NMR) spectra were recorded on a Gemini 200 MHz, Gemini-2000 300 MHz, Varian Mercury plus 400 MHz, or an Agilent VNMRS-DD2 600 MHz spectrometer. Tetramethylsilane was used as reference. Chemical shifts δ are in parts per million (ppm); the following abbreviations are used: singlet (s), doublet (d), triplet (t), quartet (q), double doublet (dd), quintet (quin), multiplet (m), broad signal (br s), apparent signal (app). <sup>13</sup>C Nuclear magnetic resonance spectra were recorded on an Agilent VNMRS-DD2 600 MHz spectrometer equipped with a cold probe. Spectra were referenced to the DMSO residual signal at δ = 39.9 ppm. Mass spectra (<i>m</i>/<i>z</i>) were recorded on Micromass ZMD or Waters ZQ mass spectrometer using ESI ionization. Isotopic distributions are quoted for the mass ion of the lowest-molecular-weight isotope (<sup>35</sup>Cl and <sup>79</sup>Br) and the number of isotopes detected. High-resolution mass spectra (HRMS) were obtained from 1 μL of a 0.05 mg/mL methanolic solution of each analyzed compound injected in a UHPLC 1290 Infinity (Agilent Technologies) coupled to a 6220 Accurate-Mass time-of-flight (TOF) mass spectrometer (Agilent Technologies). A dual ESI in positive mode was used as ionization source. TOF acquisition conditions were: scan acquisition mode (70–3000 Da, scan rate: 1.00 spec/s), gas temp: 300 °C, gas flow: 8 L/min, nebulizer: 40 psi, V cap: 2000 V, fragmentor: 150 V, skimmer 1: 65 V, octopole radio frequency peak: 250 V, and reference masses: <i>m</i>/<i>z</i> 121.050873 and 922.009798.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Chemistry: Synthetic Procedures to <b>34</b></h3><div class="NLM_p">Additional experimental procedures for all novel compounds prepared during the course of this work can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00533/suppl_file/jm9b00533_si_002.pdf" class="ext-link">Supporting Information</a>.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>tert</i>-Butyl (1r,4r)-4-(Hydroxymethyl)cyclohexylcarbamate (<b>126</b>)</h4><div class="NLM_p last">Di-<i>tert</i>-butyl dicarbonate (3.04 g, 13.9 mmol) was added to a stirred solution of ((1r,4r)-4-aminocyclohexyl)methanol (1.50 g, 11.6 mmol) in tetrahydrofuran (20 mL). After stirring overnight at ambient temperature, the solvent was evaporated and the residue partitioned between ethyl acetate and water. The organic layer was separated, washed with water and brine, dried (MgSO<sub>4</sub>), and the solvent was evaporated. The residue was treated with hexanes, and the suspension was filtered to give the title compound (2.11 g, 79%) as a white solid. Low-resolution mass spectrometry (LRMS) (<i>m</i>/<i>z</i>): 228 (M – 1)<sup>+</sup>. <sup>1</sup>H NMR δ (300 MHz, DMSO-<i>d</i><sub>6</sub>): 0.84–0.95 (m, 2H), 1.05–1.18 (m, 2H), 1.20–1.29 (m, 2H), 1.40 (s, 9H), 1.71–1.80 (m, 3H), 3.14 (m, 1H), 3.21 (t, <i>J</i> = 5.8 Hz, 2H), 4.41 (t, <i>J</i> = 5.3 Hz, 1H), 6.73 (d, <i>J</i> = 8.2 Hz, 1H).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> ((1r,4r)-4-(<i>tert</i>-Butoxycarbonylamino)cyclohexyl)methyl 4-Methylbenzene-sulfonate (<b>127</b>)</h4><div class="NLM_p last">A solution of 4-methylbenzene-1-sulfonyl chloride (2.28 g, 11.96 mmol) in dichloromethane (10 mL) was added to a solution of <i>tert</i>-butyl (1r,4r)-4-(hydroxymethyl)cyclohexylcarbamate <b>126</b> (2.11 g, 9.2 mmol) and triethylamine (1.59 mL, 11.4 mmol) in dichloromethane (50 mL), and the resulting mixture was stirred overnight at ambient temperature. The mixture was washed with 1 M aqueous sodium hydroxide solution, and the organic layer was dried (MgSO<sub>4</sub>), evaporated, and the residue was purified by flash chromatography (diethyl ether/hexanes) to give the title compound (2.91 g, 83%) as a white solid. LRMS (<i>m</i>/<i>z</i>): 382 (M – 1)<sup>+</sup>. <sup>1</sup>H NMR δ (300 MHz, CDCl<sub>3</sub>): 0.90–1.12 (m, 4H), 1.43 (s, 3H), 1.87–1.68 (m, 2H), 2.10–1.90 (m, 2H), 3.34 (m, 1H), 3.48–3.41 (m, 1H), 3.81 (d, <i>J</i> = 6.5 Hz, 2H), 4.37 (m, 1H), 7.34 (d, <i>J</i> = 8.2 Hz, 2H), 7.77 (d, <i>J</i> = 8.2 Hz, 2H).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>tert-</i>Butyl (1r,4r)-4-(Cyanomethyl)cyclohexylcarbamate (<b>128</b>)</h4><div class="NLM_p last">Sodium cyanide (0.38 g, 7.8 mmol) was added to a solution of ((1r,4r)-4-(<i>tert</i>-butoxycarbonylamino)cyclohexyl)methyl 4-methylbenzene sulfonate <b>127</b> (1.00 g, 2.6 mmol) in dimethyl sulfoxide (10 mL), and the mixture was heated to 55 °C and stirred for 20 h. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate; washed with saturated aqueous potassium carbonate solution, water, and brine; dried (MgSO<sub>4</sub>); and the solvent was evaporated. The residue was purified by flash chromatography (100% dichloromethane to 95:5 dichloromethane/methanol) to give the title compound (0.450 g, 72%) as a white solid. LRMS (<i>m</i>/<i>z</i>): 239 (M + 1)<sup>+</sup>. <sup>1</sup>H NMR δ (300 MHz, CDCl<sub>3</sub>): 4.59–4.12 (m, 1H), 3.51–3.13 (m, 1H), 2.36–0.90 (m, 20H).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-((1r,4r)-4-Aminocyclohexyl)acetonitrile Hydrochloride (<b>129</b>)</h4><div class="NLM_p last">A mixture of <i>tert</i>-butyl (1r,4r)-4-(cyanomethyl)cyclohexylcarbamate <b>128</b> (0.348 g, 1.46 mmol) and 4 M hydrogen chloride solution in dioxane (3.65 mL) was stirred overnight at ambient temperature. The solvent was evaporated in vacuo, and the residue was treated with diethyl ether. The resultant suspension was filtered to give the title compound (0.226 g, 89%) as a white solid. LRMS (<i>m</i>/<i>z</i>): 139 (M + 1)<sup>+</sup>. <sup>1</sup>H NMR δ (300 MHz, DMSO-<i>d</i><sub>6</sub>): 8.08 (br s, 3H), 2.95 (d, <i>J</i> = 4.9 Hz, 1H), 2.50 (d, <i>J</i> = 6.5 Hz, 2H), 2.00 (d, <i>J</i> = 11.6 Hz, 2H), 1.83 (d, <i>J</i> = 12.3 Hz, 2H), 1.68–1.52 (m, 1H), 1.46–1.28 (m, 2H), 1.23–1.07 (m, 2H).</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-Chloro-5-nitro-4-thiocyanatopyrimidine (<b>130</b>)</h4><div class="NLM_p last">Potassium thiocyanate (2.10 g, 21.6 mmol) was added in portions over 2 h to a stirred solution of 2,4-dichloro-5-nitropyrimidine <b>36</b> (4.00 g, 20.6 mmol) in glacial acetic acid (25 mL) cooled to 10–15 °C using an ice–water bath. The mixture was then stirred at ambient temperature for 1 h, then diluted with water, and the precipitate was filtered, washed with water and ice-cold diethyl ether, and dried to give the title compound (2.82 g, 63%) as a white solid. <sup>1</sup>H NMR δ (300 MHz, CDCl<sub>3</sub>): 9.40 (s, 1H).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(2-Methoxypyridin-3-yl)-5-nitro-4-thiocyanatopyrimidin-2-amine (<b>131</b>)</h4><div class="NLM_p last">2-Methoxypyridin-3-amine <b>92</b> (0.100 g, 0.8 mmol) was added portionwise to a stirred, cooled (ice-bath) suspension of 2-chloro-5-nitro-4-thiocyanatopyrimidine <b>130</b> (0.174 g, 0.8 mmol) in ethanol (3 mL). Triethylamine (0.170 mL, 1.2 mmol) was then added dropwise, and the mixture was stirred for 30 min at 0 °C. The precipitate was filtered and dried to give the title compound (0.135 g, 49%) as a yellow solid. LRMS (<i>m</i>/<i>z</i>): 305 (M + 1)<sup>+</sup>. <sup>1</sup>H NMR δ (300 MHz, DMSO-<i>d</i><sub>6</sub>): 3.95 (s, 3H), 7.03 (br s, 1H), 8.07 (br s, 1H), 9.24 (br s, 1H), 10.62 (s, 1H).</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-((1r,4r)-4-(2-(2-Methoxypyridin-3-ylamino)-5-nitropyrimidin-4-ylamino)cyclohexyl)acetonitrile (<b>136</b>)</h4><div class="NLM_p last">A mixture of <i>N</i>-(2-methoxypyridin-3-yl)-5-nitro-4-thiocyanatopyrimidin-2-amine <b>131</b> (0.178 g, 0.58 mmol), 2-((1r,4r)-4-aminocyclohexyl)acetonitrile hydrochloride <b>129</b> (0.123 g, 0.70 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (0.62 mL, 3.5 mmol) in tetrahydrofuran (10 mL) was stirred and heated to 50 °C. After stirring overnight, the mixture was partitioned between water and ethyl acetate and the organic extract was washed with brine, dried (MgSO<sub>4</sub>), and evaporated. The residue was purified by flash chromatography (0–50% ethyl acetate in hexanes) to give the title compound (0.109 g, 49%) as a white solid. LRMS (<i>m</i>/<i>z</i>): 384 (M + 1)<sup>+</sup>. <sup>1</sup>H NMR δ (300 MHz, CDCl<sub>3</sub>): 1.27–1.48 (m, 5H), 1.82 (m, 1H), 2.05 (d, <i>J</i> = 9.4 Hz, 2H), 2.28 (m, 2H), 2.41 (d, <i>J</i> = 6.0 Hz, 2H), 4.08 (s, 3H), 6.96 (dd, <i>J</i> = 7.7, 5.2 Hz, 1H), 7.90 (d, <i>J</i> = 4.9 Hz, 1H), 7.96 (m, 1H), 8.43 (m, 1H), 8.65 (d, <i>J</i> = 8.0 Hz, 1H), 9.08 (s, 1H).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-((1r,4r)-4-(5-Amino-2-(2-methoxypyridin-3-ylamino)pyrimidin-4-ylamino)cyclohexyl)acetonitrile (<b>140</b>)</h4><div class="NLM_p last">10% palladium on carbon (0.048 g) was added to a solution of 2-((1r,4r)-4-(2-(2-methoxypyridin-3-ylamino)-5-nitropyrimidin-4-ylamino)cyclohexyl)acetonitrile <b>136</b> (0.109 g, 0.28 mmol) in ethanol (15 mL), and the reaction mixture was stirred at ambient temperature under a hydrogen atmosphere. After 5 h, the mixture was then filtered through Celite and the filter cake was washed with ethanol. The combined filtrate and washings were concentrated to give the title compound (0.096 g, 96%) as an off-white solid. LRMS (<i>m</i>/<i>z</i>): 354 (M + 1)<sup>+</sup>. <sup>1</sup>H NMR δ (300 MHz, CDCl<sub>3</sub>): 1.19–1.43 (m, 4H), 1.76 (m, 1H), 2.06–1.95 (m, 2H), 2.30–2.17 (m, 2H), 2.35 (d, <i>J</i> = 6.5 Hz, 2H), 2.62 (s, 2H), 3.89–3.99 (m, 1H), 4.03 (s, 3H), 5.05 (d, <i>J</i> = 7.2 Hz, 1H), 6.87 (dd, <i>J</i> = 7.8, 5.0 Hz, 1H), 7.63 (s, 1H), 7.70 (dd, <i>J</i> = 5.0, 1.6 Hz, 1H), 8.69 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-((1r,4r)-4-(2-(2-Methoxypyridin-3-ylamino)-8-oxo-7<i>H</i>-purin-9(8<i>H</i>)-yl)cyclohexyl)acetonitrile (<b>144</b>)</h4><div class="NLM_p last">A mixture of 2-((1r,4r)-4-(5-amino-2-(2-methoxypyridin-3-ylamino)pyrimidin-4-ylamino)cyclohexyl)acetonitrile <b>140</b> (0.096 g, 0.27 mmol) and 1,1′-carbonylbis-1<i>H</i>-imidazole (0.088 g, 0.54 mmol) in acetonitrile (1.5 mL) was stirred and heated to 85 °C in a sealed tube. After 2 h, the solvent was evaporated and water was added to the residue. After stirring for 1 h at ambient temperature, the suspension was filtered and the solid was washed with water and dried to give the title compound (0.084 g, 74%) as an off-white solid. LRMS (<i>m</i>/<i>z</i>): 380 (M + 1)<sup>+</sup>. <sup>1</sup>H NMR δ (300 MHz, DMSO-<i>d</i><sub>6</sub>): 1.23 (m, 6H), 1.83 (m, 2H), 2.04 (m, 2H), 2.42 (m, 1H), 4.01 (s, 3H), 4.08 (m, 1H), 7.05 (m, 1H), 7.83 (m, 1H), 7.88 (m, 1H), 8.03 (m, 1H), 8.58 (m, 1H), 11.13 (br s, 1H).</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-((1r,4r)-4-(8-Oxo-2-(2-oxo-1,2-dihydropyridin-3-ylamino)-7<i>H</i>-purin-9(8<i>H</i>)-yl) cyclohexyl)acetonitrile (<b>34</b>)</h4><div class="NLM_p last">Sodium iodide (2.43 g, 16.2 mmol) and trimethylsilyl chloride (2.05 mL, 16.2 mmol) were added to a suspension of 2-((1r,4r)-4-(2-(2-methoxypyridin-3-ylamino)-8-oxo-7<i>H</i>-purin-9(8<i>H</i>)-yl) cyclohexyl)acetonitrile <b>144</b> (2.05 g, 5.4 mmol) in acetonitrile (50 mL), and the mixture was stirred and heated to 85 °C in a sealed tube. After 2 h, the mixture was concentrated and treated with saturated aqueous sodium thiosulfate solution. After stirring for 30 min, the precipitate was filtered, washed with water and diethyl ether, and dried. The resulting solid was treated with hot ethanol, filtered, and dried to give the title compound (1.60 g, 81%) as a white solid. LRMS (<i>m</i>/<i>z</i>): 366 (M + 1)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>20</sub>N<sub>7</sub>O<sub>2</sub>: 366.16730. Found [M + H]<sup>+</sup>: 366.16744. <sup>1</sup>H NMR δ (300 MHz, DMSO-<i>d</i><sub>6</sub>): 1.38–1.21 (m, 2H), 2.05–1.68 (m, 5H), 2.46–2.30 (m, 2H), 4.26–4.12 (m, 1H), 6.29–6.19 (m, 1H), 6.93 (d, <i>J</i> = 5.8 Hz, 1H), 8.01–7.89 (m, 2H), 8.29 (d, <i>J</i> = 7.1 Hz, 1H), 10.77 (br s, 1H), 11.61 (br s, 1H). <sup>13</sup>C NMR δ (151 MHz, DMSO-<i>d</i><sub>6</sub>): 23.4 (CH<sub>2</sub>), 28.7 (CH<sub>2</sub>), 31.1 (CH<sub>2</sub>), 33.7 (CH), 51.2 (CH), 106.2 (CH), 116.1 (C), 117.7 (CH), 120.0 (C), 124.6 (CH), 130.9 (C), 133.8 (CH), 151.1 (C), 153.1 (C), 153.7 (C), 157.7 (C).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00533" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00533" class="ext-link">10.1021/acs.jmedchem.9b00533</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00533/suppl_file/jm9b00533_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">General chemistry and biology experimental procedures (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00533/suppl_file/jm9b00533_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00533/suppl_file/jm9b00533_si_001.csv">jm9b00533_si_001.csv (14.15 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00533/suppl_file/jm9b00533_si_002.pdf">jm9b00533_si_002.pdf (911.32 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes are the following: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZV">6HZV</a> for <b>6</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZU">6HZU</a> for <b>34</b>. The authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b00533" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jordi Bach</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry & Screening, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0449-0161" title="Orcid link">http://orcid.org/0000-0002-0449-0161</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dbb1b4a9bfb2f5b9bab8b39bbab7b6b2a9bab7b7f5b8b4b6"><span class="__cf_email__" data-cfemail="e78d8895838ec98586848fa7868b8a8e95868b8bc984888a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Eastwood</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry & Screening, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob González</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry & Screening, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Gómez</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry & Screening, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan Antonio Alonso</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry & Screening, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Premiumlab S. L., Carretera Santa Creu de Calafell 49-B, Sant Boi de Llobregat, 08830 Barcelona, Spain (J.A.A.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Fonquerna</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry & Screening, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Estrella Lozoya</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry & Screening, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adela Orellana</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry & Screening, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Research Center, Fundació ACE, Institut Català de Neurociències Aplicades, C/ Marquès de Sentmenat 57, 08029 Barcelona, Spain (A.O.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mónica Maldonado</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry & Screening, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Calaf</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics & Metabolism, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joan Albertí</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics & Metabolism, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Admetra, C/General Ramon Despuig 17, 07013 Palma de Mallorca, Spain (J.A.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan Pérez</span> - <span class="hlFld-Affiliation affiliation">Early Galenic Development, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Andrés</span> - <span class="hlFld-Affiliation affiliation">Pathology &
Predictive Toxicology, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Innoqua Toxicology Consultants, C/ Sant Antoni Maria Claret 272 2-2, 08041 Barcelona, Spain (A.A.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neus Prats</span> - <span class="hlFld-Affiliation affiliation">Pathology &
Predictive Toxicology, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        IRB Barcelona-Institute for Research in Biomedicine, Parc Científic de Barcelona, C/Baldiri Reixac 10, 08028 Barcelona, Spain (N.P.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Carreño</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic Group, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Calama</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic Group, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jorge De Alba</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic Group, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Peptinnovate, Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage SG1 2FX, United Kingdom (J.D.A.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Calbet</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic Group, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Montserrat Miralpeix</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic Group, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Montserrat Miralpeix Pharma Consulting, Parc Científic de Barcelona, C/ Baldiri Reixac 4-8, 08028 Barcelona, Spain (M.M.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabel Ramis</span> - <span class="hlFld-Affiliation affiliation">Respiratory Therapeutic Group, , , , and , Almirall R&D, Crta. Laureà Miró 408-410, Sant
Feliu de Llobregat, 08980 Barcelona, Spain</span>; 
    <span>Present Address:
                        Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Hospital Duran i Reynals, Gran Via 199, 08908 L’Hospitalet de Llobregat, Barcelona, Spain (I.R.)</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>The authors were all full-time employees of Almirall S. A. at the time this work was completed and all funding for the work was provided by Almirall S. A.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2726-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Andreas Griessner, Alfred Lammens, Michael Blaesse, and Anja Jestel from Proteros Biostructures GmbH for X-ray structure determination of human JAK3 and JAK1 in complex with compounds <b>6</b> and <b>34</b> (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZV">6HZV</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZU">6HZU</a>). They also acknowledge Eva Codesido, Raúl Fernández, Gloria Fra, Marı́a José Roó y Pablo Veiga from GalChimia S. A. for their contribution to the synthesis and scale-up of several of the compounds described in this article. They also thank Sonia Espinosa and Josep Maria Huerta for their support on physicochemical properties analysis and structural characterization of compounds, Mireia Verdú for her contribution to the evaluation of the activity of <b>34</b> in ion channels, and Elena Barceló for performing HRMS analysis of all tested compounds.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BAL</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">GM-CSF</td><td class="NLM_def"><p class="first last">granulocyte-macrophage colony-stimulating factor</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">LRMS</td><td class="NLM_def"><p class="first last">low-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">2-(trimethylsilyl)ethoxymethyl</p></td></tr><tr><td class="NLM_term">S<sub>N</sub>Ar</td><td class="NLM_def"><p class="first last">nucleophilic aromatic substitution</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetra-<i>n</i>-butylammonium fluoride</p></td></tr><tr><td class="NLM_term">TBDPS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldiphenylsilyl</p></td></tr><tr><td class="NLM_term">Tyk2</td><td class="NLM_def"><p class="first last">tyrosine kinase 2</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultraperformance liquid chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04866" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04866" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAKS and STATs: Biological implications</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.16.1.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1146%2Fannurev.immunol.16.1.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=9597132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADyaK1cXislygurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=293-322&author=W.+J.+Leonardauthor=J.+J.+O%E2%80%99Shea&title=JAKS+and+STATs%3A+Biological+implications&doi=10.1146%2Fannurev.immunol.16.1.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">JAKS and STATS: Biological implications</span></div><div class="casAuthors">Leonard, Warren J.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">293-322</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 185 refs.  Cytokines and interferons are mols. that play central roles in the regulation of a wide array of cellular functions in the lympho-hematopoietic system.  These factors stimulate proliferation, differentiation, and survival signals, as well as specialized functions in host resistance to pathogens.  Although cytokines are known to activate multiple signaling pathways that together mediate these important functions, one of these pathways, the Jak-STAT pathway, is the focus of this chapter.  This pathway is triggered by both cytokines and interferons, and it very rapidly allows the transduction of an extracellular signal into the nucleus.  The pathway uses a novel mechanism in which cytosolic latent transcription factors, known as signal transducers and activators of transcription (STATs), are tyrosine phosphorylated by Janus family tyrosine kinases (Jaks), allowing STAT protein dimerization and nuclear translocation.  STATs then can modulate the expression of target genes.  The basic biol. of this system, including the range of known Jaks and STATs, is discussed, as are the defects in animals and human lacking some of these signaling mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkrO-nJd5D_LVg90H21EOLACvtfcHk0ljLj30Pbf7HVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislygurs%253D&md5=ac5eeeb0159c2c8769e2cb28720cdf98</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.16.1.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.16.1.293%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAKS%2520and%2520STATs%253A%2520Biological%2520implications%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1998%26volume%3D16%26spage%3D293%26epage%3D322%26doi%3D10.1146%2Fannurev.immunol.16.1.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span> <span> </span><span class="NLM_article-title">The JAK-STAT pathway</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/S0161-5890(00)00018-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2FS0161-5890%2800%2900018-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10781830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjslCmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2000&pages=1-11&author=K.+Imadaauthor=W.+J.+Leonard&title=The+JAK-STAT+pathway&doi=10.1016%2FS0161-5890%2800%2900018-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Jak-STAT pathway</span></div><div class="casAuthors">Imada, Kazuroni; Leonard, Warren J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with approx. 130 refs.  A variety of important cellular functions are regulated by cytokines.  The Jak-STAT pathway is one of the important signaling pathways downstream of cytokine receptors.  Following binding of a ligand to its cognate receptor, receptor-assocd. Jaks are activated.  STAT proteins are then in turn activated by tyrosine phosphorylation by Jak kinases, allowing their dimerization and subsequent translocation into the nucleus, where they modulate expression of target genes.  Indispensable functions of Jaks and STATs in cytokine signaling in vivo have been revealed through knockout mouse studies.  Moreover, the recent discovery of the CIS/SOCS/JAB/SSI family of inhibitors has contributed to understanding how this pathway is neg. regulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7-0QIF3Rtn7Vg90H21EOLACvtfcHk0ljLj30Pbf7HVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjslCmtLc%253D&md5=798909bbe1984c93fcc5760c6a286e57</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0161-5890%2800%2900018-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0161-5890%252800%252900018-3%26sid%3Dliteratum%253Aachs%26aulast%3DImada%26aufirst%3DK.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520JAK-STAT%2520pathway%26jtitle%3DMol.%2520Immunol.%26date%3D2000%26volume%3D37%26spage%3D1%26epage%3D11%26doi%3D10.1016%2FS0161-5890%2800%2900018-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saharinen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, V. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvennoinen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">The Janus kinases (Jaks)</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">253</span> <span class="refDoi"> DOI: 10.1186/gb-2004-5-12-253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1186%2Fgb-2004-5-12-253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=15575979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A280%3ADC%252BD2cngtlKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&author=K.+Yamaokaauthor=P.+Saharinenauthor=M.+Pesuauthor=V.+E.+T.+Holtauthor=O.+Silvennoinenauthor=J.+J.+O%E2%80%99Shea&title=The+Janus+kinases+%28Jaks%29&doi=10.1186%2Fgb-2004-5-12-253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Janus kinases (Jaks)</span></div><div class="casAuthors">Yamaoka Kunihiro; Saharinen Pipsa; Pesu Marko; Holt Vance E T 3rd; Silvennoinen Olli; O'Shea John J</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">253</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Janus kinase (Jak) family is one of ten recognized families of non-receptor tyrosine kinases.  Mammals have four members of this family, Jak1, Jak2, Jak3 and Tyrosine kinase 2 (Tyk2).  Birds, fish and insects also have Jaks.  Each protein has a kinase domain and a catalytically inactive pseudo-kinase domain, and they each bind cytokine receptors through amino-terminal FERM (Band-4.1, ezrin, radixin, moesin) domains.  Upon binding of cytokines to their receptors, Jaks are activated and phosphorylate the receptors, creating docking sites for signaling molecules, especially members of the signal transducer and activator of transcription (Stat) family.  Mutations of the Drosophila Jak (Hopscotch) have revealed developmental defects, and constitutive activation of Jaks in flies and humans is associated with leukemia-like syndromes.  Through the generation of Jak-deficient cell lines and gene-targeted mice, the essential, nonredundant functions of Jaks in cytokine signaling have been established.  Importantly, deficiency of Jak3 is the basis of human autosomal recessive severe combined immunodeficiency (SCID); accordingly, a selective Jak3 inhibitor has been developed, forming a new class of immunosuppressive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0BwDh7EYTsV1C8OJBvdfbfW6udTcc2ea1MXhdzWa_vLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cngtlKktg%253D%253D&md5=4f8335c37dc8c20245e771224c1d5b12</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2Fgb-2004-5-12-253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2004-5-12-253%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26aulast%3DSaharinen%26aufirst%3DP.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DHolt%26aufirst%3DV.%2BE.%2BT.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Janus%2520kinases%2520%2528Jaks%2529%26jtitle%3DGenome%2520Biol.%26date%3D2004%26volume%3D5%26doi%3D10.1186%2Fgb-2004-5-12-253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borie, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span> <span> </span><span class="NLM_article-title">A new modality for immunosuppression: Targeting the JAK/STAT pathway</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1038/nrd1441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1038%2Fnrd1441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=15232577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Oru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=555-564&author=J.+J.+O%E2%80%99Sheaauthor=M.+Pesuauthor=D.+C.+Borieauthor=P.+S.+Changelian&title=A+new+modality+for+immunosuppression%3A+Targeting+the+JAK%2FSTAT+pathway&doi=10.1038%2Fnrd1441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A new modality for immunosuppression: targeting the JAK/STAT pathway</span></div><div class="casAuthors">O'Shea, John J.; Pesu, Marko; Borie, Dominic C.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">555-564</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Thousands of organs are transplanted each year and millions of people suffer from autoimmune diseases, which creates a need for an armamentarium of immunosuppressive drugs.  Unfortunately, immunosuppressants have unwanted side effects owing, in part, to the fact that they have ubiquitous mol. targets.  Cytokines have emerged as important controllers of the immune response, and work during the past decade has identified Janus kinases (JAKs) and signal transducers, and activators of transcription (STATs), as crucial intracellular elements in cytokine signalling.  Here, we discuss the potential of the JAK/STAT pathway as a target for new immunosuppressants.  In particular, the inhibition of JAK3 seems to be an excellent strategy, because of the selective expression and precise functions of this kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhrBmh4tsEibVg90H21EOLACvtfcHk0lhJQxmcIbzFXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Oru7o%253D&md5=7f09261dbb7c43b4eedb750a35f8e7d5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd1441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1441%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DA%2520new%2520modality%2520for%2520immunosuppression%253A%2520Targeting%2520the%2520JAK%252FSTAT%2520pathway%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D555%26epage%3D564%26doi%3D10.1038%2Fnrd1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilks, A. F.</span></span> <span> </span><span class="NLM_article-title">The JAK kinases: Not just another kinase drug discovery target</span>. <i>Semin. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1016/j.semcdb.2008.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.semcdb.2008.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=18721891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOrur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=319-328&author=A.+F.+Wilks&title=The+JAK+kinases%3A+Not+just+another+kinase+drug+discovery+target&doi=10.1016%2Fj.semcdb.2008.07.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The JAK kinases: Not just another kinase drug discovery target</span></div><div class="casAuthors">Wilks, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">319-328</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  There are four members of the JAK family of protein tyrosine kinases (PTKs) in the human genome.  Since their discovery in 1989, great strides have been made in the understanding of their role in normal intracellular signalling.  Importantly, their roles in pathologies ranging from cancer to immune deficiencies have placed them front and center as potential drug targets.  The recent discovery of the role of activating mutations in the kinase-like domain (KLD) of JAK2 in the development of polycythemia rubra vera, and the elaboration of KLD mutation as a broader mechanism by which cells might become hyperproliferative has sparked enormous interest in the development of JAK selective drug candidates.  I review herein the progress that has been made in the discovery of JAK-targeted inhibitors, and discuss the challenges that face the development of these drugs for use in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrguIVsQ1619LVg90H21EOLACvtfcHk0lhJQxmcIbzFXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOrur%252FK&md5=8e25e860ad9df6b15aa77f549ee39134</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2008.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2008.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DWilks%26aufirst%3DA.%2BF.%26atitle%3DThe%2520JAK%2520kinases%253A%2520Not%2520just%2520another%2520kinase%2520drug%2520discovery%2520target%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2008%26volume%3D19%26spage%3D319%26epage%3D328%26doi%3D10.1016%2Fj.semcdb.2008.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Janus kinases in immune cell signaling</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>228</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00754.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+kinases+in+immune+cell+signaling&doi=10.1111%2Fj.1600-065X.2008.00754.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0lhJQxmcIbzFXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520kinases%2520in%2520immune%2520cell%2520signaling%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D273%26epage%3D287%26doi%3D10.1111%2Fj.1600-065X.2008.00754.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plenge, R.</span></span> <span> </span><span class="NLM_article-title">JAK and STAT signaling molecules in immunoregulation and immune-mediated disease</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2012.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.immuni.2012.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=22520847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFWqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=542-550&author=J.+J.+O%E2%80%99Sheaauthor=R.+Plenge&title=JAK+and+STAT+signaling+molecules+in+immunoregulation+and+immune-mediated+disease&doi=10.1016%2Fj.immuni.2012.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease</span></div><div class="casAuthors">O'Shea, John J.; Plenge, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">542-550</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The discovery of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway, a landmark in cell biol., provided a simple mechanism for gene regulation that dramatically advanced our understanding of the action of hormones, interferons, colony-stimulating factors, and interleukins.  As we learn more about the complexities of immune responses, new insights into the functions of this pathway continue to be revealed, aided by technol. that permits genome-wide views.  As we celebrate the 20th anniversary of the discovery of this paradigm in cell signaling, it is particularly edifying to see how this knowledge has rapidly been translated to human immune disease.  Not only have genome-wide assocn. studies demonstrated that this pathway is highly relevant to human autoimmunity, but targeting JAKs is now a reality in immune-mediated disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc6dj5Zf9fdLVg90H21EOLACvtfcHk0ljDBu5kKRhS8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFWqt7g%253D&md5=de187a0555549f9f00f5a41052c05352</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPlenge%26aufirst%3DR.%26atitle%3DJAK%2520and%2520STAT%2520signaling%2520molecules%2520in%2520immunoregulation%2520and%2520immune-mediated%2520disease%26jtitle%3DImmunity%26date%3D2012%26volume%3D36%26spage%3D542%26epage%3D550%26doi%3D10.1016%2Fj.immuni.2012.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span> <span> </span><span class="NLM_article-title">The JAK-STAT pathway: Impact on human disease and therapeutic intervention</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1146/annurev-med-051113-024537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1146%2Fannurev-med-051113-024537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=25587654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFyhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2015&pages=311-328&author=J.+J.+O%E2%80%99Sheaauthor=D.+M.+Schwartzauthor=A.+V.+Villarinoauthor=M.+Gadinaauthor=I.+B.+McInnesauthor=A.+Laurence&title=The+JAK-STAT+pathway%3A+Impact+on+human+disease+and+therapeutic+intervention&doi=10.1146%2Fannurev-med-051113-024537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The JAK-STAT pathway: impact on human disease and therapeutic intervention</span></div><div class="casAuthors">O'Shea, John J.; Schwartz, Daniella M.; Villarino, Alejandro V.; Gadina, Massimo; McInnes, Iain B.; Laurence, Arian</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">311-328</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The Janus kinase (JAK)-signal transducer of activators of transcription (STAT) pathway is now recognized as an evolutionarily conserved signaling pathway employed by diverse cytokines, interferons, growth factors, and related mols.  This pathway provides an elegant and remarkably straightforward mechanism whereby extracellular factors control gene expression.  It thus serves as a fundamental paradigm for how cells sense environmental cues and interpret these signals to regulate cell growth and differentiation.  Genetic mutations and polymorphisms are functionally relevant to a variety of human diseases, esp. cancer and immune-related conditions.  The clin. relevance of the pathway has been confirmed by the emergence of a new class of therapeutics that targets JAKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMxvQCRiTbL7Vg90H21EOLACvtfcHk0ljDBu5kKRhS8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFyhsLY%253D&md5=19182154f1a046df039eb4a37b66bf78</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-051113-024537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-051113-024537%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DSchwartz%26aufirst%3DD.%2BM.%26aulast%3DVillarino%26aufirst%3DA.%2BV.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DLaurence%26aufirst%3DA.%26atitle%3DThe%2520JAK-STAT%2520pathway%253A%2520Impact%2520on%2520human%2520disease%2520and%2520therapeutic%2520intervention%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2015%26volume%3D66%26spage%3D311%26epage%3D328%26doi%3D10.1146%2Fannurev-med-051113-024537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5023</span>– <span class="NLM_lpage">5038</span>, <span class="refDoi"> DOI: 10.1021/jm401490p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401490p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5023-5038&author=J.+D.+Clarkauthor=M.+E.+Flanaganauthor=J.-B.+Telliez&title=Discovery+and+development+of+Janus+kinase+%28JAK%29+inhibitors+for+inflammatory+diseases&doi=10.1021%2Fjm401490p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span></div><div class="casAuthors">Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the pathogenesis of inflammatory diseases.  As a consequence, the JAKs have received significant attention in recent years from the pharmaceutical and biotechnol. industries as therapeutic targets.  Here, we provide a review of the JAK pathways, the structure, function, and activation of the JAK enzymes followed by a detailed look at the JAK inhibitors currently in the clinic or approved for these indications.  Finally, a perspective is provided on what the past decade of research with JAK inhibitors for inflammatory indications has taught along with thoughts on what the future may hold in terms of addressing the opportunities and challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f7W5g8N6brVg90H21EOLACvtfcHk0ljDBu5kKRhS8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D&md5=6763ae2d46f52ddcda23e235a60634ae</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401490p%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitors%2520for%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5023%26epage%3D5038%26doi%3D10.1021%2Fjm401490p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verstovsek, S.</span></span> <span> </span><span class="NLM_article-title">Investigational Janus kinase inhibitors</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">699</span>, <span class="refDoi"> DOI: 10.1517/13543784.2013.774373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1517%2F13543784.2013.774373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=23432430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1elu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=687-699&author=C.+S.+Tamauthor=S.+Verstovsek&title=Investigational+Janus+kinase+inhibitors&doi=10.1517%2F13543784.2013.774373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Investigational Janus kinase inhibitors</span></div><div class="casAuthors">Tam, Constantine S.; Verstovsek, Srdan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">687-699</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Dysregulation of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway is central to the pathophysiol. of myeloproliferative neoplasms (MPN).  Small mol. inhibitors of JAK family members are currently under investigation for the treatment of MPN.  Of these, ruxolitinib has received approval for clin. use in myelofibrosis in the United States and Europe.  Areas covered: The clin. results and future development program of major JAK inhibitors, including ruxolitinib, CYT387, SAR302503, lestaurtinib, pacritinib, XL-019, LY2784544, BMS-911453, AZD1480 and NS-018 are reviewed.  Expert opinion: JAK inhibitors are effective in relieving organomegaly (splenomegaly and hepatomegaly) and constitutional symptoms of myelofibrosis and some modulate inflammatory cytokines.  However, they have little impact on disease burden and bone marrow fibrosis.  The relationship between clin. efficacy, toxicity profile and specificity of JAK family member inhibition (i.e., JAK2 specific vs JAK1/JAK2 active) is poorly defined.  Novel resistance mechanisms including heterodimerization of JAK2 with other JAK family members have been described.  It is likely that the future lies in the use of rational drug combinations that target multiple signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxyHypQHzQRbVg90H21EOLACvtfcHk0ljDBu5kKRhS8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1elu7s%253D&md5=96ecf6ef9de1ddc7dcbd79eaa48ed29a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F13543784.2013.774373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2013.774373%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DC.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DInvestigational%2520Janus%2520kinase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2013%26volume%3D22%26spage%3D687%26epage%3D699%26doi%3D10.1517%2F13543784.2013.774373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ste Marie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leusink-Muis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ark, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fokerts, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, E.</span></span> <span> </span><span class="NLM_article-title">R256 is a potent and selective IL-13/4 receptor signaling inhibitor that reduces inflammation in a mouse model of chronic asthma</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>185</i></span>, <span class="NLM_elocation-id">A2843</span> <span class="refDoi"> DOI: 10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1164%2Fajrccm-conference.2012.185.1_meetingabstracts.a2843" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2012&author=V.+Taylorauthor=S.+Siuauthor=C.+Youngauthor=L.+Ste+Marieauthor=H.+Renauthor=T.+Leusink-Muisauthor=I.+Van+Arkauthor=G.+Fokertsauthor=G.+Parkauthor=P.+Pineauthor=H.+Liauthor=E.+Masuda&title=R256+is+a+potent+and+selective+IL-13%2F4+receptor+signaling+inhibitor+that+reduces+inflammation+in+a+mouse+model+of+chronic+asthma&doi=10.1164%2Fajrccm-conference.2012.185.1_meetingabstracts.a2843"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1164%2Fajrccm-conference.2012.185.1_meetingabstracts.a2843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm-conference.2012.185.1_meetingabstracts.a2843%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DV.%26aulast%3DSiu%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DSte%2BMarie%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DLeusink-Muis%26aufirst%3DT.%26aulast%3DVan%2BArk%26aufirst%3DI.%26aulast%3DFokerts%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMasuda%26aufirst%3DE.%26atitle%3DR256%2520is%2520a%2520potent%2520and%2520selective%2520IL-13%252F4%2520receptor%2520signaling%2520inhibitor%2520that%2520reduces%2520inflammation%2520in%2520a%2520mouse%2520model%2520of%2520chronic%2520asthma%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2012%26volume%3D185%26doi%3D10.1164%2Fajrccm-conference.2012.185.1_meetingabstracts.a2843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pine, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelfand, E. W.</span></span> <span> </span><span class="NLM_article-title">Janus kinase (JAK) 3 inhibitor, R256, attenuates allergen-induced airway hyperresponsiveness and airway inflammation in mice</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>185</i></span>, <span class="NLM_elocation-id">A2766</span> <span class="refDoi"> DOI: 10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A2766</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1164%2Fajrccm-conference.2012.185.1_MeetingAbstracts.A2766" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2012&author=S.+Ashinoauthor=K.+Takedaauthor=P.+R.+Pineauthor=E.+W.+Gelfand&title=Janus+kinase+%28JAK%29+3+inhibitor%2C+R256%2C+attenuates+allergen-induced+airway+hyperresponsiveness+and+airway+inflammation+in+mice&doi=10.1164%2Fajrccm-conference.2012.185.1_MeetingAbstracts.A2766"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1164%2Fajrccm-conference.2012.185.1_MeetingAbstracts.A2766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm-conference.2012.185.1_MeetingAbstracts.A2766%26sid%3Dliteratum%253Aachs%26aulast%3DAshino%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DPine%26aufirst%3DP.%2BR.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DJanus%2520kinase%2520%2528JAK%2529%25203%2520inhibitor%252C%2520R256%252C%2520attenuates%2520allergen-induced%2520airway%2520hyperresponsiveness%2520and%2520airway%2520inflammation%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2012%26volume%3D185%26doi%3D10.1164%2Fajrccm-conference.2012.185.1_MeetingAbstracts.A2766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabnis, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortum, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a pan-Janus kinase inhibitor clinical candidate (PF-06263276) suitable for inhaled and topical delivery for the treatment of inflammatory diseases of the lungs and skin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01634</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01634" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSnsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=767-786&author=P.+Jonesauthor=R.+I.+Storerauthor=Y.+A.+Sabnisauthor=F.+M.+Wakenhutauthor=G.+A.+Whitlockauthor=K.+S.+Englandauthor=T.+Mukaiyamaauthor=C.+M.+Dehnhardtauthor=J.+W.+Coeauthor=S.+W.+Kortumauthor=J.+E.+Chrencikauthor=D.+G.+Brownauthor=R.+M.+Jonesauthor=J.+R.+Murphyauthor=T.+Yeohauthor=P.+Morganauthor=I.+Kilty&title=Design+and+synthesis+of+a+pan-Janus+kinase+inhibitor+clinical+candidate+%28PF-06263276%29+suitable+for+inhaled+and+topical+delivery+for+the+treatment+of+inflammatory+diseases+of+the+lungs+and+skin&doi=10.1021%2Facs.jmedchem.6b01634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin</span></div><div class="casAuthors">Jones, Peter; Storer, R. Ian; Sabnis, Yogesh A.; Wakenhut, Florian M.; Whitlock, Gavin A.; England, Katherine S.; Mukaiyama, Takasuke; Dehnhardt, Christoph M.; Coe, Jotham W.; Kortum, Steve W.; Chrencik, Jill E.; Brown, David G.; Jones, Rhys M.; Murphy, John R.; Yeoh, Thean; Morgan, Paul; Kilty, Iain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">767-786</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a structure-based computational method for identification of structurally novel JAK inhibitors predicted to bind beyond the ATP binding site, a potent series of indazoles was identified as selective pan-JAK inhibitors with a type 1.5 binding mode.  Optimization of the series for potency and increased duration of action commensurate with inhaled or topical delivery resulted in PF-06263276 which was advanced into clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEt2oMBlGsBbVg90H21EOLACvtfcHk0lgAYB_4VqKCyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSnsr3J&md5=a69247c21ff53a3b7d9c63cf0af72101</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01634%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DWakenhut%26aufirst%3DF.%2BM.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26aulast%3DEngland%26aufirst%3DK.%2BS.%26aulast%3DMukaiyama%26aufirst%3DT.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DKortum%26aufirst%3DS.%2BW.%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DMurphy%26aufirst%3DJ.%2BR.%26aulast%3DYeoh%26aufirst%3DT.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DKilty%26aufirst%3DI.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520pan-Janus%2520kinase%2520inhibitor%2520clinical%2520candidate%2520%2528PF-06263276%2529%2520suitable%2520for%2520inhaled%2520and%2520topical%2520delivery%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%2520of%2520the%2520lungs%2520and%2520skin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D767%26epage%3D786%26doi%3D10.1021%2Facs.jmedchem.6b01634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiegman, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiffert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossios, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adcock, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothaul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Main, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, F.</span></span> <span> </span><span class="NLM_article-title">The selective pan-Janus kinase (JAK) inhibitor VR588 demonstrates potent anti-inflammatory activity in a murine chronic house dust mite (HDM) model of asthma</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>191</i></span>, <span class="NLM_elocation-id">A6435</span> <span class="refDoi"> DOI: 10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A6435</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1164%2Fajrccm-conference.2015.191.1_MeetingAbstracts.A6435" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2015&author=C.+H.+Wiegmanauthor=K.+E.+Russellauthor=J.+Seiffertauthor=C.+Rossiosauthor=I.+M.+Adcockauthor=A.+Rothaulauthor=M.+Mainauthor=F.+Morgan&title=The+selective+pan-Janus+kinase+%28JAK%29+inhibitor+VR588+demonstrates+potent+anti-inflammatory+activity+in+a+murine+chronic+house+dust+mite+%28HDM%29+model+of+asthma&doi=10.1164%2Fajrccm-conference.2015.191.1_MeetingAbstracts.A6435"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1164%2Fajrccm-conference.2015.191.1_MeetingAbstracts.A6435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm-conference.2015.191.1_MeetingAbstracts.A6435%26sid%3Dliteratum%253Aachs%26aulast%3DWiegman%26aufirst%3DC.%2BH.%26aulast%3DRussell%26aufirst%3DK.%2BE.%26aulast%3DSeiffert%26aufirst%3DJ.%26aulast%3DRossios%26aufirst%3DC.%26aulast%3DAdcock%26aufirst%3DI.%2BM.%26aulast%3DRothaul%26aufirst%3DA.%26aulast%3DMain%26aufirst%3DM.%26aulast%3DMorgan%26aufirst%3DF.%26atitle%3DThe%2520selective%2520pan-Janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520VR588%2520demonstrates%2520potent%2520anti-inflammatory%2520activity%2520in%2520a%2520murine%2520chronic%2520house%2520dust%2520mite%2520%2528HDM%2529%2520model%2520of%2520asthma%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2015%26volume%3D191%26doi%3D10.1164%2Fajrccm-conference.2015.191.1_MeetingAbstracts.A6435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, P. J.</span></span> <span> </span><span class="NLM_article-title">The JAK-STAT signaling pathway: input and output integration</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">2623</span>– <span class="NLM_lpage">2629</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.178.5.2623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.4049%2Fjimmunol.178.5.2623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=17312100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFSju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=2623-2629&author=P.+J.+Murray&title=The+JAK-STAT+signaling+pathway%3A+input+and+output+integration&doi=10.4049%2Fjimmunol.178.5.2623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The JAK-STAT Signaling Pathway: Input and Output Integration</span></div><div class="casAuthors">Murray, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2623-2629</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">A review.  Universal and essential to cytokine receptor signaling, the JAK-STAT pathway is one of the best understood signal transduction cascades.  Almost 40 cytokine receptors signal through combinations of four JAK and seven STAT family members, suggesting commonality across the JAK-STAT signaling system.  Despite intense study, there remain substantial gaps in understanding how the cascades are activated and regulated.  Using the examples of the IL-6 and IL-10 receptors, the author discusses how diverse outcomes in gene expression result from regulatory events that effect the JAK1-STAT3 pathway, common to both receptors.  I also consider receptor preferences by different STATs and interpretive problems in the use of STAT-deficient cells and mice.  Finally, the author considers how the suppressor of cytokine signaling (SOCS) proteins regulate the quality and quantity of STAT signals from cytokine receptors.  New data suggests that SOCS proteins introduce addnl. diversity into the JAK-STAT pathway by adjusting the output of activated STATs that alters downstream gene activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcUsn_Apl_EbVg90H21EOLACvtfcHk0lgfkAJ9I3i8AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFSju78%253D&md5=4f3eb8e58b729f4dab66ab7c1a2dcdab</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.178.5.2623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.178.5.2623%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520JAK-STAT%2520signaling%2520pathway%253A%2520input%2520and%2520output%2520integration%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D2623%26epage%3D2629%26doi%3D10.4049%2Fjimmunol.178.5.2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yew-Booth, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrell, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belvisi, M. G.</span></span> <span> </span><span class="NLM_article-title">JAK-STAT pathway activation in COPD</span>. <i>Eur. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.1183/09031936.00228414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1183%2F09031936.00228414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=26113679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1yltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2015&pages=843-845&author=L.+Yew-Boothauthor=M.+A.+Birrellauthor=M.+S.+Lauauthor=K.+Bakerauthor=V.+Jonesauthor=I.+Kiltyauthor=M.+G.+Belvisi&title=JAK-STAT+pathway+activation+in+COPD&doi=10.1183%2F09031936.00228414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">JAK-STAT pathway activation in COPD</span></div><div class="casAuthors">Yew-Booth, Liang; Birrell, Mark A.; Lau, Ming Sum; Baker, Katie; Jones, Victoria; Kilty, Iain; Belvisi, Maria G.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">843-845</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">This paper studies about study on janus kinase-signal transducer and activator of transcription pathway activation in chronic obstructive pulmonary disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3jgAptWVbSrVg90H21EOLACvtfcHk0lgfkAJ9I3i8AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1yltbo%253D&md5=c906b753b01b3b0fcd485bc37812cf49</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1183%2F09031936.00228414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00228414%26sid%3Dliteratum%253Aachs%26aulast%3DYew-Booth%26aufirst%3DL.%26aulast%3DBirrell%26aufirst%3DM.%2BA.%26aulast%3DLau%26aufirst%3DM.%2BS.%26aulast%3DBaker%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DV.%26aulast%3DKilty%26aufirst%3DI.%26aulast%3DBelvisi%26aufirst%3DM.%2BG.%26atitle%3DJAK-STAT%2520pathway%2520activation%2520in%2520COPD%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2015%26volume%3D46%26spage%3D843%26epage%3D845%26doi%3D10.1183%2F09031936.00228414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vale, K.</span></span> <span> </span><span class="NLM_article-title">Targeting the JAK-STAT pathway in the treatment of ‘Th2-high’ severe asthma</span>. <i>Future Med Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.4155/fmc.16.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.4155%2Ffmc.16.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=26934038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=405-419&author=K.+Vale&title=Targeting+the+JAK-STAT+pathway+in+the+treatment+of+%E2%80%98Th2-high%E2%80%99+severe+asthma&doi=10.4155%2Ffmc.16.4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthma</span></div><div class="casAuthors">Vale, Kara</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">405-419</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Severe asthma is a heterogeneous disease characterized by reversible airway obstruction, chronic inflammation and airway remodeling.  Phenotyping and/or endotyping can lead to a more personalized treatment strategy, improving the efficacy of novel drugs.  Atopic asthma is assocd. with high levels of Th2 cells, implicated in a no. of inflammatory responses.  Differentiation of these cells from naive T cells occurs primarily via the JAK-STAT signaling pathway.  Targeting this pathway through inhibition of activating cytokines (IL-4 and IL-13) and their receptors, the JAKs or the STATs, has been shown to have a therapeutic effect on asthma pathol.  There are a no. of novel drugs currently in development, which target various pathway components; these include both biologics and small mols. at various stages of development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQvivwT_WLX7Vg90H21EOLACvtfcHk0lgfkAJ9I3i8AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCgtrY%253D&md5=9daf51792510bb538c966ed03d348bcc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4155%2Ffmc.16.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.16.4%26sid%3Dliteratum%253Aachs%26aulast%3DVale%26aufirst%3DK.%26atitle%3DTargeting%2520the%2520JAK-STAT%2520pathway%2520in%2520the%2520treatment%2520of%2520%25E2%2580%2598Th2-high%25E2%2580%2599%2520severe%2520asthma%26jtitle%3DFuture%2520Med%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D405%26epage%3D419%26doi%3D10.4155%2Ffmc.16.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kudlacz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conklyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCurdy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissette, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P.</span></span> <span> </span><span class="NLM_article-title">The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models</span>. <i>Am. J. Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1046/j.1600-6143.2003.00281.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1046%2Fj.1600-6143.2003.00281.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=14678034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsVCmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=51-57&author=E.+Kudlaczauthor=B.+Perryauthor=P.+Sawyerauthor=M.+Conklynauthor=S.+McCurdyauthor=W.+Brissetteauthor=A.+M.+Flanaganauthor=P.+Changelian&title=The+novel+JAK-3+inhibitor+CP-690550+is+a+potent+immunosuppressive+agent+in+various+murine+models&doi=10.1046%2Fj.1600-6143.2003.00281.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models</span></div><div class="casAuthors">Kudlacz, Elizabeth; Perry, Bret; Sawyer, Perry; Conklyn, Maryrose; McCurdy, Sandra; Brissette, William; Flanagan, Mark; Changelian, Paul</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Transplantation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-57</span>CODEN:
                <span class="NLM_cas:coden">AJTMBR</span>;
        ISSN:<span class="NLM_cas:issn">1600-6135</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">JAK-3 kinase has been shown to play a key role in cytokine signaling via γc, e.g. IL-2, 4, 7, 9, 15, and 21.  The current study describes the immunosuppressive effects of CP-690550, a novel, small mol. inhibitor of JAK-3, in various murine models.  In vitro, CP-690550 effectively inhibited a murine mixed lymphocyte reaction (MLR).  Mice chronically dosed with CP-690550 (1.5-15 mg/kg/day) demonstrated dose- and time-dependent alterations in lymphocyte subsets when examd. by flow cytometry.  The most dramatic change obsd. was a 96% redn. in splenic NK1.1+TCRβ- cell nos. following 21 days of treatment.  Delayed-type hypersensitivity (DTH) responses in sensitized mice were reduced in a dose-dependent manner following treatment with the JAK-3 inhibitor (1.87-30 mg/kg, s.c.).  Extended survival of neonatal Balb/c hearts implanted into the ear pinna of MHC mismatched C3H/HEN mice was obsd. with CP-690550 monotherapy (10-30 mg/kg/day), but improved upon combination with cyclosporin (10 mg/kg/day).  These data support the participation of JAK-3 in various lymphocyte homeostatic functions in mature mice.  Furthermore, the ability of CP-690550 to extend cardiac allograft survival in murine models suggests it may afford a new treatment for prevention of transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhJAFi7wg6_7Vg90H21EOLACvtfcHk0lgns7WM18NtNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsVCmtbs%253D&md5=33f2f4c56b1463036d92943bddd4e0e6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1046%2Fj.1600-6143.2003.00281.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1600-6143.2003.00281.x%26sid%3Dliteratum%253Aachs%26aulast%3DKudlacz%26aufirst%3DE.%26aulast%3DPerry%26aufirst%3DB.%26aulast%3DSawyer%26aufirst%3DP.%26aulast%3DConklyn%26aufirst%3DM.%26aulast%3DMcCurdy%26aufirst%3DS.%26aulast%3DBrissette%26aufirst%3DW.%26aulast%3DFlanagan%26aufirst%3DA.%2BM.%26aulast%3DChangelian%26aufirst%3DP.%26atitle%3DThe%2520novel%2520JAK-3%2520inhibitor%2520CP-690550%2520is%2520a%2520potent%2520immunosuppressive%2520agent%2520in%2520various%2520murine%2520models%26jtitle%3DAm.%2520J.%2520Transplant.%26date%3D2004%26volume%3D4%26spage%3D51%26epage%3D57%26doi%3D10.1046%2Fj.1600-6143.2003.00281.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joetham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pine, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelfand, E. W.</span></span> <span> </span><span class="NLM_article-title">Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">1162</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2013.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.jaci.2013.10.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=24365136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWjt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2014&pages=1162-1174&author=S.+Ashinoauthor=K.+Takedaauthor=H.+Liauthor=V.+Taylorauthor=A.+Joethamauthor=P.+R.+Pineauthor=E.+W.+Gelfand&title=Janus+kinase+1%2F3+signaling+pathways+are+key+initiators+of+TH2+differentiation+and+lung+allergic+responses&doi=10.1016%2Fj.jaci.2013.10.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses</span></div><div class="casAuthors">Ashino, Shigeru; Takeda, Katsuyuki; Li, Hui; Taylor, Vanessa; Joetham, Anthony; Pine, Polly R.; Gelfand, Erwin W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1162-1174.e4</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are regulators of signaling through cytokine receptors.  The importance of JAK1/3 signaling on TH2 differentiation and development of lung allergic responses has not been investigated.  We sought to examine a selective JAK1/3 inhibitor (R256) on differentiation of TH subsets in vitro and on development of ovalbumin (OVA)-induced airway hyperresponsiveness (AHR) and inflammation in an exptl. model of asthma.  A selective JAK1/3 inhibitor was used to assay the importance of this pathway on induction of TH1, TH2, and TH17 differentiation in vitro.  In vivo, the effects of inhibiting JAK1/3 signaling were examd. by administering the inhibitor during the sensitization or allergen challenge phases in the primary challenge model or just before provocative challenge in the secondary challenge model.  Airway inflammation and AHR were examd. after the last airway challenge.  In vitro, R256 inhibited differentiation of TH2 but not TH1 or TH17 cells, which was assocd. with downregulation of signal transducer and activator of transcription (STAT) 6 and STAT5 phosphorylation.  However, once polarized, TH2 cells were unaffected by the inhibitor.  In vivo, R256 administered during the OVA sensitization phase prevented the development of AHR, airway eosinophilia, mucus hypersecretion, and TH2 cytokine prodn. without changes in TH1 and TH17 cytokine levels, indicating that selective blockade of TH2 differentiation was crit.  Inhibitor administration after OVA sensitization but during the challenge phases in the primary or secondary challenge models similarly suppressed AHR, airway eosinophilia, and mucus hypersecretion without any redn. in TH2 cytokine prodn., suggesting the inhibitory effects were downstream of TH2 cytokine receptor signaling pathways.  Targeting the TH2-dependent JAK/STAT activation pathway represents a novel therapeutic approach for the treatment of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr4ff4hwDPqLVg90H21EOLACvtfcHk0lgns7WM18NtNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWjt73P&md5=2157366e5e2485ca7341006324ee0f62</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2013.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2013.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DAshino%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DTaylor%26aufirst%3DV.%26aulast%3DJoetham%26aufirst%3DA.%26aulast%3DPine%26aufirst%3DP.%2BR.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DJanus%2520kinase%25201%252F3%2520signaling%2520pathways%2520are%2520key%2520initiators%2520of%2520TH2%2520differentiation%2520and%2520lung%2520allergic%2520responses%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2014%26volume%3D133%26spage%3D1162%26epage%3D1174%26doi%3D10.1016%2Fj.jaci.2013.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domènech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreño, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calaf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordoba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albertí, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Alba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prats, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span> <span> </span><span class="NLM_article-title">New inhaled pan-JAK inhibitor A is efficacious at reducing allergen-induced airway inflammation in rat</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>189</i></span>, <span class="NLM_elocation-id">A4217</span> <span class="refDoi"> DOI: 10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A4217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1164%2Fajrccm-conference.2014.189.1_MeetingAbstracts.A4217" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2014&author=I.+Ramisauthor=E.+Calamaauthor=A.+Dom%C3%A8nechauthor=C.+Carre%C3%B1oauthor=E.+Calafauthor=M.+Cordobaauthor=J.+Albert%C3%ADauthor=J.+De+Albaauthor=J.+Bachauthor=N.+Pratsauthor=M.+Miralpeix&title=New+inhaled+pan-JAK+inhibitor+A+is+efficacious+at+reducing+allergen-induced+airway+inflammation+in+rat&doi=10.1164%2Fajrccm-conference.2014.189.1_MeetingAbstracts.A4217"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1164%2Fajrccm-conference.2014.189.1_MeetingAbstracts.A4217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm-conference.2014.189.1_MeetingAbstracts.A4217%26sid%3Dliteratum%253Aachs%26aulast%3DRamis%26aufirst%3DI.%26aulast%3DCalama%26aufirst%3DE.%26aulast%3DDom%25C3%25A8nech%26aufirst%3DA.%26aulast%3DCarre%25C3%25B1o%26aufirst%3DC.%26aulast%3DCalaf%26aufirst%3DE.%26aulast%3DCordoba%26aufirst%3DM.%26aulast%3DAlbert%25C3%25AD%26aufirst%3DJ.%26aulast%3DDe%2BAlba%26aufirst%3DJ.%26aulast%3DBach%26aufirst%3DJ.%26aulast%3DPrats%26aufirst%3DN.%26aulast%3DMiralpeix%26aufirst%3DM.%26atitle%3DNew%2520inhaled%2520pan-JAK%2520inhibitor%2520A%2520is%2520efficacious%2520at%2520reducing%2520allergen-induced%2520airway%2520inflammation%2520in%2520rat%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2014%26volume%3D189%26doi%3D10.1164%2Fajrccm-conference.2014.189.1_MeetingAbstracts.A4217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domènech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreño, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Alba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prats, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span> <span> </span><span class="NLM_article-title">Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.pupt.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.pupt.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=28087469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFaqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=60-67&author=E.+Calamaauthor=I.+Ramisauthor=A.+Dom%C3%A8nechauthor=C.+Carre%C3%B1oauthor=J.+De+Albaauthor=N.+Pratsauthor=M.+Miralpeix&title=Tofacitinib+ameliorates+inflammation+in+a+rat+model+of+airway+neutrophilia+induced+by+inhaled+LPS&doi=10.1016%2Fj.pupt.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS</span></div><div class="casAuthors">Calama, Elena; Ramis, Isabel; Domenech, Anna; Carreno, Cristina; De Alba, Jorge; Prats, Neus; Miralpeix, Montserrat</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60-67</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Janus Kinase (JAK) family mediates the cytokine receptor-induced signalling pathways involved in inflammatory processes.  The activation of the signal transducers and activators of transcription (STATs) by JAK kinases is a key point in these pathways.  Four JAK proteins, JAK1, JAK2, JAK3 and tyrosine kinase 2 (Tyk2) assoc. with the intracellular domains of surface cytokine receptors are phosphorylating STATs and modulating gene expression.  The aim of this study was to explore the role of JAK inhibition in an acute model of inhaled lipopolysaccharide (LPS)-induced airway inflammation in rats through evaluating the effects of tofacitinib, a marketed pan-JAK inhibitor.  Specifically, some pulmonary inflammation parameters were studied and the lung STAT3 phosphorylation was assessed as a target engagement marker of JAK inhibition in the model.  Rats were exposed to an aerosol of LPS (0.1 mg/mL) or phosphate-buffered saline (PBS) during 40 min.  Bronchoalveolar lavage fluid (BALF) and lung samples were collected 4 h after PBS or LPS exposure.  Neutrophils in BALF were counted and a panel of cytokines were measured in BALF.  Phosphorylation of STAT3 was studied in lung homogenates by ELISA and localization of phospho-STAT3 (pSTAT3) in lung tissue was also evaluated by immunohistochem.  In order to assess the effect of JAK inhibition, tofacitinib was administered 1 h before challenge at doses of 3, 10 and 30 mg/kg p.o.  Inhaled LPS challenge induced an augment of neutrophils and cytokines in the BALF as well as an increase in pSTAT3 expression in the lungs.  Tofacitinib by oral route inhibited the LPS-induced airway neutrophilia, the levels of some cytokines in the BALF and the phosphorylation of STAT3 in the lung tissue.  In summary, this study shows that JAK inhibition ameliorates inhaled LPS-induced airway inflammation in rats, suggesting that at least JAK/STAT3 signalling is involved in the establishment of the pulmonary neutrophilia induced by LPS.  JAKs inhibitors should be further investigated as a potential therapy for respiratory inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphnUWqHs2borVg90H21EOLACvtfcHk0lgns7WM18NtNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFaqsbk%253D&md5=58debbe489a440dbbd54508d4083e1d7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DCalama%26aufirst%3DE.%26aulast%3DRamis%26aufirst%3DI.%26aulast%3DDom%25C3%25A8nech%26aufirst%3DA.%26aulast%3DCarre%25C3%25B1o%26aufirst%3DC.%26aulast%3DDe%2BAlba%26aufirst%3DJ.%26aulast%3DPrats%26aufirst%3DN.%26aulast%3DMiralpeix%26aufirst%3DM.%26atitle%3DTofacitinib%2520ameliorates%2520inflammation%2520in%2520a%2520rat%2520model%2520of%2520airway%2520neutrophilia%2520induced%2520by%2520inhaled%2520LPS%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2017%26spage%3D60%26epage%3D67%26doi%3D10.1016%2Fj.pupt.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruwanpura, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlahos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramm, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardin, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozinovski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, B. J.</span></span> <span> </span><span class="NLM_article-title">Deregulated stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice</span>. <i>Am. J. Physiol.: Lung Cell. Mol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">L627</span>– <span class="NLM_lpage">L639</span>, <span class="refDoi"> DOI: 10.1152/ajplung.00285.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1152%2Fajplung.00285.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=22268122" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2012&pages=L627-L639&author=S.+M.+Ruwanpuraauthor=L.+McLeodauthor=A.+Millerauthor=J.+Jonesauthor=R.+Vlahosauthor=G.+Rammauthor=A.+Longanoauthor=P.+G.+Bardinauthor=S.+Bozinovskiauthor=G.+P.+Andersonauthor=B.+J.+Jenkins&title=Deregulated+stat3+signaling+dissociates+pulmonary+inflammation+from+emphysema+in+gp130+mutant+mice&doi=10.1152%2Fajplung.00285.2011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00285.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00285.2011%26sid%3Dliteratum%253Aachs%26aulast%3DRuwanpura%26aufirst%3DS.%2BM.%26aulast%3DMcLeod%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DVlahos%26aufirst%3DR.%26aulast%3DRamm%26aufirst%3DG.%26aulast%3DLongano%26aufirst%3DA.%26aulast%3DBardin%26aufirst%3DP.%2BG.%26aulast%3DBozinovski%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DG.%2BP.%26aulast%3DJenkins%26aufirst%3DB.%2BJ.%26atitle%3DDeregulated%2520stat3%2520signaling%2520dissociates%2520pulmonary%2520inflammation%2520from%2520emphysema%2520in%2520gp130%2520mutant%2520mice%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Lung%2520Cell.%2520Mol.%2520Physiol.%26date%3D2012%26volume%3D302%26spage%3DL627%26epage%3DL639%26doi%3D10.1152%2Fajplung.00285.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullings, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puddicombe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lordan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucchieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djukanovic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howarth, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holgate, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. E.</span></span> <span> </span><span class="NLM_article-title">Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">832</span>– <span class="NLM_lpage">838</span>, <span class="refDoi"> DOI: 10.1067/mai.2001.119554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1067%2Fmai.2001.119554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=11692112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVGlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=832-838&author=R.+E.+Mullingsauthor=S.+J.+Wilsonauthor=S.+M.+Puddicombeauthor=J.+L.+Lordanauthor=F.+Bucchieriauthor=R.+Djukanovicauthor=P.+H.+Howarthauthor=S.+Harperauthor=S.+T.+Holgateauthor=D.+E.+Davies&title=Signal+transducer+and+activator+of+transcription+6+%28STAT-6%29+expression+and+function+in+asthmatic+bronchial+epithelium&doi=10.1067%2Fmai.2001.119554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium</span></div><div class="casAuthors">Mullings, Rebecca E.; Wilson, Susan J.; Puddicombe, Sarah M.; Lordan, James L.; Bucchieri, Fabio; Djukanovic, Ratko; Howarth, Peter H.; Harper, Steven; Holgate, Stephen T.; Davies, Donna E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">832-838</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">Asthma is assocd. with increased prodn. of IL-4 and IL-13.  Because many of the effects of these cytokines are mediated by activation of signal transducer and activator of transcription 6 (STAT-6), we investigated expression and function of this transcription factor in the airways.  STAT-6 expression was investigated through use of immunohistochem. or RT-PCR applied to bronchial biopsy specimens or brushings from normal control or asthmatic subjects.  STAT-6 function was investigated by means of Western blotting and ELISA applied to primary epithelial cell cultures.  Immunohistochem. revealed that the bronchial epithelium was the major site of STAT-6 expression, both cytoplasmic and nuclear staining being obsd.  The level of STAT-6 expression in subjects with mild asthma (median [range] percent epithelial staining, 3.4% [0% to 16.0%]; n = 14) did not differ significantly from that in normal controls (4.7% [0.0% to 20.0%]; n = 11); however, in subjects with severe asthma, epithelial STAT-6 expression (13.7% [4.8% to 25.7%]; n = 9) was increased in comparison with subjects with mild asthma and normal controls (P < .05).  RT-PCR anal. showed that epithelial STAT-6 expression was heterogeneous and comprised both full-length STAT-6 and the dominant-neg. variant that lacks the SH2 domain.  Treatment of primary cultures of bronchial epithelial cells with IL-4 resulted in STAT-6 phosphorylation and stimulation of IL-8 secretion; however, no difference in the responses of epithelial cells was obsd. between normal (n = 12) and asthmatic (n = 14) donors.  These data demonstrate expression and activation of STAT-6 in normal and asthmatic bronchial epithelium.  The activity of this transcription factor is likely to play a key role in mediating the responses of the bronchial epithelium to TH2 cytokines that are characteristic of the asthmatic phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq76lU-gxy-3rVg90H21EOLACvtfcHk0lgk6FEtb0CtTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVGlug%253D%253D&md5=96868c50b23c6578fea3f777ff295f12</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1067%2Fmai.2001.119554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmai.2001.119554%26sid%3Dliteratum%253Aachs%26aulast%3DMullings%26aufirst%3DR.%2BE.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DPuddicombe%26aufirst%3DS.%2BM.%26aulast%3DLordan%26aufirst%3DJ.%2BL.%26aulast%3DBucchieri%26aufirst%3DF.%26aulast%3DDjukanovic%26aufirst%3DR.%26aulast%3DHowarth%26aufirst%3DP.%2BH.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26atitle%3DSignal%2520transducer%2520and%2520activator%2520of%2520transcription%25206%2520%2528STAT-6%2529%2520expression%2520and%2520function%2520in%2520asthmatic%2520bronchial%2520epithelium%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2001%26volume%3D108%26spage%3D832%26epage%3D838%26doi%3D10.1067%2Fmai.2001.119554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christodoulopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemiere, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulet, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laviolette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivenstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamid, Q.</span></span> <span> </span><span class="NLM_article-title">TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">586</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1067/mai.2001.114883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1067%2Fmai.2001.114883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=11295643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1eiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2001&pages=586-591&author=P.+Christodoulopoulosauthor=L.+Cameronauthor=Y.+Nakamuraauthor=C.+Lemiereauthor=S.+Muroauthor=M.+Dugasauthor=L.+P.+Bouletauthor=M.+Lavioletteauthor=R.+Olivensteinauthor=Q.+Hamid&title=TH2+cytokine-associated+transcription+factors+in+atopic+and+nonatopic+asthma%3A+evidence+for+differential+signal+transducer+and+activator+of+transcription+6+expression&doi=10.1067%2Fmai.2001.114883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: Evidence for differential signal transducer and activator of transcription 6 expression</span></div><div class="casAuthors">Christodoulopoulos, Pota; Cameron, Lisa; Nakamura, Yutaka; Lemiere, Catherine; Muro, Shigeo; Dugas, Mario; Boulet, Louis-Philippe; Laviolette, Michel; Olivenstein, Ron; Hamid, Qutayba</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">586-591</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">The expression of IL-4 and IL-5 is increased in patients with atopic asthma compared with control subjects and correlates with indexes of pulmonary function.  In nonatopic asthma the expression of IL-4, unlike IL-5, fails to correlate with pulmonary function, and compared with their atopic counterparts, these patients have fewer cells expressing IL-4 receptor (IL-4R).  As such, a deficiency in the IL-4 signaling pathway may be implicated in nonatopic asthma.  The transcription factors GATA-3 and cMAF mediate IL-4 and IL-5 synthesis, whereas signal transducer and activator of transcription 6 (STAT-6) is crit. for IL-4R signaling.  This study examines the expression profile of these transcription factors in asthma, according to atopic status.  With immunocytochem., the expression of GATA-3, cMAF, and STAT-6 protein was detd. in sections of bronchial biopsy specimens from patients with atopic asthma, patients with nonatopic asthma, and control subjects.  Higher nos. of cells expressing GATA-3 and cMAF were obsd. in patients with atopic and those with nonatopic asthma than in control subjects and patients with tuberculosis.  There were also more STAT-6-immunoreactive cells in patients with atopic and those with nonatopic asthma than in control subjects.  Notably, however, fewer cells expressing STAT-6 protein were obsd. in nonatopic vs. atopic asthma.  These results demonstrate the upregulation of GATA-3 and cMAF in both variants of asthma and indicate that reduced IL-4R signaling, because of lower STAT-6 expression, may be a feature of nonatopic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreuRzqfJ5vlbVg90H21EOLACvtfcHk0lgk6FEtb0CtTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1eiurc%253D&md5=2e4619a6f5da632f326bb2ec5cca0fce</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1067%2Fmai.2001.114883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmai.2001.114883%26sid%3Dliteratum%253Aachs%26aulast%3DChristodoulopoulos%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DL.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DLemiere%26aufirst%3DC.%26aulast%3DMuro%26aufirst%3DS.%26aulast%3DDugas%26aufirst%3DM.%26aulast%3DBoulet%26aufirst%3DL.%2BP.%26aulast%3DLaviolette%26aufirst%3DM.%26aulast%3DOlivenstein%26aufirst%3DR.%26aulast%3DHamid%26aufirst%3DQ.%26atitle%3DTH2%2520cytokine-associated%2520transcription%2520factors%2520in%2520atopic%2520and%2520nonatopic%2520asthma%253A%2520evidence%2520for%2520differential%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25206%2520expression%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2001%26volume%3D107%26spage%3D586%26epage%3D591%26doi%3D10.1067%2Fmai.2001.114883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAK inhibition as a therapeutic strategy for immune and inflammatory diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1038%2Fnrd.2017.201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=29104284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=843-862&author=D.+M.+Schwartzauthor=Y.+Kannoauthor=A.+Villarinoauthor=M.+Wardauthor=M.+Gadinaauthor=J.+J.+O%E2%80%99Shea&title=JAK+inhibition+as+a+therapeutic+strategy+for+immune+and+inflammatory+diseases&doi=10.1038%2Fnrd.2017.201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">JAK inhibition as a therapeutic strategy for immune and inflammatory diseases</span></div><div class="casAuthors">Schwartz, Daniella M.; Kanno, Yuka; Villarino, Alejandro; Ward, Michael; Gadina, Massimo; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">843-862</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The discovery of cytokines as key drivers of immune-mediated diseases has spurred efforts to target their assocd. signalling pathways.  Janus kinases (JAKs) are essential signalling mediators downstream of many pro-inflammatory cytokines, and small-mol. inhibitors of JAKs (jakinibs) have gained traction as safe and efficacious options for the treatment of inflammation-driven pathologies such as rheumatoid arthritis, psoriasis and inflammatory bowel disease.  Building on the clin. success of first-generation jakinibs, second-generation compds. that claim to be more selective are currently undergoing development and proceeding to clin. trials.  However, important questions remain about the advantages and limitations of improved JAK selectivity, optimal routes and dosing regimens and how best to identify patients who will benefit from jakinibs.  This Review discusses the biol. of jakinibs from a translational perspective, focusing on recent insights from clin. trials, the development of novel agents and the use of jakinibs in a spectrum of immune and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9TNpGT01l8rVg90H21EOLACvtfcHk0lgGCpNBvoOm5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqsLnO&md5=4607422f83f94c0c7194935d6d460c31</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.201%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DD.%2BM.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DVillarino%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DM.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAK%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520for%2520immune%2520and%2520inflammatory%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D843%26epage%3D862%26doi%3D10.1038%2Fnrd.2017.201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K.</span></span> <span> </span><span class="NLM_article-title">Optimisation of DMPK by the inhaled route: challenges and approaches</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.2174/138920012800166571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.2174%2F138920012800166571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=22299825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=457-473&author=A.+E.+Cooperauthor=D.+Fergusonauthor=K.+Grime&title=Optimisation+of+DMPK+by+the+inhaled+route%3A+challenges+and+approaches&doi=10.2174%2F138920012800166571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Optimisation of DMPK by the inhaled route: challenges and approaches</span></div><div class="casAuthors">Cooper, Anne E.; Ferguson, Douglas; Grime, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-473</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in inhalation delivery over recent years has led to an expansion in the understanding of lung pharmacokinetics.  Historically optimization of inhaled drugs focused largely on development of material properties, consistent with achieving a good lung deposition, alongside demonstrating appropriate in vivo efficacy with little understanding of the relationship to pharmacokinetics in the lung.  Recent efforts have led to an increased understanding of lung concns. and how to maximize exposure to achieve the desired pharmacol. response at a dose consistent with development of an inhaled product.  Although there is a prerequisite for excellent potency in inhalation delivery, it is essential that this be combined with pharmacokinetic properties that allow sufficient free concn. at the effect site in lung to exert the pharmacol. response for an appropriate dosing interval.  Increases in basicity, polarity and/or decreases in aq. soly. can extend pharmacokinetic duration and assist in finding the right balance between lung and systemic exposure.  Current evidence suggests there are similarities in lung retention in rat and dog and that animal lung concn. data can enable pharmacokinetic-pharmacodynamic relationships to be derived thus providing more confidence in the requirements for man.  Although inhaled delivery is challenging from a pharmacokinetic point of view, direct evaluation of exposure in the target organ has enabled further understanding of the drivers for drug disposition and highlighted the need for further development of predictive lung pharmacokinetic tools in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxztkVtHyCeLVg90H21EOLACvtfcHk0lgGCpNBvoOm5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D&md5=1dec4f52aeda55fe6ea888c289216d94</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F138920012800166571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920012800166571%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DA.%2BE.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DGrime%26aufirst%3DK.%26atitle%3DOptimisation%2520of%2520DMPK%2520by%2520the%2520inhaled%2520route%253A%2520challenges%2520and%2520approaches%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2012%26volume%3D13%26spage%3D457%26epage%3D473%26doi%3D10.2174%2F138920012800166571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnstedt, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paradkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsbury, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintero, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diller, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letourneau, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riviello, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appell, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sills, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quadros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimble, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, M. L.</span></span> <span> </span><span class="NLM_article-title">2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6788</span>– <span class="NLM_lpage">6792</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.09.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.bmcl.2009.09.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=19836234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6788-6792&author=A.+G.+Coleauthor=A.+C.+Bohnstedtauthor=V.+Paradkarauthor=C.+Kingsburyauthor=J.+G.+Quinteroauthor=H.+Parkauthor=Y.+Luauthor=M.+Youauthor=I.+Neaguauthor=D.+J.+Dillerauthor=J.+J.+Letourneauauthor=Y.+Shaoauthor=R.+A.+Jamesauthor=C.+M.+Rivielloauthor=K.+K.+Hoauthor=T.+H.+Linauthor=B.+Wangauthor=K.+C.+Appellauthor=M.+Sillsauthor=E.+Quadrosauthor=E.+F.+Kimbleauthor=M.+H.+Ohlmeyerauthor=M.+L.+Webb&title=2-Benzimidazolyl-9-%28chroman-4-yl%29-purinone+derivatives+as+JAK3+inhibitors&doi=10.1016%2Fj.bmcl.2009.09.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors</span></div><div class="casAuthors">Cole, Andrew G.; Bohnstedt, Adolph C.; Paradkar, Vidyadhar; Kingsbury, Celia; Quintero, Jorge G.; Park, Haengsoon; Lu, Yingchun; You, Ming; Neagu, Irina; Diller, David J.; Letourneau, Jeffrey J.; Shao, Yuefei; James, Ray A.; Riviello, Christopher M.; Ho, Koc-Kan; Lin, Tsung H.; Wang, Bojing; Appell, Kenneth C.; Sills, Matthew; Quadros, Elizabeth; Kimble, Earl F.; Ohlmeyer, Michael H. J.; Webb, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6788-6792</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel class of Janus tyrosine kinase 3 (JAK3) inhibitors based on a 2-benzimidazoylpurinone core structure is described.  Through substitution of the benzimidazoyl moiety and optimization of the N-9 substituent of the purinone, compd. 24 was identified incorporating a chroman-based functional group.  Compd. 24 shows excellent kinase activity, good oral bioavailability and demonstrates efficacy in an acute mechanistic mouse model through inhibition of interleukin-2 (IL-2) induced interferon-γ (IFN-γ) prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbMepBVB2WHrVg90H21EOLACvtfcHk0lgGCpNBvoOm5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGisb%252FE&md5=a72a00cbf7218fe781e6a4b760185fd1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.080%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DBohnstedt%26aufirst%3DA.%2BC.%26aulast%3DParadkar%26aufirst%3DV.%26aulast%3DKingsbury%26aufirst%3DC.%26aulast%3DQuintero%26aufirst%3DJ.%2BG.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DM.%26aulast%3DNeagu%26aufirst%3DI.%26aulast%3DDiller%26aufirst%3DD.%2BJ.%26aulast%3DLetourneau%26aufirst%3DJ.%2BJ.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DJames%26aufirst%3DR.%2BA.%26aulast%3DRiviello%26aufirst%3DC.%2BM.%26aulast%3DHo%26aufirst%3DK.%2BK.%26aulast%3DLin%26aufirst%3DT.%2BH.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DAppell%26aufirst%3DK.%2BC.%26aulast%3DSills%26aufirst%3DM.%26aulast%3DQuadros%26aufirst%3DE.%26aulast%3DKimble%26aufirst%3DE.%2BF.%26aulast%3DOhlmeyer%26aufirst%3DM.%2BH.%26aulast%3DWebb%26aufirst%3DM.%2BL.%26atitle%3D2-Benzimidazolyl-9-%2528chroman-4-yl%2529-purinone%2520derivatives%2520as%2520JAK3%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6788%26epage%3D6792%26doi%3D10.1016%2Fj.bmcl.2009.09.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, C. L.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieth, M.</span></span> <span> </span><span class="NLM_article-title">Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1549</span>– <span class="NLM_lpage">1562</span>, <span class="refDoi"> DOI: 10.1002/jcc.10306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1002%2Fjcc.10306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=12925999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFent70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=1549-1562&author=G.+Wuauthor=D.+H.+Robertsonauthor=C.+L.+Brooksauthor=M.+Vieth&title=Detailed+analysis+of+grid-based+molecular+docking%3A+A+case+study+of+CDOCKER+-+A+CHARMm-based+MD+docking+algorithm&doi=10.1002%2Fjcc.10306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm</span></div><div class="casAuthors">Wu, Guosheng; Robertson, Daniel H.; Brooks, Charles L., III; Vieth, Michal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1549-1562</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The influence of various factors on the accuracy of protein-ligand docking is examd.  The factors investigated include the role of a grid representation of protein-ligand interactions, the initial ligand conformation and orientation, the sampling rate of the energy hyper-surface, and the final minimization.  A representative docking method is used to study these factors, namely, CDOCKER, a mol. dynamics (MD) simulated-annealing-based algorithm.  A major emphasis in these studies is to compare the relative performance and accuracy of various grid-based approxns. to explicit all-atom force field calcns.  In these docking studies, the protein is kept rigid while the ligands are treated as fully flexible and a final minimization step is used to refine the docked poses.  A docking success rate of 74% is obsd. when an explicit all-atom representation of the protein (full force field) is used, while a lower accuracy of 66-76% is obsd. for grid-based methods.  All docking expts. considered a 41-member protein-ligand validation set.  A significant improvement in accuracy (76 vs. 66%) for the grid-based docking is achieved if the explicit all-atom force field is used in a final minimization step to refine the docking poses.  Statistical anal. shows that even lower-accuracy grid-based energy representations can be effectively used when followed with full force field minimization.  The results of these grid-based protocols are statistically indistinguishable from the detailed at. dockings and provide up to a sixfold redn. in computation time.  For the test case examd. here, improving the docking accuracy did not necessarily enhance the ability to est. binding affinities using the docked structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvNo4ih6vcd7Vg90H21EOLACvtfcHk0lgSVxjsYHKFjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFent70%253D&md5=34d16a1774c60ea18a5f7da58f478b71</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fjcc.10306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.10306%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DRobertson%26aufirst%3DD.%2BH.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26aulast%3DVieth%26aufirst%3DM.%26atitle%3DDetailed%2520analysis%2520of%2520grid-based%2520molecular%2520docking%253A%2520A%2520case%2520study%2520of%2520CDOCKER%2520-%2520A%2520CHARMm-based%2520MD%2520docking%2520algorithm%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2003%26volume%3D24%26spage%3D1549%26epage%3D1562%26doi%3D10.1002%2Fjcc.10306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">This series of purinone JAK inhibitors bearing an imidazo[1,2-<i>a</i>]pyridine hinge binder has been covered by the following patent application:</p></div><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, P. R.</span>; <span class="NLM_string-name">González, J.</span>; <span class="NLM_string-name">Gómez, E.</span>; <span class="NLM_string-name">Bach, J.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl Imidazolone Derivatives as JAK Inhibitors</span>. <span class="NLM_patent">WO2011/157397</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+R.+Eastwood&author=J.+Gonz%C3%A1lez&author=E.+G%C3%B3mez&author=J.+Bach&title=Heteroaryl+Imidazolone+Derivatives+as+JAK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEastwood%26aufirst%3DP.%2BR.%26atitle%3DHeteroaryl%2520Imidazolone%2520Derivatives%2520as%2520JAK%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">A similar approach using a pyrazolo[1,5-<i>a</i>]pyridine ring as hinge binder motif has been reported by Palau Pharmax:</p></div><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span>; <span class="NLM_string-name">Salas, J.</span>; <span class="NLM_string-name">Soliva, R.</span>; <span class="NLM_string-name">Rodríguez, S.</span>; <span class="NLM_string-name">Sicre, M.
C.</span></span> <span> </span><span class="NLM_article-title">N-Containing Heteroaryl Derivatives as JAK3 Kinase Inhibitors</span>. <span class="NLM_patent">WO2011/051452</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+Almansa&author=J.+Salas&author=R.+Soliva&author=S.+Rodr%C3%ADguez&author=M.%0AC.+Sicre&title=N-Containing+Heteroaryl+Derivatives+as+JAK3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DN-Containing%2520Heteroaryl%2520Derivatives%2520as%2520JAK3%2520Kinase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">After the publication of Almirall’s patent WO2011/157397, Ligand pharma also reported the use of an imidazo[1,2-a]pyridine ring as hinge binder motif for their JAK inhibitors:</p></div><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, A. G.</span>; <span class="NLM_string-name">James, R. A.</span>; <span class="NLM_string-name">Shao, Y.</span>; <span class="NLM_string-name">Letourneau, J. J.</span>; <span class="NLM_string-name">Quintero, J. G.</span>; <span class="NLM_string-name">Riviello, C. M.</span>; <span class="NLM_string-name">Zhi, L.</span></span> <span> </span><span class="NLM_article-title">Janus Kinase Inhibitor and Methods</span>. <span class="NLM_patent">WO2013/025628</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+G.+Cole&author=R.+A.+James&author=Y.+Shao&author=J.+J.+Letourneau&author=J.+G.+Quintero&author=C.+M.+Riviello&author=L.+Zhi&title=Janus+Kinase+Inhibitor+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DA.%2BG.%26atitle%3DJanus%2520Kinase%2520Inhibitor%2520and%2520Methods%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korniski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmons, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommers, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenbrink, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, T. E.</span></span> <span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.+C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6&doi=10.1016%2Fj.jmb.2010.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0lgSVxjsYHKFjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433%26doi%3D10.1016%2Fj.jmb.2010.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamert, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walden, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilks, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossjohn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucet, I. S.</span></span> <span> </span><span class="NLM_article-title">Dissecting specificity in the Janus kinases: the structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>387</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2009.01.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.jmb.2009.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=19361440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=219-232&author=N.+K.+Williamsauthor=R.+S.+Bamertauthor=O.+Patelauthor=C.+Wangauthor=P.+M.+Waldenauthor=A.+F.+Wilksauthor=E.+Fantinoauthor=J.+Rossjohnauthor=I.+S.+Lucet&title=Dissecting+specificity+in+the+Janus+kinases%3A+the+structures+of+JAK-specific+inhibitors+complexed+to+the+JAK1+and+JAK2+protein+tyrosine+kinase+domains&doi=10.1016%2Fj.jmb.2009.01.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains</span></div><div class="casAuthors">Williams, Neal K.; Bamert, Rebecca S.; Patel, Onisha; Wang, Christina; Walden, Patricia M.; Wilks, Andrew F.; Fantino, Emmanuelle; Rossjohn, Jamie; Lucet, Isabelle S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">219-232</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Janus kinases (JAKs) are a pivotal family of protein tyrosine kinases (PTKs) that play prominent roles in numerous cytokine signaling pathways, with aberrant JAK activity assocd. with a variety of hematopoietic malignancies, cardiovascular diseases and immune-related disorders.  Whereas the structures of the JAK2 and JAK3 PTK domains have been detd., the structure of the JAK1 PTK domain is unknown.  Here, we report the high-resoln. crystal structures of the "active form" of the JAK1 PTK domain in complex with two JAK inhibitors, a tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one (CMP6) and (3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile (CP-690,550), and compare them with the corresponding JAK2 PTK inhibitor complexes.  Both inhibitors bound in a similar manner to JAK1, namely buried deep within a constricted ATP-binding site, thereby providing a basis for the potent inhibition of JAK1.  As expected, the mode of inhibitor binding in JAK1 was very similar to that obsd. in JAK2, highlighting the challenges in developing JAK-specific inhibitors that target the ATP-binding site.  Nevertheless, differences surrounding the JAK1 and JAK2 ATP-binding sites were apparent, thereby providing a platform for the rational design of JAK2- and JAK1-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQDLkMkCgiLbVg90H21EOLACvtfcHk0lgowbjqi9UT_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D&md5=79957755d04323057b5acf7e9d2c56ca</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DN.%2BK.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DPatel%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWalden%26aufirst%3DP.%2BM.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3DLucet%26aufirst%3DI.%2BS.%26atitle%3DDissecting%2520specificity%2520in%2520the%2520Janus%2520kinases%253A%2520the%2520structures%2520of%2520JAK-specific%2520inhibitors%2520complexed%2520to%2520the%2520JAK1%2520and%2520JAK2%2520protein%2520tyrosine%2520kinase%2520domains%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D387%26spage%3D219%26epage%3D232%26doi%3D10.1016%2Fj.jmb.2009.01.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">This screening selectivity panel was mainly formed by kinases inhibited by JAK inhibitors (29) and completed with a selection of diverse representative kinases from the whole kinome (7). Kinases inhibited by JAK inhibitors have been identified through literature analysis and internal profiling of competitors’ compounds. List of selected kinases from the kinome includes EGFR, IGF-1R, IKKα, JNK1α1, JNK2α2, MEK1 and TAK1. JAK inhibitors described in this article have shown poor activity when tested against kinases not included in this panel.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">Compound <b>34</b> was negative for genotoxicity with and without metabolic activation in the GreenScreen HC assays performed at Gentronix (highest concentration tested: 39 μg/mL). In the Ames II, Ames MPF and Ames MPF <i>E. coli</i> Combo mutagenicity assay performed at Xenometrix, <b>34</b> proved to be negative in all strains at the concentrations tested (highest concentration tested: 1581 μg/mL).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':[],'ref35':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing Ze  Wang</span>, <span class="hlFld-ContribAuthor ">Yang Fan  Shi</span>, <span class="hlFld-ContribAuthor ">Yu Peng  Jiang</span>, <span class="hlFld-ContribAuthor ">Yuan Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">Jian Zhong  Huo</span>, <span class="hlFld-ContribAuthor ">Ling  Fei</span>, <span class="hlFld-ContribAuthor ">Jed  LaCoste</span>, <span class="hlFld-ContribAuthor ">Xin Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Bin  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Post-modification preparation of dual-emission <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="135666203853497d5a5a">[email protected]</a> MOFs-based hybrid material and its application in highly sensitive ratiometric sensing for asthma wonder drug-procaterol enhanced by HCO3- and temperature. </span><span class="cited-content_cbyCitation_journal-name">Sensors and Actuators B: Chemical</span><span> <strong>2021,</strong> <em>344 </em>, 130199. <a href="https://doi.org/10.1016/j.snb.2021.130199" title="DOI URL">https://doi.org/10.1016/j.snb.2021.130199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.snb.2021.130199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.snb.2021.130199%26sid%3Dliteratum%253Aachs%26jtitle%3DSensors%2520and%2520Actuators%2520B%253A%2520Chemical%26atitle%3DPost-modification%252Bpreparation%252Bof%252Bdual-emission%252BEu3%25252B%252540ZnII%252BMOFs-based%252Bhybrid%252Bmaterial%252Band%252Bits%252Bapplication%252Bin%252Bhighly%252Bsensitive%252Bratiometric%252Bsensing%252Bfor%252Basthma%252Bwonder%252Bdrug-procaterol%252Benhanced%252Bby%252BHCO3-%252Band%252Btemperature%26aulast%3DWang%26aufirst%3DXing%2BZe%26date%3D2021%26volume%3D344%26spage%3D130199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun  Zhang</span>, <span class="hlFld-ContribAuthor ">Andrew  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridones in drug discovery: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>38 </em>, 127849. <a href="https://doi.org/10.1016/j.bmcl.2021.127849" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127849%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyridones%252Bin%252Bdrug%252Bdiscovery%25253A%252BRecent%252Badvances%26aulast%3DZhang%26aufirst%3DYun%26date%3D2021%26volume%3D38%26spage%3D127849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Lo Bello</span>, <span class="hlFld-ContribAuthor ">Philip M.  Hansbro</span>, <span class="hlFld-ContribAuthor ">Chantal  Donovan</span>, <span class="hlFld-ContribAuthor ">Irene  Coppolino</span>, <span class="hlFld-ContribAuthor ">Sharon  Mumby</span>, <span class="hlFld-ContribAuthor ">Ian M.  Adcock</span>, <span class="hlFld-ContribAuthor ">Gaetano  Caramori</span>. </span><span class="cited-content_cbyCitation_article-title">New drugs under development for COPD. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 419-431. <a href="https://doi.org/10.1080/14728214.2020.1819982" title="DOI URL">https://doi.org/10.1080/14728214.2020.1819982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728214.2020.1819982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728214.2020.1819982%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DNew%252Bdrugs%252Bunder%252Bdevelopment%252Bfor%252BCOPD%26aulast%3DLo%2BBello%26aufirst%3DFederica%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D4%26spage%3D419%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy E  Defnet</span>, <span class="hlFld-ContribAuthor ">Jeffery D  Hasday</span>, <span class="hlFld-ContribAuthor ">Paul  Shapiro</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase inhibitors in the treatment of obstructive pulmonary diseases. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2020,</strong> <em>51 </em>, 11-18. <a href="https://doi.org/10.1016/j.coph.2020.03.005" title="DOI URL">https://doi.org/10.1016/j.coph.2020.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2020.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2020.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DKinase%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Bobstructive%252Bpulmonary%252Bdiseases%26aulast%3DDefnet%26aufirst%3DAmy%2BE%26date%3D2020%26volume%3D51%26spage%3D11%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Luc  Décout</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems—Purines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14915-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14915-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14915-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14915-7%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%2525E2%252580%252594Purines%26aulast%3DD%25C3%25A9cout%26aufirst%3DJean-Luc%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Novel Purinone JAK Inhibitor <b>2</b> Bearing an Imidazo[1,2-<i>a</i>]pyridine Ring as Hinge Binder Motif</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0001.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystallographic structure of human JAK3 binding site in complex with <b>6</b> determined at 2.5 Å resolution [Protein Data Bank (PDB) entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZV">6HZV</a>]. For clarity, only interacting amino acids are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Novel Purinone JAK Inhibitors Bearing an Aminopyridone Ring as Hinge Binder</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0002.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlapping studies with compounds <b>31</b> (pink), <b>34</b> (blue), and tofacitinib (green) showing similar arrangement of nitrile group in all of the cases and also carbonyl disposition of amides in <b>31</b> and tofacitinib.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0003.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystallographic structure of human JAK1 binding site complexed with compound <b>34</b> determined at 2.2 Å resolution (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZU">6HZU</a>). For clarity, only interacting amino acids are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0004.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Heat map showing the kinase inhibition profile of <b>34</b> dosed at 10 μM against a panel of 38 kinases at [ATP] = <i>K</i><sub>m</sub>. Colors correspond to % inhibition of a given kinase as shown in the legend.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0005.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Pharmacokinetic profile of <b>34</b> after intratracheal administration as a nanosuspension.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0006.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of intratracheal administration of compound <b>34</b> on (A) neutrophil count in BALF; <i>n</i> = 14–16/group and (B) IL-6 levels in BALF; <i>n</i> = 9–12/group, in the rat LPS challenge model. *** <i>P</i> < 0.001, ** <i>P</i> < 0.01 treated vs LPS group, analysis of variance + Dunnett’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Initial Imidazopyridine Compounds <b>2</b>–<b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R–NH<sub>2</sub>, <i>N</i>,<i>N</i>-diisopropylethylamine (DIEA), CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to room temperature (rt), 91–95%; (b) H<sub>2</sub>, Pd/C, ZnBr<sub>2</sub>, EtOAc, rt, 97–99%; (c) CDI, THF or CH<sub>3</sub>CN, 80 °C, 65–80%; (d) NaH, SEM–Cl, dimethylformamide (DMF), 0 °C to rt, 86–90%; (e) Pd(PPh<sub>3</sub>)<sub>4</sub>, KOAc, dimethylacetamide (DMA), 150 °C, 35–68%; (f) TBAF, CH<sub>2</sub>Cl<sub>2</sub>, rt to 70 °C or HCl 4 N, 70 °C, 32–83%.</p></p></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Imidazopyridines: Synthesis of N-Alkylated Purinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeI, NaH, DMF, 0 °C or R–Cl, K<sub>2</sub>CO<sub>3</sub>, DMF, rt to 90 °C, 45–88%; (b) <b>46</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, KOAc, DMA, 150 °C, 11–40%; (c) 1-bromo-2-methoxyethane, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 60%; (d) 2-(2-bromoethoxy)tetrahydro-2<i>H</i>-pyran, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 90%; (e) <b>45</b> or <b>46</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, KOAc, DMA, 150 °C then 2 N HCl, rt, 14–77%; (f) (<i>R</i>)- or (<i>S</i>)-4-(chloromethyl)-2,2-dimethyl-1,3-dioxolane, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 52–67%; (g) <b>46</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, KOAc, DMA, 150 °C then 4 N HCl, rt to 70 °C, 43–47%.</p></p></figure><figure data-id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Imidazopyridines: Synthesis of Common Intermediate <b>63</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS, dioxane, H<sub>2</sub>O, 0–60 °C, 79%; (b) NaOMe, NH<sub>4</sub>Cl, MeOH, reflux, 90%; (c) Et<sub>3</sub>N, EtOH, 90 °C, 60%; (d) POCl<sub>3</sub>, 90 °C, 57%.</p></p></figure><figure data-id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0015.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Imidazopyridines: Synthesis of 9-Substituted Purinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R–NH<sub>2</sub>, DIEA, THF, rt, 72–93%; (b) SnCl<sub>2</sub>, EtOH, 80 °C or H<sub>2</sub>, Pd/C, EtOH, 51–97%; (c) CDI, CH<sub>3</sub>CN, 80 °C, 30–74%.</p></p></figure><figure data-id="sch7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0016.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Imidazopyridines: Synthesis of Alcohols <b>15</b> and <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DIEA, THF, rt, 81–87%; (b) H<sub>2</sub>, Pd/C, EtOH, 75–82%; (c) CDI, CH<sub>3</sub>CN, 80 °C, 67–91%; (d) TBAF, THF, rt, 55%; (e) CsF, DMF, 60 °C, 47%.</p></p></figure><figure data-id="sch8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0017.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Pyridones: Early Introduction of Lipophilic Pocket Group<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R–NH<sub>2</sub>, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 56–99%; (b) H<sub>2</sub>, Pt/C, ZnBr<sub>2</sub>, EtOAc, rt [R = (<i>R</i>)-8-fluorochromane, 75%]; H<sub>2</sub>, Pd/C, EtOH, rt [R = (<i>R</i>)-2-ethyl-5-fluoropyridine, 30%] or SnCl<sub>2</sub>, EtOH, reflux [R = <i>trans</i>-2-cyclohexylacetonitrile, 70%]; (c) CDI, CH<sub>3</sub>CN, 80 °C, 63–99%; (d) NaH, SEM–Cl, DMF, 0 °C, 58–83%; (e) Pd<sub>2</sub>(dba)<sub>3</sub>, Xanthphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C, 33–81%; (f) TBAF, THF, 70 °C or trifluoroacetic acid, NH<sub>3</sub>, MeOH, 60 °C, 56–97%; (g) TMSCl, NaI, CH<sub>3</sub>CN, 80 °C, 45–96%.</p></p></figure><figure data-id="sch9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0018.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Aminopyridines <b>93</b>–<b>96</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOMe, MeOH, reflux, 78–87%; (b) H<sub>2</sub>, Pd/C, EtOH, rt, 87–98% or H<sub>2</sub>, Pt/C, ZnBr<sub>2</sub>, EtOAc, rt (R = Cl, 99%); (c) H<sub>2</sub>O<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 97%; (d) NaH, MeI, DMF, 0 °C to rt, 38%; (e) H<sub>2</sub>SO<sub>4</sub>, HNO<sub>3</sub>, 0–85 °C, 43%; (f) MeI, Ag<sub>2</sub>CO<sub>3</sub>, CHCl<sub>3</sub>, rt, 55%.</p></p></figure><figure data-id="sch10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Aminonitrile <b>129</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Boc<sub>2</sub>O, THF, rt, 79%; (b) TsCl, CH<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N, rt, 83%; (c) NaCN, dimethyl sulfoxide (DMSO), 55 °C, 72%; (d) 4 N HCl, dioxane, rt, 89%.</p></p></figure><figure data-id="sch11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Pyridones: Early Introduction of the Hinge Binder Motif<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KSCN, AcOH, 0 °C to rt, 63%; (b) <b>92</b>, Et<sub>3</sub>N, EtOH, 0 °C (49%) or <b>94</b>, DIEA, THF, 0 °C (19%); (c) DIEA, THF, 50 °C, 21–99%; (d) H<sub>2</sub>, Pd/C, EtOH, 88–99%; (e) CDI, CH<sub>3</sub>CN, 70 °C, 21–85%; (f) 4 N HCl, dioxane, rt, 98–99%; (g) 2,5-dioxopyrrolidin-1-yl 2-cyanoacetamide, Et<sub>3</sub>N, DMF, rt, 20–54%; (h) NaI, TMSCl, CH<sub>3</sub>CN, 70 °C (81%).</p></p></figure><figure data-id="sch12" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/medium/jm9b00533_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Pyridones: Synthesis of Compound <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b00533/20191018/images/large/jm9b00533_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00533&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DIEA, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 95%; (b) SnCl<sub>2</sub>, EtOH, 80 °C, 99%; (c) CDI, CH<sub>3</sub>CN, 70 °C, 26%; (d) NaH, SEM–Cl, DMF, 0 °C, 71%; (e) Pd<sub>2</sub>(dba)<sub>3</sub>, Xanthphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C, 79%; (f) TBAF, THF, 70 °C, 45%; (g) H<sub>2</sub>, Pd/C, THF/EtOAc, 88%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAKS and STATs: Biological implications</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.16.1.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1146%2Fannurev.immunol.16.1.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=9597132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADyaK1cXislygurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=293-322&author=W.+J.+Leonardauthor=J.+J.+O%E2%80%99Shea&title=JAKS+and+STATs%3A+Biological+implications&doi=10.1146%2Fannurev.immunol.16.1.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">JAKS and STATS: Biological implications</span></div><div class="casAuthors">Leonard, Warren J.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">293-322</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 185 refs.  Cytokines and interferons are mols. that play central roles in the regulation of a wide array of cellular functions in the lympho-hematopoietic system.  These factors stimulate proliferation, differentiation, and survival signals, as well as specialized functions in host resistance to pathogens.  Although cytokines are known to activate multiple signaling pathways that together mediate these important functions, one of these pathways, the Jak-STAT pathway, is the focus of this chapter.  This pathway is triggered by both cytokines and interferons, and it very rapidly allows the transduction of an extracellular signal into the nucleus.  The pathway uses a novel mechanism in which cytosolic latent transcription factors, known as signal transducers and activators of transcription (STATs), are tyrosine phosphorylated by Janus family tyrosine kinases (Jaks), allowing STAT protein dimerization and nuclear translocation.  STATs then can modulate the expression of target genes.  The basic biol. of this system, including the range of known Jaks and STATs, is discussed, as are the defects in animals and human lacking some of these signaling mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkrO-nJd5D_LVg90H21EOLACvtfcHk0liF07f9QkmTkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislygurs%253D&md5=ac5eeeb0159c2c8769e2cb28720cdf98</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.16.1.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.16.1.293%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAKS%2520and%2520STATs%253A%2520Biological%2520implications%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1998%26volume%3D16%26spage%3D293%26epage%3D322%26doi%3D10.1146%2Fannurev.immunol.16.1.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, W. J.</span></span> <span> </span><span class="NLM_article-title">The JAK-STAT pathway</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/S0161-5890(00)00018-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2FS0161-5890%2800%2900018-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10781830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjslCmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2000&pages=1-11&author=K.+Imadaauthor=W.+J.+Leonard&title=The+JAK-STAT+pathway&doi=10.1016%2FS0161-5890%2800%2900018-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Jak-STAT pathway</span></div><div class="casAuthors">Imada, Kazuroni; Leonard, Warren J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with approx. 130 refs.  A variety of important cellular functions are regulated by cytokines.  The Jak-STAT pathway is one of the important signaling pathways downstream of cytokine receptors.  Following binding of a ligand to its cognate receptor, receptor-assocd. Jaks are activated.  STAT proteins are then in turn activated by tyrosine phosphorylation by Jak kinases, allowing their dimerization and subsequent translocation into the nucleus, where they modulate expression of target genes.  Indispensable functions of Jaks and STATs in cytokine signaling in vivo have been revealed through knockout mouse studies.  Moreover, the recent discovery of the CIS/SOCS/JAB/SSI family of inhibitors has contributed to understanding how this pathway is neg. regulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7-0QIF3Rtn7Vg90H21EOLACvtfcHk0liF07f9QkmTkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjslCmtLc%253D&md5=798909bbe1984c93fcc5760c6a286e57</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0161-5890%2800%2900018-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0161-5890%252800%252900018-3%26sid%3Dliteratum%253Aachs%26aulast%3DImada%26aufirst%3DK.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520JAK-STAT%2520pathway%26jtitle%3DMol.%2520Immunol.%26date%3D2000%26volume%3D37%26spage%3D1%26epage%3D11%26doi%3D10.1016%2FS0161-5890%2800%2900018-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saharinen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, V. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvennoinen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">The Janus kinases (Jaks)</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">253</span> <span class="refDoi"> DOI: 10.1186/gb-2004-5-12-253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1186%2Fgb-2004-5-12-253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=15575979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A280%3ADC%252BD2cngtlKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&author=K.+Yamaokaauthor=P.+Saharinenauthor=M.+Pesuauthor=V.+E.+T.+Holtauthor=O.+Silvennoinenauthor=J.+J.+O%E2%80%99Shea&title=The+Janus+kinases+%28Jaks%29&doi=10.1186%2Fgb-2004-5-12-253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Janus kinases (Jaks)</span></div><div class="casAuthors">Yamaoka Kunihiro; Saharinen Pipsa; Pesu Marko; Holt Vance E T 3rd; Silvennoinen Olli; O'Shea John J</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">253</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Janus kinase (Jak) family is one of ten recognized families of non-receptor tyrosine kinases.  Mammals have four members of this family, Jak1, Jak2, Jak3 and Tyrosine kinase 2 (Tyk2).  Birds, fish and insects also have Jaks.  Each protein has a kinase domain and a catalytically inactive pseudo-kinase domain, and they each bind cytokine receptors through amino-terminal FERM (Band-4.1, ezrin, radixin, moesin) domains.  Upon binding of cytokines to their receptors, Jaks are activated and phosphorylate the receptors, creating docking sites for signaling molecules, especially members of the signal transducer and activator of transcription (Stat) family.  Mutations of the Drosophila Jak (Hopscotch) have revealed developmental defects, and constitutive activation of Jaks in flies and humans is associated with leukemia-like syndromes.  Through the generation of Jak-deficient cell lines and gene-targeted mice, the essential, nonredundant functions of Jaks in cytokine signaling have been established.  Importantly, deficiency of Jak3 is the basis of human autosomal recessive severe combined immunodeficiency (SCID); accordingly, a selective Jak3 inhibitor has been developed, forming a new class of immunosuppressive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0BwDh7EYTsV1C8OJBvdfbfW6udTcc2ebE3VzufvLAs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cngtlKktg%253D%253D&md5=4f8335c37dc8c20245e771224c1d5b12</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2Fgb-2004-5-12-253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2004-5-12-253%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26aulast%3DSaharinen%26aufirst%3DP.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DHolt%26aufirst%3DV.%2BE.%2BT.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Janus%2520kinases%2520%2528Jaks%2529%26jtitle%3DGenome%2520Biol.%26date%3D2004%26volume%3D5%26doi%3D10.1186%2Fgb-2004-5-12-253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borie, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span> <span> </span><span class="NLM_article-title">A new modality for immunosuppression: Targeting the JAK/STAT pathway</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1038/nrd1441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1038%2Fnrd1441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=15232577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Oru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=555-564&author=J.+J.+O%E2%80%99Sheaauthor=M.+Pesuauthor=D.+C.+Borieauthor=P.+S.+Changelian&title=A+new+modality+for+immunosuppression%3A+Targeting+the+JAK%2FSTAT+pathway&doi=10.1038%2Fnrd1441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A new modality for immunosuppression: targeting the JAK/STAT pathway</span></div><div class="casAuthors">O'Shea, John J.; Pesu, Marko; Borie, Dominic C.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">555-564</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Thousands of organs are transplanted each year and millions of people suffer from autoimmune diseases, which creates a need for an armamentarium of immunosuppressive drugs.  Unfortunately, immunosuppressants have unwanted side effects owing, in part, to the fact that they have ubiquitous mol. targets.  Cytokines have emerged as important controllers of the immune response, and work during the past decade has identified Janus kinases (JAKs) and signal transducers, and activators of transcription (STATs), as crucial intracellular elements in cytokine signalling.  Here, we discuss the potential of the JAK/STAT pathway as a target for new immunosuppressants.  In particular, the inhibition of JAK3 seems to be an excellent strategy, because of the selective expression and precise functions of this kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhrBmh4tsEibVg90H21EOLACvtfcHk0lgfMiFdZyYnUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Oru7o%253D&md5=7f09261dbb7c43b4eedb750a35f8e7d5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd1441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1441%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DA%2520new%2520modality%2520for%2520immunosuppression%253A%2520Targeting%2520the%2520JAK%252FSTAT%2520pathway%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D555%26epage%3D564%26doi%3D10.1038%2Fnrd1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilks, A. F.</span></span> <span> </span><span class="NLM_article-title">The JAK kinases: Not just another kinase drug discovery target</span>. <i>Semin. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1016/j.semcdb.2008.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.semcdb.2008.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=18721891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOrur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=319-328&author=A.+F.+Wilks&title=The+JAK+kinases%3A+Not+just+another+kinase+drug+discovery+target&doi=10.1016%2Fj.semcdb.2008.07.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The JAK kinases: Not just another kinase drug discovery target</span></div><div class="casAuthors">Wilks, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">319-328</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  There are four members of the JAK family of protein tyrosine kinases (PTKs) in the human genome.  Since their discovery in 1989, great strides have been made in the understanding of their role in normal intracellular signalling.  Importantly, their roles in pathologies ranging from cancer to immune deficiencies have placed them front and center as potential drug targets.  The recent discovery of the role of activating mutations in the kinase-like domain (KLD) of JAK2 in the development of polycythemia rubra vera, and the elaboration of KLD mutation as a broader mechanism by which cells might become hyperproliferative has sparked enormous interest in the development of JAK selective drug candidates.  I review herein the progress that has been made in the discovery of JAK-targeted inhibitors, and discuss the challenges that face the development of these drugs for use in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrguIVsQ1619LVg90H21EOLACvtfcHk0lgfMiFdZyYnUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOrur%252FK&md5=8e25e860ad9df6b15aa77f549ee39134</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2008.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2008.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DWilks%26aufirst%3DA.%2BF.%26atitle%3DThe%2520JAK%2520kinases%253A%2520Not%2520just%2520another%2520kinase%2520drug%2520discovery%2520target%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2008%26volume%3D19%26spage%3D319%26epage%3D328%26doi%3D10.1016%2Fj.semcdb.2008.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoreschi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Janus kinases in immune cell signaling</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>228</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00754.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+kinases+in+immune+cell+signaling&doi=10.1111%2Fj.1600-065X.2008.00754.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0lhPiMvh4Hs4zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520kinases%2520in%2520immune%2520cell%2520signaling%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D273%26epage%3D287%26doi%3D10.1111%2Fj.1600-065X.2008.00754.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plenge, R.</span></span> <span> </span><span class="NLM_article-title">JAK and STAT signaling molecules in immunoregulation and immune-mediated disease</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2012.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.immuni.2012.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=22520847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFWqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=542-550&author=J.+J.+O%E2%80%99Sheaauthor=R.+Plenge&title=JAK+and+STAT+signaling+molecules+in+immunoregulation+and+immune-mediated+disease&doi=10.1016%2Fj.immuni.2012.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease</span></div><div class="casAuthors">O'Shea, John J.; Plenge, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">542-550</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The discovery of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway, a landmark in cell biol., provided a simple mechanism for gene regulation that dramatically advanced our understanding of the action of hormones, interferons, colony-stimulating factors, and interleukins.  As we learn more about the complexities of immune responses, new insights into the functions of this pathway continue to be revealed, aided by technol. that permits genome-wide views.  As we celebrate the 20th anniversary of the discovery of this paradigm in cell signaling, it is particularly edifying to see how this knowledge has rapidly been translated to human immune disease.  Not only have genome-wide assocn. studies demonstrated that this pathway is highly relevant to human autoimmunity, but targeting JAKs is now a reality in immune-mediated disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc6dj5Zf9fdLVg90H21EOLACvtfcHk0lhPiMvh4Hs4zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFWqt7g%253D&md5=de187a0555549f9f00f5a41052c05352</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPlenge%26aufirst%3DR.%26atitle%3DJAK%2520and%2520STAT%2520signaling%2520molecules%2520in%2520immunoregulation%2520and%2520immune-mediated%2520disease%26jtitle%3DImmunity%26date%3D2012%26volume%3D36%26spage%3D542%26epage%3D550%26doi%3D10.1016%2Fj.immuni.2012.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span> <span> </span><span class="NLM_article-title">The JAK-STAT pathway: Impact on human disease and therapeutic intervention</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1146/annurev-med-051113-024537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1146%2Fannurev-med-051113-024537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=25587654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFyhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2015&pages=311-328&author=J.+J.+O%E2%80%99Sheaauthor=D.+M.+Schwartzauthor=A.+V.+Villarinoauthor=M.+Gadinaauthor=I.+B.+McInnesauthor=A.+Laurence&title=The+JAK-STAT+pathway%3A+Impact+on+human+disease+and+therapeutic+intervention&doi=10.1146%2Fannurev-med-051113-024537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The JAK-STAT pathway: impact on human disease and therapeutic intervention</span></div><div class="casAuthors">O'Shea, John J.; Schwartz, Daniella M.; Villarino, Alejandro V.; Gadina, Massimo; McInnes, Iain B.; Laurence, Arian</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">311-328</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The Janus kinase (JAK)-signal transducer of activators of transcription (STAT) pathway is now recognized as an evolutionarily conserved signaling pathway employed by diverse cytokines, interferons, growth factors, and related mols.  This pathway provides an elegant and remarkably straightforward mechanism whereby extracellular factors control gene expression.  It thus serves as a fundamental paradigm for how cells sense environmental cues and interpret these signals to regulate cell growth and differentiation.  Genetic mutations and polymorphisms are functionally relevant to a variety of human diseases, esp. cancer and immune-related conditions.  The clin. relevance of the pathway has been confirmed by the emergence of a new class of therapeutics that targets JAKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMxvQCRiTbL7Vg90H21EOLACvtfcHk0lhPiMvh4Hs4zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFyhsLY%253D&md5=19182154f1a046df039eb4a37b66bf78</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-051113-024537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-051113-024537%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DSchwartz%26aufirst%3DD.%2BM.%26aulast%3DVillarino%26aufirst%3DA.%2BV.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DLaurence%26aufirst%3DA.%26atitle%3DThe%2520JAK-STAT%2520pathway%253A%2520Impact%2520on%2520human%2520disease%2520and%2520therapeutic%2520intervention%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2015%26volume%3D66%26spage%3D311%26epage%3D328%26doi%3D10.1146%2Fannurev-med-051113-024537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5023</span>– <span class="NLM_lpage">5038</span>, <span class="refDoi"> DOI: 10.1021/jm401490p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401490p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5023-5038&author=J.+D.+Clarkauthor=M.+E.+Flanaganauthor=J.-B.+Telliez&title=Discovery+and+development+of+Janus+kinase+%28JAK%29+inhibitors+for+inflammatory+diseases&doi=10.1021%2Fjm401490p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span></div><div class="casAuthors">Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the pathogenesis of inflammatory diseases.  As a consequence, the JAKs have received significant attention in recent years from the pharmaceutical and biotechnol. industries as therapeutic targets.  Here, we provide a review of the JAK pathways, the structure, function, and activation of the JAK enzymes followed by a detailed look at the JAK inhibitors currently in the clinic or approved for these indications.  Finally, a perspective is provided on what the past decade of research with JAK inhibitors for inflammatory indications has taught along with thoughts on what the future may hold in terms of addressing the opportunities and challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f7W5g8N6brVg90H21EOLACvtfcHk0lhPiMvh4Hs4zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D&md5=6763ae2d46f52ddcda23e235a60634ae</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401490p%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitors%2520for%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5023%26epage%3D5038%26doi%3D10.1021%2Fjm401490p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verstovsek, S.</span></span> <span> </span><span class="NLM_article-title">Investigational Janus kinase inhibitors</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">699</span>, <span class="refDoi"> DOI: 10.1517/13543784.2013.774373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1517%2F13543784.2013.774373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=23432430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1elu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=687-699&author=C.+S.+Tamauthor=S.+Verstovsek&title=Investigational+Janus+kinase+inhibitors&doi=10.1517%2F13543784.2013.774373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Investigational Janus kinase inhibitors</span></div><div class="casAuthors">Tam, Constantine S.; Verstovsek, Srdan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">687-699</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Dysregulation of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway is central to the pathophysiol. of myeloproliferative neoplasms (MPN).  Small mol. inhibitors of JAK family members are currently under investigation for the treatment of MPN.  Of these, ruxolitinib has received approval for clin. use in myelofibrosis in the United States and Europe.  Areas covered: The clin. results and future development program of major JAK inhibitors, including ruxolitinib, CYT387, SAR302503, lestaurtinib, pacritinib, XL-019, LY2784544, BMS-911453, AZD1480 and NS-018 are reviewed.  Expert opinion: JAK inhibitors are effective in relieving organomegaly (splenomegaly and hepatomegaly) and constitutional symptoms of myelofibrosis and some modulate inflammatory cytokines.  However, they have little impact on disease burden and bone marrow fibrosis.  The relationship between clin. efficacy, toxicity profile and specificity of JAK family member inhibition (i.e., JAK2 specific vs JAK1/JAK2 active) is poorly defined.  Novel resistance mechanisms including heterodimerization of JAK2 with other JAK family members have been described.  It is likely that the future lies in the use of rational drug combinations that target multiple signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxyHypQHzQRbVg90H21EOLACvtfcHk0lhxHRmTkqDjrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1elu7s%253D&md5=96ecf6ef9de1ddc7dcbd79eaa48ed29a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F13543784.2013.774373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2013.774373%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DC.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DInvestigational%2520Janus%2520kinase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2013%26volume%3D22%26spage%3D687%26epage%3D699%26doi%3D10.1517%2F13543784.2013.774373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ste Marie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leusink-Muis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ark, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fokerts, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, E.</span></span> <span> </span><span class="NLM_article-title">R256 is a potent and selective IL-13/4 receptor signaling inhibitor that reduces inflammation in a mouse model of chronic asthma</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>185</i></span>, <span class="NLM_elocation-id">A2843</span> <span class="refDoi"> DOI: 10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1164%2Fajrccm-conference.2012.185.1_meetingabstracts.a2843" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2012&author=V.+Taylorauthor=S.+Siuauthor=C.+Youngauthor=L.+Ste+Marieauthor=H.+Renauthor=T.+Leusink-Muisauthor=I.+Van+Arkauthor=G.+Fokertsauthor=G.+Parkauthor=P.+Pineauthor=H.+Liauthor=E.+Masuda&title=R256+is+a+potent+and+selective+IL-13%2F4+receptor+signaling+inhibitor+that+reduces+inflammation+in+a+mouse+model+of+chronic+asthma&doi=10.1164%2Fajrccm-conference.2012.185.1_meetingabstracts.a2843"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1164%2Fajrccm-conference.2012.185.1_meetingabstracts.a2843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm-conference.2012.185.1_meetingabstracts.a2843%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DV.%26aulast%3DSiu%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DSte%2BMarie%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DLeusink-Muis%26aufirst%3DT.%26aulast%3DVan%2BArk%26aufirst%3DI.%26aulast%3DFokerts%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMasuda%26aufirst%3DE.%26atitle%3DR256%2520is%2520a%2520potent%2520and%2520selective%2520IL-13%252F4%2520receptor%2520signaling%2520inhibitor%2520that%2520reduces%2520inflammation%2520in%2520a%2520mouse%2520model%2520of%2520chronic%2520asthma%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2012%26volume%3D185%26doi%3D10.1164%2Fajrccm-conference.2012.185.1_meetingabstracts.a2843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pine, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelfand, E. W.</span></span> <span> </span><span class="NLM_article-title">Janus kinase (JAK) 3 inhibitor, R256, attenuates allergen-induced airway hyperresponsiveness and airway inflammation in mice</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>185</i></span>, <span class="NLM_elocation-id">A2766</span> <span class="refDoi"> DOI: 10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A2766</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1164%2Fajrccm-conference.2012.185.1_MeetingAbstracts.A2766" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2012&author=S.+Ashinoauthor=K.+Takedaauthor=P.+R.+Pineauthor=E.+W.+Gelfand&title=Janus+kinase+%28JAK%29+3+inhibitor%2C+R256%2C+attenuates+allergen-induced+airway+hyperresponsiveness+and+airway+inflammation+in+mice&doi=10.1164%2Fajrccm-conference.2012.185.1_MeetingAbstracts.A2766"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1164%2Fajrccm-conference.2012.185.1_MeetingAbstracts.A2766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm-conference.2012.185.1_MeetingAbstracts.A2766%26sid%3Dliteratum%253Aachs%26aulast%3DAshino%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DPine%26aufirst%3DP.%2BR.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DJanus%2520kinase%2520%2528JAK%2529%25203%2520inhibitor%252C%2520R256%252C%2520attenuates%2520allergen-induced%2520airway%2520hyperresponsiveness%2520and%2520airway%2520inflammation%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2012%26volume%3D185%26doi%3D10.1164%2Fajrccm-conference.2012.185.1_MeetingAbstracts.A2766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabnis, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortum, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a pan-Janus kinase inhibitor clinical candidate (PF-06263276) suitable for inhaled and topical delivery for the treatment of inflammatory diseases of the lungs and skin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01634</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01634" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSnsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=767-786&author=P.+Jonesauthor=R.+I.+Storerauthor=Y.+A.+Sabnisauthor=F.+M.+Wakenhutauthor=G.+A.+Whitlockauthor=K.+S.+Englandauthor=T.+Mukaiyamaauthor=C.+M.+Dehnhardtauthor=J.+W.+Coeauthor=S.+W.+Kortumauthor=J.+E.+Chrencikauthor=D.+G.+Brownauthor=R.+M.+Jonesauthor=J.+R.+Murphyauthor=T.+Yeohauthor=P.+Morganauthor=I.+Kilty&title=Design+and+synthesis+of+a+pan-Janus+kinase+inhibitor+clinical+candidate+%28PF-06263276%29+suitable+for+inhaled+and+topical+delivery+for+the+treatment+of+inflammatory+diseases+of+the+lungs+and+skin&doi=10.1021%2Facs.jmedchem.6b01634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin</span></div><div class="casAuthors">Jones, Peter; Storer, R. Ian; Sabnis, Yogesh A.; Wakenhut, Florian M.; Whitlock, Gavin A.; England, Katherine S.; Mukaiyama, Takasuke; Dehnhardt, Christoph M.; Coe, Jotham W.; Kortum, Steve W.; Chrencik, Jill E.; Brown, David G.; Jones, Rhys M.; Murphy, John R.; Yeoh, Thean; Morgan, Paul; Kilty, Iain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">767-786</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a structure-based computational method for identification of structurally novel JAK inhibitors predicted to bind beyond the ATP binding site, a potent series of indazoles was identified as selective pan-JAK inhibitors with a type 1.5 binding mode.  Optimization of the series for potency and increased duration of action commensurate with inhaled or topical delivery resulted in PF-06263276 which was advanced into clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEt2oMBlGsBbVg90H21EOLACvtfcHk0lixdP8-HpKXBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSnsr3J&md5=a69247c21ff53a3b7d9c63cf0af72101</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01634%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DWakenhut%26aufirst%3DF.%2BM.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26aulast%3DEngland%26aufirst%3DK.%2BS.%26aulast%3DMukaiyama%26aufirst%3DT.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DKortum%26aufirst%3DS.%2BW.%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DMurphy%26aufirst%3DJ.%2BR.%26aulast%3DYeoh%26aufirst%3DT.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DKilty%26aufirst%3DI.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520pan-Janus%2520kinase%2520inhibitor%2520clinical%2520candidate%2520%2528PF-06263276%2529%2520suitable%2520for%2520inhaled%2520and%2520topical%2520delivery%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%2520of%2520the%2520lungs%2520and%2520skin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D767%26epage%3D786%26doi%3D10.1021%2Facs.jmedchem.6b01634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiegman, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiffert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossios, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adcock, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothaul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Main, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, F.</span></span> <span> </span><span class="NLM_article-title">The selective pan-Janus kinase (JAK) inhibitor VR588 demonstrates potent anti-inflammatory activity in a murine chronic house dust mite (HDM) model of asthma</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>191</i></span>, <span class="NLM_elocation-id">A6435</span> <span class="refDoi"> DOI: 10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A6435</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1164%2Fajrccm-conference.2015.191.1_MeetingAbstracts.A6435" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2015&author=C.+H.+Wiegmanauthor=K.+E.+Russellauthor=J.+Seiffertauthor=C.+Rossiosauthor=I.+M.+Adcockauthor=A.+Rothaulauthor=M.+Mainauthor=F.+Morgan&title=The+selective+pan-Janus+kinase+%28JAK%29+inhibitor+VR588+demonstrates+potent+anti-inflammatory+activity+in+a+murine+chronic+house+dust+mite+%28HDM%29+model+of+asthma&doi=10.1164%2Fajrccm-conference.2015.191.1_MeetingAbstracts.A6435"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1164%2Fajrccm-conference.2015.191.1_MeetingAbstracts.A6435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm-conference.2015.191.1_MeetingAbstracts.A6435%26sid%3Dliteratum%253Aachs%26aulast%3DWiegman%26aufirst%3DC.%2BH.%26aulast%3DRussell%26aufirst%3DK.%2BE.%26aulast%3DSeiffert%26aufirst%3DJ.%26aulast%3DRossios%26aufirst%3DC.%26aulast%3DAdcock%26aufirst%3DI.%2BM.%26aulast%3DRothaul%26aufirst%3DA.%26aulast%3DMain%26aufirst%3DM.%26aulast%3DMorgan%26aufirst%3DF.%26atitle%3DThe%2520selective%2520pan-Janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520VR588%2520demonstrates%2520potent%2520anti-inflammatory%2520activity%2520in%2520a%2520murine%2520chronic%2520house%2520dust%2520mite%2520%2528HDM%2529%2520model%2520of%2520asthma%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2015%26volume%3D191%26doi%3D10.1164%2Fajrccm-conference.2015.191.1_MeetingAbstracts.A6435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, P. J.</span></span> <span> </span><span class="NLM_article-title">The JAK-STAT signaling pathway: input and output integration</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">2623</span>– <span class="NLM_lpage">2629</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.178.5.2623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.4049%2Fjimmunol.178.5.2623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=17312100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFSju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=2623-2629&author=P.+J.+Murray&title=The+JAK-STAT+signaling+pathway%3A+input+and+output+integration&doi=10.4049%2Fjimmunol.178.5.2623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The JAK-STAT Signaling Pathway: Input and Output Integration</span></div><div class="casAuthors">Murray, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2623-2629</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">A review.  Universal and essential to cytokine receptor signaling, the JAK-STAT pathway is one of the best understood signal transduction cascades.  Almost 40 cytokine receptors signal through combinations of four JAK and seven STAT family members, suggesting commonality across the JAK-STAT signaling system.  Despite intense study, there remain substantial gaps in understanding how the cascades are activated and regulated.  Using the examples of the IL-6 and IL-10 receptors, the author discusses how diverse outcomes in gene expression result from regulatory events that effect the JAK1-STAT3 pathway, common to both receptors.  I also consider receptor preferences by different STATs and interpretive problems in the use of STAT-deficient cells and mice.  Finally, the author considers how the suppressor of cytokine signaling (SOCS) proteins regulate the quality and quantity of STAT signals from cytokine receptors.  New data suggests that SOCS proteins introduce addnl. diversity into the JAK-STAT pathway by adjusting the output of activated STATs that alters downstream gene activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcUsn_Apl_EbVg90H21EOLACvtfcHk0lixdP8-HpKXBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFSju78%253D&md5=4f3eb8e58b729f4dab66ab7c1a2dcdab</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.178.5.2623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.178.5.2623%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520JAK-STAT%2520signaling%2520pathway%253A%2520input%2520and%2520output%2520integration%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D2623%26epage%3D2629%26doi%3D10.4049%2Fjimmunol.178.5.2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yew-Booth, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrell, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belvisi, M. G.</span></span> <span> </span><span class="NLM_article-title">JAK-STAT pathway activation in COPD</span>. <i>Eur. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.1183/09031936.00228414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1183%2F09031936.00228414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=26113679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1yltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2015&pages=843-845&author=L.+Yew-Boothauthor=M.+A.+Birrellauthor=M.+S.+Lauauthor=K.+Bakerauthor=V.+Jonesauthor=I.+Kiltyauthor=M.+G.+Belvisi&title=JAK-STAT+pathway+activation+in+COPD&doi=10.1183%2F09031936.00228414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">JAK-STAT pathway activation in COPD</span></div><div class="casAuthors">Yew-Booth, Liang; Birrell, Mark A.; Lau, Ming Sum; Baker, Katie; Jones, Victoria; Kilty, Iain; Belvisi, Maria G.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">843-845</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">This paper studies about study on janus kinase-signal transducer and activator of transcription pathway activation in chronic obstructive pulmonary disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3jgAptWVbSrVg90H21EOLACvtfcHk0liNr55m3c9Sbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1yltbo%253D&md5=c906b753b01b3b0fcd485bc37812cf49</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1183%2F09031936.00228414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00228414%26sid%3Dliteratum%253Aachs%26aulast%3DYew-Booth%26aufirst%3DL.%26aulast%3DBirrell%26aufirst%3DM.%2BA.%26aulast%3DLau%26aufirst%3DM.%2BS.%26aulast%3DBaker%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DV.%26aulast%3DKilty%26aufirst%3DI.%26aulast%3DBelvisi%26aufirst%3DM.%2BG.%26atitle%3DJAK-STAT%2520pathway%2520activation%2520in%2520COPD%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2015%26volume%3D46%26spage%3D843%26epage%3D845%26doi%3D10.1183%2F09031936.00228414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vale, K.</span></span> <span> </span><span class="NLM_article-title">Targeting the JAK-STAT pathway in the treatment of ‘Th2-high’ severe asthma</span>. <i>Future Med Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.4155/fmc.16.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.4155%2Ffmc.16.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=26934038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=405-419&author=K.+Vale&title=Targeting+the+JAK-STAT+pathway+in+the+treatment+of+%E2%80%98Th2-high%E2%80%99+severe+asthma&doi=10.4155%2Ffmc.16.4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthma</span></div><div class="casAuthors">Vale, Kara</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">405-419</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Severe asthma is a heterogeneous disease characterized by reversible airway obstruction, chronic inflammation and airway remodeling.  Phenotyping and/or endotyping can lead to a more personalized treatment strategy, improving the efficacy of novel drugs.  Atopic asthma is assocd. with high levels of Th2 cells, implicated in a no. of inflammatory responses.  Differentiation of these cells from naive T cells occurs primarily via the JAK-STAT signaling pathway.  Targeting this pathway through inhibition of activating cytokines (IL-4 and IL-13) and their receptors, the JAKs or the STATs, has been shown to have a therapeutic effect on asthma pathol.  There are a no. of novel drugs currently in development, which target various pathway components; these include both biologics and small mols. at various stages of development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQvivwT_WLX7Vg90H21EOLACvtfcHk0liNr55m3c9Sbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCgtrY%253D&md5=9daf51792510bb538c966ed03d348bcc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4155%2Ffmc.16.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.16.4%26sid%3Dliteratum%253Aachs%26aulast%3DVale%26aufirst%3DK.%26atitle%3DTargeting%2520the%2520JAK-STAT%2520pathway%2520in%2520the%2520treatment%2520of%2520%25E2%2580%2598Th2-high%25E2%2580%2599%2520severe%2520asthma%26jtitle%3DFuture%2520Med%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D405%26epage%3D419%26doi%3D10.4155%2Ffmc.16.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kudlacz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conklyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCurdy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissette, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P.</span></span> <span> </span><span class="NLM_article-title">The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models</span>. <i>Am. J. Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1046/j.1600-6143.2003.00281.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1046%2Fj.1600-6143.2003.00281.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=14678034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsVCmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=51-57&author=E.+Kudlaczauthor=B.+Perryauthor=P.+Sawyerauthor=M.+Conklynauthor=S.+McCurdyauthor=W.+Brissetteauthor=A.+M.+Flanaganauthor=P.+Changelian&title=The+novel+JAK-3+inhibitor+CP-690550+is+a+potent+immunosuppressive+agent+in+various+murine+models&doi=10.1046%2Fj.1600-6143.2003.00281.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models</span></div><div class="casAuthors">Kudlacz, Elizabeth; Perry, Bret; Sawyer, Perry; Conklyn, Maryrose; McCurdy, Sandra; Brissette, William; Flanagan, Mark; Changelian, Paul</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Transplantation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-57</span>CODEN:
                <span class="NLM_cas:coden">AJTMBR</span>;
        ISSN:<span class="NLM_cas:issn">1600-6135</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">JAK-3 kinase has been shown to play a key role in cytokine signaling via γc, e.g. IL-2, 4, 7, 9, 15, and 21.  The current study describes the immunosuppressive effects of CP-690550, a novel, small mol. inhibitor of JAK-3, in various murine models.  In vitro, CP-690550 effectively inhibited a murine mixed lymphocyte reaction (MLR).  Mice chronically dosed with CP-690550 (1.5-15 mg/kg/day) demonstrated dose- and time-dependent alterations in lymphocyte subsets when examd. by flow cytometry.  The most dramatic change obsd. was a 96% redn. in splenic NK1.1+TCRβ- cell nos. following 21 days of treatment.  Delayed-type hypersensitivity (DTH) responses in sensitized mice were reduced in a dose-dependent manner following treatment with the JAK-3 inhibitor (1.87-30 mg/kg, s.c.).  Extended survival of neonatal Balb/c hearts implanted into the ear pinna of MHC mismatched C3H/HEN mice was obsd. with CP-690550 monotherapy (10-30 mg/kg/day), but improved upon combination with cyclosporin (10 mg/kg/day).  These data support the participation of JAK-3 in various lymphocyte homeostatic functions in mature mice.  Furthermore, the ability of CP-690550 to extend cardiac allograft survival in murine models suggests it may afford a new treatment for prevention of transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhJAFi7wg6_7Vg90H21EOLACvtfcHk0liNr55m3c9Sbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsVCmtbs%253D&md5=33f2f4c56b1463036d92943bddd4e0e6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1046%2Fj.1600-6143.2003.00281.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1600-6143.2003.00281.x%26sid%3Dliteratum%253Aachs%26aulast%3DKudlacz%26aufirst%3DE.%26aulast%3DPerry%26aufirst%3DB.%26aulast%3DSawyer%26aufirst%3DP.%26aulast%3DConklyn%26aufirst%3DM.%26aulast%3DMcCurdy%26aufirst%3DS.%26aulast%3DBrissette%26aufirst%3DW.%26aulast%3DFlanagan%26aufirst%3DA.%2BM.%26aulast%3DChangelian%26aufirst%3DP.%26atitle%3DThe%2520novel%2520JAK-3%2520inhibitor%2520CP-690550%2520is%2520a%2520potent%2520immunosuppressive%2520agent%2520in%2520various%2520murine%2520models%26jtitle%3DAm.%2520J.%2520Transplant.%26date%3D2004%26volume%3D4%26spage%3D51%26epage%3D57%26doi%3D10.1046%2Fj.1600-6143.2003.00281.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joetham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pine, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelfand, E. W.</span></span> <span> </span><span class="NLM_article-title">Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">1162</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2013.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.jaci.2013.10.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=24365136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWjt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2014&pages=1162-1174&author=S.+Ashinoauthor=K.+Takedaauthor=H.+Liauthor=V.+Taylorauthor=A.+Joethamauthor=P.+R.+Pineauthor=E.+W.+Gelfand&title=Janus+kinase+1%2F3+signaling+pathways+are+key+initiators+of+TH2+differentiation+and+lung+allergic+responses&doi=10.1016%2Fj.jaci.2013.10.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses</span></div><div class="casAuthors">Ashino, Shigeru; Takeda, Katsuyuki; Li, Hui; Taylor, Vanessa; Joetham, Anthony; Pine, Polly R.; Gelfand, Erwin W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1162-1174.e4</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are regulators of signaling through cytokine receptors.  The importance of JAK1/3 signaling on TH2 differentiation and development of lung allergic responses has not been investigated.  We sought to examine a selective JAK1/3 inhibitor (R256) on differentiation of TH subsets in vitro and on development of ovalbumin (OVA)-induced airway hyperresponsiveness (AHR) and inflammation in an exptl. model of asthma.  A selective JAK1/3 inhibitor was used to assay the importance of this pathway on induction of TH1, TH2, and TH17 differentiation in vitro.  In vivo, the effects of inhibiting JAK1/3 signaling were examd. by administering the inhibitor during the sensitization or allergen challenge phases in the primary challenge model or just before provocative challenge in the secondary challenge model.  Airway inflammation and AHR were examd. after the last airway challenge.  In vitro, R256 inhibited differentiation of TH2 but not TH1 or TH17 cells, which was assocd. with downregulation of signal transducer and activator of transcription (STAT) 6 and STAT5 phosphorylation.  However, once polarized, TH2 cells were unaffected by the inhibitor.  In vivo, R256 administered during the OVA sensitization phase prevented the development of AHR, airway eosinophilia, mucus hypersecretion, and TH2 cytokine prodn. without changes in TH1 and TH17 cytokine levels, indicating that selective blockade of TH2 differentiation was crit.  Inhibitor administration after OVA sensitization but during the challenge phases in the primary or secondary challenge models similarly suppressed AHR, airway eosinophilia, and mucus hypersecretion without any redn. in TH2 cytokine prodn., suggesting the inhibitory effects were downstream of TH2 cytokine receptor signaling pathways.  Targeting the TH2-dependent JAK/STAT activation pathway represents a novel therapeutic approach for the treatment of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr4ff4hwDPqLVg90H21EOLACvtfcHk0lhkbUhsrh20KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWjt73P&md5=2157366e5e2485ca7341006324ee0f62</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2013.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2013.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DAshino%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DTaylor%26aufirst%3DV.%26aulast%3DJoetham%26aufirst%3DA.%26aulast%3DPine%26aufirst%3DP.%2BR.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DJanus%2520kinase%25201%252F3%2520signaling%2520pathways%2520are%2520key%2520initiators%2520of%2520TH2%2520differentiation%2520and%2520lung%2520allergic%2520responses%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2014%26volume%3D133%26spage%3D1162%26epage%3D1174%26doi%3D10.1016%2Fj.jaci.2013.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domènech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreño, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calaf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordoba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albertí, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Alba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prats, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span> <span> </span><span class="NLM_article-title">New inhaled pan-JAK inhibitor A is efficacious at reducing allergen-induced airway inflammation in rat</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>189</i></span>, <span class="NLM_elocation-id">A4217</span> <span class="refDoi"> DOI: 10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A4217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1164%2Fajrccm-conference.2014.189.1_MeetingAbstracts.A4217" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2014&author=I.+Ramisauthor=E.+Calamaauthor=A.+Dom%C3%A8nechauthor=C.+Carre%C3%B1oauthor=E.+Calafauthor=M.+Cordobaauthor=J.+Albert%C3%ADauthor=J.+De+Albaauthor=J.+Bachauthor=N.+Pratsauthor=M.+Miralpeix&title=New+inhaled+pan-JAK+inhibitor+A+is+efficacious+at+reducing+allergen-induced+airway+inflammation+in+rat&doi=10.1164%2Fajrccm-conference.2014.189.1_MeetingAbstracts.A4217"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1164%2Fajrccm-conference.2014.189.1_MeetingAbstracts.A4217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm-conference.2014.189.1_MeetingAbstracts.A4217%26sid%3Dliteratum%253Aachs%26aulast%3DRamis%26aufirst%3DI.%26aulast%3DCalama%26aufirst%3DE.%26aulast%3DDom%25C3%25A8nech%26aufirst%3DA.%26aulast%3DCarre%25C3%25B1o%26aufirst%3DC.%26aulast%3DCalaf%26aufirst%3DE.%26aulast%3DCordoba%26aufirst%3DM.%26aulast%3DAlbert%25C3%25AD%26aufirst%3DJ.%26aulast%3DDe%2BAlba%26aufirst%3DJ.%26aulast%3DBach%26aufirst%3DJ.%26aulast%3DPrats%26aufirst%3DN.%26aulast%3DMiralpeix%26aufirst%3DM.%26atitle%3DNew%2520inhaled%2520pan-JAK%2520inhibitor%2520A%2520is%2520efficacious%2520at%2520reducing%2520allergen-induced%2520airway%2520inflammation%2520in%2520rat%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2014%26volume%3D189%26doi%3D10.1164%2Fajrccm-conference.2014.189.1_MeetingAbstracts.A4217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domènech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreño, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Alba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prats, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span> <span> </span><span class="NLM_article-title">Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.pupt.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.pupt.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=28087469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFaqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=60-67&author=E.+Calamaauthor=I.+Ramisauthor=A.+Dom%C3%A8nechauthor=C.+Carre%C3%B1oauthor=J.+De+Albaauthor=N.+Pratsauthor=M.+Miralpeix&title=Tofacitinib+ameliorates+inflammation+in+a+rat+model+of+airway+neutrophilia+induced+by+inhaled+LPS&doi=10.1016%2Fj.pupt.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS</span></div><div class="casAuthors">Calama, Elena; Ramis, Isabel; Domenech, Anna; Carreno, Cristina; De Alba, Jorge; Prats, Neus; Miralpeix, Montserrat</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60-67</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Janus Kinase (JAK) family mediates the cytokine receptor-induced signalling pathways involved in inflammatory processes.  The activation of the signal transducers and activators of transcription (STATs) by JAK kinases is a key point in these pathways.  Four JAK proteins, JAK1, JAK2, JAK3 and tyrosine kinase 2 (Tyk2) assoc. with the intracellular domains of surface cytokine receptors are phosphorylating STATs and modulating gene expression.  The aim of this study was to explore the role of JAK inhibition in an acute model of inhaled lipopolysaccharide (LPS)-induced airway inflammation in rats through evaluating the effects of tofacitinib, a marketed pan-JAK inhibitor.  Specifically, some pulmonary inflammation parameters were studied and the lung STAT3 phosphorylation was assessed as a target engagement marker of JAK inhibition in the model.  Rats were exposed to an aerosol of LPS (0.1 mg/mL) or phosphate-buffered saline (PBS) during 40 min.  Bronchoalveolar lavage fluid (BALF) and lung samples were collected 4 h after PBS or LPS exposure.  Neutrophils in BALF were counted and a panel of cytokines were measured in BALF.  Phosphorylation of STAT3 was studied in lung homogenates by ELISA and localization of phospho-STAT3 (pSTAT3) in lung tissue was also evaluated by immunohistochem.  In order to assess the effect of JAK inhibition, tofacitinib was administered 1 h before challenge at doses of 3, 10 and 30 mg/kg p.o.  Inhaled LPS challenge induced an augment of neutrophils and cytokines in the BALF as well as an increase in pSTAT3 expression in the lungs.  Tofacitinib by oral route inhibited the LPS-induced airway neutrophilia, the levels of some cytokines in the BALF and the phosphorylation of STAT3 in the lung tissue.  In summary, this study shows that JAK inhibition ameliorates inhaled LPS-induced airway inflammation in rats, suggesting that at least JAK/STAT3 signalling is involved in the establishment of the pulmonary neutrophilia induced by LPS.  JAKs inhibitors should be further investigated as a potential therapy for respiratory inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphnUWqHs2borVg90H21EOLACvtfcHk0lhkbUhsrh20KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFaqsbk%253D&md5=58debbe489a440dbbd54508d4083e1d7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DCalama%26aufirst%3DE.%26aulast%3DRamis%26aufirst%3DI.%26aulast%3DDom%25C3%25A8nech%26aufirst%3DA.%26aulast%3DCarre%25C3%25B1o%26aufirst%3DC.%26aulast%3DDe%2BAlba%26aufirst%3DJ.%26aulast%3DPrats%26aufirst%3DN.%26aulast%3DMiralpeix%26aufirst%3DM.%26atitle%3DTofacitinib%2520ameliorates%2520inflammation%2520in%2520a%2520rat%2520model%2520of%2520airway%2520neutrophilia%2520induced%2520by%2520inhaled%2520LPS%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2017%26spage%3D60%26epage%3D67%26doi%3D10.1016%2Fj.pupt.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruwanpura, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlahos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramm, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardin, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozinovski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, B. J.</span></span> <span> </span><span class="NLM_article-title">Deregulated stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice</span>. <i>Am. J. Physiol.: Lung Cell. Mol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">L627</span>– <span class="NLM_lpage">L639</span>, <span class="refDoi"> DOI: 10.1152/ajplung.00285.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1152%2Fajplung.00285.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=22268122" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2012&pages=L627-L639&author=S.+M.+Ruwanpuraauthor=L.+McLeodauthor=A.+Millerauthor=J.+Jonesauthor=R.+Vlahosauthor=G.+Rammauthor=A.+Longanoauthor=P.+G.+Bardinauthor=S.+Bozinovskiauthor=G.+P.+Andersonauthor=B.+J.+Jenkins&title=Deregulated+stat3+signaling+dissociates+pulmonary+inflammation+from+emphysema+in+gp130+mutant+mice&doi=10.1152%2Fajplung.00285.2011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00285.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00285.2011%26sid%3Dliteratum%253Aachs%26aulast%3DRuwanpura%26aufirst%3DS.%2BM.%26aulast%3DMcLeod%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DVlahos%26aufirst%3DR.%26aulast%3DRamm%26aufirst%3DG.%26aulast%3DLongano%26aufirst%3DA.%26aulast%3DBardin%26aufirst%3DP.%2BG.%26aulast%3DBozinovski%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DG.%2BP.%26aulast%3DJenkins%26aufirst%3DB.%2BJ.%26atitle%3DDeregulated%2520stat3%2520signaling%2520dissociates%2520pulmonary%2520inflammation%2520from%2520emphysema%2520in%2520gp130%2520mutant%2520mice%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Lung%2520Cell.%2520Mol.%2520Physiol.%26date%3D2012%26volume%3D302%26spage%3DL627%26epage%3DL639%26doi%3D10.1152%2Fajplung.00285.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullings, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puddicombe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lordan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucchieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djukanovic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howarth, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holgate, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. E.</span></span> <span> </span><span class="NLM_article-title">Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">832</span>– <span class="NLM_lpage">838</span>, <span class="refDoi"> DOI: 10.1067/mai.2001.119554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1067%2Fmai.2001.119554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=11692112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVGlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=832-838&author=R.+E.+Mullingsauthor=S.+J.+Wilsonauthor=S.+M.+Puddicombeauthor=J.+L.+Lordanauthor=F.+Bucchieriauthor=R.+Djukanovicauthor=P.+H.+Howarthauthor=S.+Harperauthor=S.+T.+Holgateauthor=D.+E.+Davies&title=Signal+transducer+and+activator+of+transcription+6+%28STAT-6%29+expression+and+function+in+asthmatic+bronchial+epithelium&doi=10.1067%2Fmai.2001.119554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium</span></div><div class="casAuthors">Mullings, Rebecca E.; Wilson, Susan J.; Puddicombe, Sarah M.; Lordan, James L.; Bucchieri, Fabio; Djukanovic, Ratko; Howarth, Peter H.; Harper, Steven; Holgate, Stephen T.; Davies, Donna E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">832-838</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">Asthma is assocd. with increased prodn. of IL-4 and IL-13.  Because many of the effects of these cytokines are mediated by activation of signal transducer and activator of transcription 6 (STAT-6), we investigated expression and function of this transcription factor in the airways.  STAT-6 expression was investigated through use of immunohistochem. or RT-PCR applied to bronchial biopsy specimens or brushings from normal control or asthmatic subjects.  STAT-6 function was investigated by means of Western blotting and ELISA applied to primary epithelial cell cultures.  Immunohistochem. revealed that the bronchial epithelium was the major site of STAT-6 expression, both cytoplasmic and nuclear staining being obsd.  The level of STAT-6 expression in subjects with mild asthma (median [range] percent epithelial staining, 3.4% [0% to 16.0%]; n = 14) did not differ significantly from that in normal controls (4.7% [0.0% to 20.0%]; n = 11); however, in subjects with severe asthma, epithelial STAT-6 expression (13.7% [4.8% to 25.7%]; n = 9) was increased in comparison with subjects with mild asthma and normal controls (P < .05).  RT-PCR anal. showed that epithelial STAT-6 expression was heterogeneous and comprised both full-length STAT-6 and the dominant-neg. variant that lacks the SH2 domain.  Treatment of primary cultures of bronchial epithelial cells with IL-4 resulted in STAT-6 phosphorylation and stimulation of IL-8 secretion; however, no difference in the responses of epithelial cells was obsd. between normal (n = 12) and asthmatic (n = 14) donors.  These data demonstrate expression and activation of STAT-6 in normal and asthmatic bronchial epithelium.  The activity of this transcription factor is likely to play a key role in mediating the responses of the bronchial epithelium to TH2 cytokines that are characteristic of the asthmatic phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq76lU-gxy-3rVg90H21EOLACvtfcHk0lge5jhvcgUEmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVGlug%253D%253D&md5=96868c50b23c6578fea3f777ff295f12</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1067%2Fmai.2001.119554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmai.2001.119554%26sid%3Dliteratum%253Aachs%26aulast%3DMullings%26aufirst%3DR.%2BE.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DPuddicombe%26aufirst%3DS.%2BM.%26aulast%3DLordan%26aufirst%3DJ.%2BL.%26aulast%3DBucchieri%26aufirst%3DF.%26aulast%3DDjukanovic%26aufirst%3DR.%26aulast%3DHowarth%26aufirst%3DP.%2BH.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26atitle%3DSignal%2520transducer%2520and%2520activator%2520of%2520transcription%25206%2520%2528STAT-6%2529%2520expression%2520and%2520function%2520in%2520asthmatic%2520bronchial%2520epithelium%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2001%26volume%3D108%26spage%3D832%26epage%3D838%26doi%3D10.1067%2Fmai.2001.119554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christodoulopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemiere, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulet, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laviolette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivenstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamid, Q.</span></span> <span> </span><span class="NLM_article-title">TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">586</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1067/mai.2001.114883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1067%2Fmai.2001.114883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=11295643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1eiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2001&pages=586-591&author=P.+Christodoulopoulosauthor=L.+Cameronauthor=Y.+Nakamuraauthor=C.+Lemiereauthor=S.+Muroauthor=M.+Dugasauthor=L.+P.+Bouletauthor=M.+Lavioletteauthor=R.+Olivensteinauthor=Q.+Hamid&title=TH2+cytokine-associated+transcription+factors+in+atopic+and+nonatopic+asthma%3A+evidence+for+differential+signal+transducer+and+activator+of+transcription+6+expression&doi=10.1067%2Fmai.2001.114883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: Evidence for differential signal transducer and activator of transcription 6 expression</span></div><div class="casAuthors">Christodoulopoulos, Pota; Cameron, Lisa; Nakamura, Yutaka; Lemiere, Catherine; Muro, Shigeo; Dugas, Mario; Boulet, Louis-Philippe; Laviolette, Michel; Olivenstein, Ron; Hamid, Qutayba</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">586-591</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">The expression of IL-4 and IL-5 is increased in patients with atopic asthma compared with control subjects and correlates with indexes of pulmonary function.  In nonatopic asthma the expression of IL-4, unlike IL-5, fails to correlate with pulmonary function, and compared with their atopic counterparts, these patients have fewer cells expressing IL-4 receptor (IL-4R).  As such, a deficiency in the IL-4 signaling pathway may be implicated in nonatopic asthma.  The transcription factors GATA-3 and cMAF mediate IL-4 and IL-5 synthesis, whereas signal transducer and activator of transcription 6 (STAT-6) is crit. for IL-4R signaling.  This study examines the expression profile of these transcription factors in asthma, according to atopic status.  With immunocytochem., the expression of GATA-3, cMAF, and STAT-6 protein was detd. in sections of bronchial biopsy specimens from patients with atopic asthma, patients with nonatopic asthma, and control subjects.  Higher nos. of cells expressing GATA-3 and cMAF were obsd. in patients with atopic and those with nonatopic asthma than in control subjects and patients with tuberculosis.  There were also more STAT-6-immunoreactive cells in patients with atopic and those with nonatopic asthma than in control subjects.  Notably, however, fewer cells expressing STAT-6 protein were obsd. in nonatopic vs. atopic asthma.  These results demonstrate the upregulation of GATA-3 and cMAF in both variants of asthma and indicate that reduced IL-4R signaling, because of lower STAT-6 expression, may be a feature of nonatopic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreuRzqfJ5vlbVg90H21EOLACvtfcHk0lge5jhvcgUEmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1eiurc%253D&md5=2e4619a6f5da632f326bb2ec5cca0fce</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1067%2Fmai.2001.114883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmai.2001.114883%26sid%3Dliteratum%253Aachs%26aulast%3DChristodoulopoulos%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DL.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DLemiere%26aufirst%3DC.%26aulast%3DMuro%26aufirst%3DS.%26aulast%3DDugas%26aufirst%3DM.%26aulast%3DBoulet%26aufirst%3DL.%2BP.%26aulast%3DLaviolette%26aufirst%3DM.%26aulast%3DOlivenstein%26aufirst%3DR.%26aulast%3DHamid%26aufirst%3DQ.%26atitle%3DTH2%2520cytokine-associated%2520transcription%2520factors%2520in%2520atopic%2520and%2520nonatopic%2520asthma%253A%2520evidence%2520for%2520differential%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25206%2520expression%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2001%26volume%3D107%26spage%3D586%26epage%3D591%26doi%3D10.1067%2Fmai.2001.114883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">JAK inhibition as a therapeutic strategy for immune and inflammatory diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1038%2Fnrd.2017.201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=29104284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=843-862&author=D.+M.+Schwartzauthor=Y.+Kannoauthor=A.+Villarinoauthor=M.+Wardauthor=M.+Gadinaauthor=J.+J.+O%E2%80%99Shea&title=JAK+inhibition+as+a+therapeutic+strategy+for+immune+and+inflammatory+diseases&doi=10.1038%2Fnrd.2017.201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">JAK inhibition as a therapeutic strategy for immune and inflammatory diseases</span></div><div class="casAuthors">Schwartz, Daniella M.; Kanno, Yuka; Villarino, Alejandro; Ward, Michael; Gadina, Massimo; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">843-862</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The discovery of cytokines as key drivers of immune-mediated diseases has spurred efforts to target their assocd. signalling pathways.  Janus kinases (JAKs) are essential signalling mediators downstream of many pro-inflammatory cytokines, and small-mol. inhibitors of JAKs (jakinibs) have gained traction as safe and efficacious options for the treatment of inflammation-driven pathologies such as rheumatoid arthritis, psoriasis and inflammatory bowel disease.  Building on the clin. success of first-generation jakinibs, second-generation compds. that claim to be more selective are currently undergoing development and proceeding to clin. trials.  However, important questions remain about the advantages and limitations of improved JAK selectivity, optimal routes and dosing regimens and how best to identify patients who will benefit from jakinibs.  This Review discusses the biol. of jakinibs from a translational perspective, focusing on recent insights from clin. trials, the development of novel agents and the use of jakinibs in a spectrum of immune and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9TNpGT01l8rVg90H21EOLACvtfcHk0lge5jhvcgUEmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqsLnO&md5=4607422f83f94c0c7194935d6d460c31</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.201%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DD.%2BM.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DVillarino%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DM.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAK%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520for%2520immune%2520and%2520inflammatory%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D843%26epage%3D862%26doi%3D10.1038%2Fnrd.2017.201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K.</span></span> <span> </span><span class="NLM_article-title">Optimisation of DMPK by the inhaled route: challenges and approaches</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.2174/138920012800166571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.2174%2F138920012800166571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=22299825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=457-473&author=A.+E.+Cooperauthor=D.+Fergusonauthor=K.+Grime&title=Optimisation+of+DMPK+by+the+inhaled+route%3A+challenges+and+approaches&doi=10.2174%2F138920012800166571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Optimisation of DMPK by the inhaled route: challenges and approaches</span></div><div class="casAuthors">Cooper, Anne E.; Ferguson, Douglas; Grime, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-473</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in inhalation delivery over recent years has led to an expansion in the understanding of lung pharmacokinetics.  Historically optimization of inhaled drugs focused largely on development of material properties, consistent with achieving a good lung deposition, alongside demonstrating appropriate in vivo efficacy with little understanding of the relationship to pharmacokinetics in the lung.  Recent efforts have led to an increased understanding of lung concns. and how to maximize exposure to achieve the desired pharmacol. response at a dose consistent with development of an inhaled product.  Although there is a prerequisite for excellent potency in inhalation delivery, it is essential that this be combined with pharmacokinetic properties that allow sufficient free concn. at the effect site in lung to exert the pharmacol. response for an appropriate dosing interval.  Increases in basicity, polarity and/or decreases in aq. soly. can extend pharmacokinetic duration and assist in finding the right balance between lung and systemic exposure.  Current evidence suggests there are similarities in lung retention in rat and dog and that animal lung concn. data can enable pharmacokinetic-pharmacodynamic relationships to be derived thus providing more confidence in the requirements for man.  Although inhaled delivery is challenging from a pharmacokinetic point of view, direct evaluation of exposure in the target organ has enabled further understanding of the drivers for drug disposition and highlighted the need for further development of predictive lung pharmacokinetic tools in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxztkVtHyCeLVg90H21EOLACvtfcHk0lgInZWYIavGOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D&md5=1dec4f52aeda55fe6ea888c289216d94</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F138920012800166571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920012800166571%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DA.%2BE.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DGrime%26aufirst%3DK.%26atitle%3DOptimisation%2520of%2520DMPK%2520by%2520the%2520inhaled%2520route%253A%2520challenges%2520and%2520approaches%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2012%26volume%3D13%26spage%3D457%26epage%3D473%26doi%3D10.2174%2F138920012800166571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnstedt, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paradkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsbury, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintero, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diller, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letourneau, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riviello, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appell, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sills, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quadros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimble, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlmeyer, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, M. L.</span></span> <span> </span><span class="NLM_article-title">2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6788</span>– <span class="NLM_lpage">6792</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.09.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.bmcl.2009.09.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=19836234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6788-6792&author=A.+G.+Coleauthor=A.+C.+Bohnstedtauthor=V.+Paradkarauthor=C.+Kingsburyauthor=J.+G.+Quinteroauthor=H.+Parkauthor=Y.+Luauthor=M.+Youauthor=I.+Neaguauthor=D.+J.+Dillerauthor=J.+J.+Letourneauauthor=Y.+Shaoauthor=R.+A.+Jamesauthor=C.+M.+Rivielloauthor=K.+K.+Hoauthor=T.+H.+Linauthor=B.+Wangauthor=K.+C.+Appellauthor=M.+Sillsauthor=E.+Quadrosauthor=E.+F.+Kimbleauthor=M.+H.+Ohlmeyerauthor=M.+L.+Webb&title=2-Benzimidazolyl-9-%28chroman-4-yl%29-purinone+derivatives+as+JAK3+inhibitors&doi=10.1016%2Fj.bmcl.2009.09.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors</span></div><div class="casAuthors">Cole, Andrew G.; Bohnstedt, Adolph C.; Paradkar, Vidyadhar; Kingsbury, Celia; Quintero, Jorge G.; Park, Haengsoon; Lu, Yingchun; You, Ming; Neagu, Irina; Diller, David J.; Letourneau, Jeffrey J.; Shao, Yuefei; James, Ray A.; Riviello, Christopher M.; Ho, Koc-Kan; Lin, Tsung H.; Wang, Bojing; Appell, Kenneth C.; Sills, Matthew; Quadros, Elizabeth; Kimble, Earl F.; Ohlmeyer, Michael H. J.; Webb, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6788-6792</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel class of Janus tyrosine kinase 3 (JAK3) inhibitors based on a 2-benzimidazoylpurinone core structure is described.  Through substitution of the benzimidazoyl moiety and optimization of the N-9 substituent of the purinone, compd. 24 was identified incorporating a chroman-based functional group.  Compd. 24 shows excellent kinase activity, good oral bioavailability and demonstrates efficacy in an acute mechanistic mouse model through inhibition of interleukin-2 (IL-2) induced interferon-γ (IFN-γ) prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbMepBVB2WHrVg90H21EOLACvtfcHk0lgInZWYIavGOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGisb%252FE&md5=a72a00cbf7218fe781e6a4b760185fd1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.080%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DBohnstedt%26aufirst%3DA.%2BC.%26aulast%3DParadkar%26aufirst%3DV.%26aulast%3DKingsbury%26aufirst%3DC.%26aulast%3DQuintero%26aufirst%3DJ.%2BG.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DM.%26aulast%3DNeagu%26aufirst%3DI.%26aulast%3DDiller%26aufirst%3DD.%2BJ.%26aulast%3DLetourneau%26aufirst%3DJ.%2BJ.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DJames%26aufirst%3DR.%2BA.%26aulast%3DRiviello%26aufirst%3DC.%2BM.%26aulast%3DHo%26aufirst%3DK.%2BK.%26aulast%3DLin%26aufirst%3DT.%2BH.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DAppell%26aufirst%3DK.%2BC.%26aulast%3DSills%26aufirst%3DM.%26aulast%3DQuadros%26aufirst%3DE.%26aulast%3DKimble%26aufirst%3DE.%2BF.%26aulast%3DOhlmeyer%26aufirst%3DM.%2BH.%26aulast%3DWebb%26aufirst%3DM.%2BL.%26atitle%3D2-Benzimidazolyl-9-%2528chroman-4-yl%2529-purinone%2520derivatives%2520as%2520JAK3%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6788%26epage%3D6792%26doi%3D10.1016%2Fj.bmcl.2009.09.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, C. L.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieth, M.</span></span> <span> </span><span class="NLM_article-title">Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1549</span>– <span class="NLM_lpage">1562</span>, <span class="refDoi"> DOI: 10.1002/jcc.10306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1002%2Fjcc.10306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=12925999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFent70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=1549-1562&author=G.+Wuauthor=D.+H.+Robertsonauthor=C.+L.+Brooksauthor=M.+Vieth&title=Detailed+analysis+of+grid-based+molecular+docking%3A+A+case+study+of+CDOCKER+-+A+CHARMm-based+MD+docking+algorithm&doi=10.1002%2Fjcc.10306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm</span></div><div class="casAuthors">Wu, Guosheng; Robertson, Daniel H.; Brooks, Charles L., III; Vieth, Michal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1549-1562</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The influence of various factors on the accuracy of protein-ligand docking is examd.  The factors investigated include the role of a grid representation of protein-ligand interactions, the initial ligand conformation and orientation, the sampling rate of the energy hyper-surface, and the final minimization.  A representative docking method is used to study these factors, namely, CDOCKER, a mol. dynamics (MD) simulated-annealing-based algorithm.  A major emphasis in these studies is to compare the relative performance and accuracy of various grid-based approxns. to explicit all-atom force field calcns.  In these docking studies, the protein is kept rigid while the ligands are treated as fully flexible and a final minimization step is used to refine the docked poses.  A docking success rate of 74% is obsd. when an explicit all-atom representation of the protein (full force field) is used, while a lower accuracy of 66-76% is obsd. for grid-based methods.  All docking expts. considered a 41-member protein-ligand validation set.  A significant improvement in accuracy (76 vs. 66%) for the grid-based docking is achieved if the explicit all-atom force field is used in a final minimization step to refine the docking poses.  Statistical anal. shows that even lower-accuracy grid-based energy representations can be effectively used when followed with full force field minimization.  The results of these grid-based protocols are statistically indistinguishable from the detailed at. dockings and provide up to a sixfold redn. in computation time.  For the test case examd. here, improving the docking accuracy did not necessarily enhance the ability to est. binding affinities using the docked structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvNo4ih6vcd7Vg90H21EOLACvtfcHk0lhMJ4uqZOIaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFent70%253D&md5=34d16a1774c60ea18a5f7da58f478b71</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fjcc.10306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.10306%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DRobertson%26aufirst%3DD.%2BH.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26aulast%3DVieth%26aufirst%3DM.%26atitle%3DDetailed%2520analysis%2520of%2520grid-based%2520molecular%2520docking%253A%2520A%2520case%2520study%2520of%2520CDOCKER%2520-%2520A%2520CHARMm-based%2520MD%2520docking%2520algorithm%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2003%26volume%3D24%26spage%3D1549%26epage%3D1562%26doi%3D10.1002%2Fjcc.10306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">This series of purinone JAK inhibitors bearing an imidazo[1,2-<i>a</i>]pyridine hinge binder has been covered by the following patent application:</p></div><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, P. R.</span>; <span class="NLM_string-name">González, J.</span>; <span class="NLM_string-name">Gómez, E.</span>; <span class="NLM_string-name">Bach, J.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl Imidazolone Derivatives as JAK Inhibitors</span>. <span class="NLM_patent">WO2011/157397</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+R.+Eastwood&author=J.+Gonz%C3%A1lez&author=E.+G%C3%B3mez&author=J.+Bach&title=Heteroaryl+Imidazolone+Derivatives+as+JAK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEastwood%26aufirst%3DP.%2BR.%26atitle%3DHeteroaryl%2520Imidazolone%2520Derivatives%2520as%2520JAK%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">A similar approach using a pyrazolo[1,5-<i>a</i>]pyridine ring as hinge binder motif has been reported by Palau Pharmax:</p></div><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span>; <span class="NLM_string-name">Salas, J.</span>; <span class="NLM_string-name">Soliva, R.</span>; <span class="NLM_string-name">Rodríguez, S.</span>; <span class="NLM_string-name">Sicre, M.
C.</span></span> <span> </span><span class="NLM_article-title">N-Containing Heteroaryl Derivatives as JAK3 Kinase Inhibitors</span>. <span class="NLM_patent">WO2011/051452</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+Almansa&author=J.+Salas&author=R.+Soliva&author=S.+Rodr%C3%ADguez&author=M.%0AC.+Sicre&title=N-Containing+Heteroaryl+Derivatives+as+JAK3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DN-Containing%2520Heteroaryl%2520Derivatives%2520as%2520JAK3%2520Kinase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">After the publication of Almirall’s patent WO2011/157397, Ligand pharma also reported the use of an imidazo[1,2-a]pyridine ring as hinge binder motif for their JAK inhibitors:</p></div><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, A. G.</span>; <span class="NLM_string-name">James, R. A.</span>; <span class="NLM_string-name">Shao, Y.</span>; <span class="NLM_string-name">Letourneau, J. J.</span>; <span class="NLM_string-name">Quintero, J. G.</span>; <span class="NLM_string-name">Riviello, C. M.</span>; <span class="NLM_string-name">Zhi, L.</span></span> <span> </span><span class="NLM_article-title">Janus Kinase Inhibitor and Methods</span>. <span class="NLM_patent">WO2013/025628</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+G.+Cole&author=R.+A.+James&author=Y.+Shao&author=J.+J.+Letourneau&author=J.+G.+Quintero&author=C.+M.+Riviello&author=L.+Zhi&title=Janus+Kinase+Inhibitor+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DA.%2BG.%26atitle%3DJanus%2520Kinase%2520Inhibitor%2520and%2520Methods%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korniski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmons, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommers, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenbrink, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, T. E.</span></span> <span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.+C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6&doi=10.1016%2Fj.jmb.2010.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0lj1Z4S63SHdPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433%26doi%3D10.1016%2Fj.jmb.2010.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamert, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walden, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilks, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossjohn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucet, I. S.</span></span> <span> </span><span class="NLM_article-title">Dissecting specificity in the Janus kinases: the structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>387</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2009.01.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=10.1016%2Fj.jmb.2009.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=19361440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=219-232&author=N.+K.+Williamsauthor=R.+S.+Bamertauthor=O.+Patelauthor=C.+Wangauthor=P.+M.+Waldenauthor=A.+F.+Wilksauthor=E.+Fantinoauthor=J.+Rossjohnauthor=I.+S.+Lucet&title=Dissecting+specificity+in+the+Janus+kinases%3A+the+structures+of+JAK-specific+inhibitors+complexed+to+the+JAK1+and+JAK2+protein+tyrosine+kinase+domains&doi=10.1016%2Fj.jmb.2009.01.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains</span></div><div class="casAuthors">Williams, Neal K.; Bamert, Rebecca S.; Patel, Onisha; Wang, Christina; Walden, Patricia M.; Wilks, Andrew F.; Fantino, Emmanuelle; Rossjohn, Jamie; Lucet, Isabelle S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">219-232</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Janus kinases (JAKs) are a pivotal family of protein tyrosine kinases (PTKs) that play prominent roles in numerous cytokine signaling pathways, with aberrant JAK activity assocd. with a variety of hematopoietic malignancies, cardiovascular diseases and immune-related disorders.  Whereas the structures of the JAK2 and JAK3 PTK domains have been detd., the structure of the JAK1 PTK domain is unknown.  Here, we report the high-resoln. crystal structures of the "active form" of the JAK1 PTK domain in complex with two JAK inhibitors, a tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one (CMP6) and (3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile (CP-690,550), and compare them with the corresponding JAK2 PTK inhibitor complexes.  Both inhibitors bound in a similar manner to JAK1, namely buried deep within a constricted ATP-binding site, thereby providing a basis for the potent inhibition of JAK1.  As expected, the mode of inhibitor binding in JAK1 was very similar to that obsd. in JAK2, highlighting the challenges in developing JAK-specific inhibitors that target the ATP-binding site.  Nevertheless, differences surrounding the JAK1 and JAK2 ATP-binding sites were apparent, thereby providing a platform for the rational design of JAK2- and JAK1-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQDLkMkCgiLbVg90H21EOLACvtfcHk0lj1Z4S63SHdPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D&md5=79957755d04323057b5acf7e9d2c56ca</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DN.%2BK.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DPatel%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWalden%26aufirst%3DP.%2BM.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3DLucet%26aufirst%3DI.%2BS.%26atitle%3DDissecting%2520specificity%2520in%2520the%2520Janus%2520kinases%253A%2520the%2520structures%2520of%2520JAK-specific%2520inhibitors%2520complexed%2520to%2520the%2520JAK1%2520and%2520JAK2%2520protein%2520tyrosine%2520kinase%2520domains%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D387%26spage%3D219%26epage%3D232%26doi%3D10.1016%2Fj.jmb.2009.01.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">This screening selectivity panel was mainly formed by kinases inhibited by JAK inhibitors (29) and completed with a selection of diverse representative kinases from the whole kinome (7). Kinases inhibited by JAK inhibitors have been identified through literature analysis and internal profiling of competitors’ compounds. List of selected kinases from the kinome includes EGFR, IGF-1R, IKKα, JNK1α1, JNK2α2, MEK1 and TAK1. JAK inhibitors described in this article have shown poor activity when tested against kinases not included in this panel.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">Compound <b>34</b> was negative for genotoxicity with and without metabolic activation in the GreenScreen HC assays performed at Gentronix (highest concentration tested: 39 μg/mL). In the Ames II, Ames MPF and Ames MPF <i>E. coli</i> Combo mutagenicity assay performed at Xenometrix, <b>34</b> proved to be negative in all strains at the concentrations tested (highest concentration tested: 1581 μg/mL).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZV','PDB','6HZV'); return false;">PDB: 6HZV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZU','PDB','6HZU'); return false;">PDB: 6HZU</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00533">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_31612"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00533">10.1021/acs.jmedchem.9b00533</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00533/suppl_file/jm9b00533_si_001.csv">CSV</a>)</p></li><li><p class="inline">General chemistry and biology experimental procedures (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00533/suppl_file/jm9b00533_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00533/suppl_file/jm9b00533_si_001.csv">jm9b00533_si_001.csv (14.15 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00533/suppl_file/jm9b00533_si_002.pdf">jm9b00533_si_002.pdf (911.32 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes are the following: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZV">6HZV</a> for <b>6</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HZU">6HZU</a> for <b>34</b>. The authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00533&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00533%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-20%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00533" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a9dd5f913cfa","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
